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ABSTRACT OF THE DISSERTATION 
Design, Synthesis and Characterization of Synthetic Ion  
Receptors as Biologically Functional Ion Carriers and Channels 
 
by 
Carl Yamnitz 
 
Doctor of Philosophy in Chemistry 
Washington University, 2010 
Dr. George W. Gokel, Thesis Advisor 
 
The study of proteins and natural molecules that transport cations and anions across 
biological membranes has been a major focus of biochemistry and cellular biology for 
more than a century. The function of ion transporters is vital for all known forms of life. 
Natural and synthetic transporters can have applications as antimicrobial agents, in nerve 
impulse transduction and cell signaling. 
The current work was performed to further the understanding of a diverse array of 
novel and previously-studied synthetic molecules as membrane-active ion transporters.  
In the process, important facets such as ion binding capacity, aggregation behavior, ion 
transport functionality, and antimicrobial activity are investigated.  While these studies 
yield structural and mechanistic insights into our own research group’s synthetic systems, 
they may also aid in understanding both other synthetic ion transporters as well as natural 
ion carriers and channels.  
iii 
Among the studies that are performed, is the design, synthesis and characterization 
of members of the dipicolinic dianilide class of compounds as synthetic chloride 
channels.  In originating this project, an array of both known and novel synthetic chloride 
receptors were modeled computationally.  These compounds were selected for their 
synthetic accessibility and potential use as a chloride transporter.  While some of the 
dipicolinic dianilides or closely-related isophthalic dianilides have been previously 
reported, few have been investigated for chloride-binding activity and none for chloride 
transport activity.  Chloride binding and transport activity were correlated to the 
structural variations within the family, which entailed variation of aromatic substituents.  
This class of molecules are made in a one step synthesis from commercially-available 
materials.  Some members elicit rapid chloride transport activity (over 80% in 10 minutes 
or less) at low micromolar concentrations. At least one of these select members displays 
channel functionality in planar bilayers—one of the smallest family of compounds known 
to do so.  Molecular modeling and monitoring aggregation formation by fluorescence 
spectroscopy reveals that a stack of transporter monomers presents a geometric 
arrangement conducive of transmembrane pore formation. 
This class of compounds, among others, is investigated for antimicrobial activity in 
Gram negative E. coli. While no activity is present for these chloride transporters, co-
application with a known antimicrobial cation transporter diminishes the antimicrobial 
activity of the latter in Gram positive S. epidermidis. 
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1 
CHAPTER 1 
 
The Design, Synthesis and Characterization of Synthetic Ion 
Receptors as Biologically Functional Ion Carriers and Channels 
 
Background 
  
Life and Compartmentalization 
One of the seven pillars of life, as defined by Daniel Koshland,1 is 
compartmentalization, or the separation of the other essentials of life from its environment.  
Compartmentalization is important as it allows for the regulation of chemical 
concentrations and, by proxy, regulation of chemical reactions.  While in the simplest 
forms of cellular life, like prokaryotic bacteria, one level of compartmentalization is 
sufficient,2 in more advanced forms, this compartmentalization is further manifested in 
cellular organelles such as the nucleus and mitochondria.3  Without doubt, 
compartmentalization entails isolation, utilizing barriers to the ingress and egress of certain 
chemical species, but it cannot be fully achieved without the selective and regulated 
control of the transport of selected species.    
To use a historical metaphor, the major cities of medieval and classical Eurasia 
could almost certainly not have existed without thick walls to keep out bandits and deter 
invaders.  However, with the walls in place, there would have been no city at all without 
gates and guards to allow merchants, soldiers and citizens to pass through freely.  
 
2 
Phospholipid Membrane 
In the most common forms of life, the isolation aspect of compartmentalization is 
accomplished via cellular membranes composed mainly of phospholipids.4  Phospholipids, 
such as the dioleoylphosphatidylcholine molecule seen in Figure 1.1, are amphiphilic 
molecules with hydrophilic charged polar head-group moieties, a region of intermediate 
polarity, and long, hydrophobic acyl tails.  A phospholipid membrane is composed of two 
leaflets or layers, a characteristic that gives rise to the alternate nomenclature of 
“phospholipid bilayer.”  Within a leaflet, the polar head-group of a phospholipid is aligned 
with the polar head-groups of other directly adjacent monomers.  Likewise, the 
hydrophobic tails are in close contact with the acyl tails of adjacent monomers.4  The 
leaflets themselves are arranged in a tail-to-tail fashion with the polar head-groups of each 
layer directed out toward the polar aqueous surroundings, minimizing the exposure of non-
polar hydrophobic moieties to the polar aqueous environment.5  If this bilayer were 
extended into a spherical or other hollow 3-dimensional shape, a vesicle or compartment 
would be formed.  The end result is that a distinctly hydrophobic slab, located in the 
interior of the bilayer, separates the aqueous intracellular domain from the aqueous 
extracellular environment.   
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Figure 1.1 Cartoon representation of a phospholipid bilayer showing phospholipid 
monomers (in box) aligning tail to tail, with hydrophilic head groups exposed to the 
aqueous environment. A monomer here represents a molecule of a typical phospholipid, 
dioleoylphosphatidyl choline (DOPC). 
 
Membrane Permeability 
While lipophilic molecules can pass freely from one leaflet of the bilayer to the 
other, they cannot permeate into the aqueous surroundings.  Conversely, for all but the 
smallest uncharged molecules exhibiting a polar surface (water, molecular oxygen, etc.) or 
densely-charged surface (sodium cation, chloride anion, adenosine triphosphate), the 
energy barrier required to permeate the non-polar region of the bilayer is too high to pass 
from aqueous phase to aqueous phase without assistance.  However, these species can 
associate into the aqueous milieu as well as with the hydrophilic head-group domain of the 
phospholipid bilayer.6   A summary of these different chemical species can be seen in 
Table 1.1. 
 
 
 
4 
Type Examples Membrane Permeable? 
Non-polar hexane Yes 
Large polar glucose No 
Small polar H2O Yes 
Dense Surface Charge Na+, Cl¯, ATP4- No 
Hindered or Diffuse 
Surface Charge I¯ Yes 
Table 1.1 Summary of the permeability of chemical species through 
membranes.  
 
Concentration Gradients 
As previously stated, the impermeability of ions through the phospholipid 
membrane imparts the ability to isolate aqueous environments from one another. Thus, 
through either natural circumstances or (more often) directed effort by a cell, ion 
concentrations can vary between the extracellular matrix and the cytosol.  It is because of 
this aspect—ion homeostasis—that many cellular processes function.  The regulation of 
intra- and extracellular ion concentrations is paramount to the maintenance of a fully 
functional cell.  Undesired disruption of this regulation can cause apoptosis—programmed 
cell death—or in extreme cases, necrosis—immediate cell death.  This latter event can 
occur from disruption of osmotic balance and cytolysis, or rupturing of the cell membrane, 
as water can move freely through the phospholipid bilayer.  The general intra- and 
extracellular concentrations of common ions in mammals7 are presented in Table 1.2.  This 
relative trend in ion concentrations is seen throughout most biological systems, from 
mammals to E. coli. 
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Ion Intracellular Concentration 
Extracellular 
Concentration 
K+ 139 mM 4 mM 
Na+ 12 mM 145 mM 
Cl¯ 4 mM 116 mM 
Table 1.2 Intra- and extracellular ion concentrations of mammalian cells.7 
 
Amphiphilic Molecules 
The mixed hydrophobic-hydrophilic nature of amphiphiles theoretically allows 
them, in an aggregated state, to permeate both the hydrophobic bilayer interior as well as 
the aqueous bilayer exterior.  In aqueous milieu, the amphiphilic monomers arrange in 
such a way that their polar head-groups are directed externally into the polar aqueous 
exterior.  Hydrophobic tails are directed inward, minimizing the number and degree of 
hydrophobic-hydrophilic contacts.  Conversely, aggregates in a non-polar environment 
would be composed of polar head-groups in proximity to one another in three dimensions 
and lipophilic tails exposed to the similarly lipophilic surroundings.  However, the 
formation of either of these types of aggregates is highly dependent on the geometric 
constraints of the molecules, and not every type of amphiphile would be able to form each 
type of aggregate.8  
Either arrangement can result in (among others) flat bilayers or disks as with 
phospholipid bilayers, large hollow, spherical aggregates called vesicles or small single 
“layer” aggregates called micelles.  The occurrence of each type of aggregate depends on a 
number of factors, including shape of the monomer, monomer concentration and 
temperature.  While phospholipid membranes are themselves formed by amphiphiles, 
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many of the species that interact with them (or insert) in various ways are also 
amphiphiles.9   
 
Natural Ion Carriers and Channels 
 With a phospholipid bilayer creating an appropriate isolating structure for cells, a 
mechanism for the selective transfer of ions and molecules into and out of a cell or 
organelle completes the compartmentalization requirement of life.  Most of the larger polar 
species (sugars, membrane-impermeable proteins) pass into and out of the cell via 
endocytosis and exocytosis, respectively.  While the transport of these species is of 
extreme importance and is well-studied,10 the current work is concerned exclusively with 
the transport of ions across membranes. 
Along with endo- and exocytosis, the transport of ions across a phospholipid 
membrane might have been one of the first processes developed in the evolution of life.  In 
these early stages it is likely that a small amphiphilic molecule would bind with the ion in 
the aqueous media and ferry it through the membrane. 
As evolution progressed, these simple molecules became more elaborate and 
complex; a new mode of ion transport developed in the form of the ion channel—a 
molecule or aggregate that spanned the lipid bilayer while forming a water-filled cavity 
through which ions could pass.  Natural ion channels are amphiphilic protein molecules 
that insert into the membrane bilayer and span the distance between the separated aqueous 
domains.11  In most cases, these ion channels present an outer hydrophobic surface to the 
similarly non-polar domain of the bilayer, while forming an ion-conducting pore lined with 
polar, hydrophilic residues.12  The presence of these polar residues effectively lowers the 
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energetic barrier in the microenvironment of the pore for passage of the ion between 
aqueous domains. 
These ion channels have been perfected by eons of evolution, as by trial and error, 
the best mix of amino acids in the best positions form pores of optimal geometry with 
selectivity filters and gating mechanisms able to determine what is transported and what 
conditions would be required for transport.  Some channels evolved even further into 
pumps—structures able to actively transport ions or molecules against the concentration 
gradient.  It is with these structures that cells are able to maintain ion homeostasis and 
concentration gradients.  
 
Receptors, Carriers and Channels  
 
Carriers Versus Channels 
The carrier mechanism is often likened to a boat ferrying passengers back and forth 
across a river, while a channel is analogous to a bridge spanning the river, allowing the free 
and continuous passage of anyone wishing to cross. The metaphorical comparison extends 
to the rate of transport observed with the two separate mechanisms. An ion-carrying 
molecule first binds an ion on one side of the membrane barrier, diffuses across the 
membrane, and releases the ion on the far side of the barrier, repeating until equilibrium is 
established.  
Potassium transport by valinomycin, one of the best known ion carriers, reaches a 
level of 104 ions per second13 while a functional pore may conduct ions at a rate of 107 or 
even 108 ions per second.14 However, the size of the channel is another issue, as only a 
certain number of ions can pass a confined space at any given time.  Like a draw bridge, 
8 
the channel may open and close at intervals, with no ions or current passing across the 
barrier when the channel is closed. If two channels are open simultaneously in a cell or 
other system, the current and ion transport rate will be double that of a single channel. 
 
Synthetic Versus Natural Channels and Carriers 
The extremely large sizes of natural ion channels make them impossible to create 
without genetically-controlled biosynthesis.  Protein crystallization,13,15 sequencing16 and 
induced mutation17 has led to a wealth of discoveries about essential (conserved) residues 
and their contributions to pore,18 gate18 and selectivity filter geometries.19  However, this 
work is extremely resource-intensive and difficult to achieve.  Smaller synthetic 
compounds can offer a viable, easily-modifiable, and less resource-intensive alternative to 
research with natural ion channels.  While such complexities as true ligand gating20 (as 
opposed to pore blockage21) may be difficult or even impossible to achieve with smaller 
synthetic systems, such fundamentals as pore geometry and ion selectivity can be 
investigated.22 
The work of chemical biologists is to create and utilize synthetic, often abiotic, 
compounds to elicit a desired activity in biological or biological model systems or to 
further the understanding of those systems.  In the context of ion homeostasis and ion 
channels, a simpler synthetic molecule can yield important insights into exactly what can 
exhibit channel or carrier activity,23 what can exhibit ion selectivity24 and how channels 
can form by folding,25 aggregation,26 membrane reorganization27 or some combination of 
the three.28 
 
 
9 
Measuring Carrier and Channel Activity 
Both carriers and channels, by definition, must exhibit ion transport activity. An 
assay in a biological model system is often the first step in characterizing a molecule as 
such.  Ion transport activity can be gauged by using a variety of biophysical techniques, 
with some methods seeing more use recently.29 
An octanol/water partitioning has often been used for determining the 
hydophobicity of compounds (log P).  Octanol provides a very rough approximation of the 
polarity and character of a phospholipid bilayer.  Likewise, the partitioning of chloroform 
and water has been used in the same context to form discrete hydrophilic and hydrophobic 
layers.  The U-tube test uses a U-shaped container to separate two aqueous layers with a 
layer of chloroform at the bottom of the “U.” A salt containing the transport target ion is 
added to one of the aqueous layers along with a suspected transporter.  After gentle stirring 
of the system, the ion will be present in the second aqueous layer if a transporter is present, 
as it has been carried through the hydrophobic layer by the transporting compound.30 
While this system can impart important information, it is an extremely simplified 
version of very complex natural cell membranes that can vary significantly from species to 
species and even from cell type to cell type within the same species.  Most importantly, the 
U-tube test can only characterize a transporter as a carrier.  If a compound acts solely as a 
channel, it may not exhibit transport activity, as its ion transport dependence is based on 
insertion into a membrane and transport across a distance of roughly 30Å, not diffusion 
across a membrane.  For a better assay, a better model of a natural system is required. 
Liposomes, or phospholipid vesicles, are artificially created models of natural cells 
with an internal volume of aqueous buffer surrounded by a phospholipid bilayer.  In most 
cases, these liposomes are formed exclusively with solutions of phospholipids, but 
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different phospholipids could be used in varied proportions, and amphiphilic molecules 
such as cholesterol can also be incorporated.  After formation and purification, spherical 
liposomes of uniform size can be isolated with an internal aqueous solution that can be 
different from the external buffer.  It is with these model systems that further investigations 
can be made. 
Three common methods have been used in measuring ion transport in vesicles—
NMR,31 ion-selective electrode,32 and fluorescent reporter.33  All three methods are 
dependent on a reporter system that cannot cross the membrane and vesicles formed with 
an internal aqueous solution that is different from the external solution.  Most importantly, 
all three methods use time-dependent measurements, allowing the characterization of not 
only transport activity, but also transport rate. 
 
Receptors: Ion Recognition 
In all cases of ion transport, the transporter must interact in some way with the ion.  
Thus, many synthetic ion transporters have their roots in supramolecular chemistry and ion 
receptors.34  Most studies in the ion receptor field focus on solid-state binding geometries 
and maximizing ion-binding strength (with values usually achieved in less competitive 
non-polar solvents and counter-ions with diffuse charge densities).  However, the field of 
transmembrane ion transport is more subtle—stronger binding is not always better and 
binding geometries in the solid state do not necessarily comport with binding in solution. 
In aqueous solution, both direct transporter-ion interactions as well as indirect 
interactions via organized water molecules can occur.  While direct transporter-ion 
interactions would seem to be the preferred method of interaction energetically, this is not 
necessarily the case.  Aquated ions are surrounded by a hydration shell—a three-
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dimensional array of water molecules with dipoles oriented toward the ion.  Cations 
interact weakly with water’s oxygen lone pairs, while anions act as hydrogen bond 
acceptors for water’s protons.  While a single water-ion interaction is relatively weak, an 
entire solvation shell as a whole is held tightly to the ion.  Shedding a solvation shell or a 
part thereof can be energetically expensive.  Any favorable binding energy present with a 
direct association of a transporter is counter-acted by this energy penalty.   
Another aspect to consider is that an active transporter requires a dynamic 
interaction with the transported ion.  Exceptionally strong binding with the ion could result 
in a binding equilibrium weighted heavily toward the complex, with ion uptake occurring 
rapidly, but ion release occurring slowly.  Essentially, this would impede the passage of 
ions through the channel or preclude further uptake of ions by a carrier.  
Considering this, a compound that orders water molecules or interacts with a 
solvation sphere, rather than with the ion itself may be a more active transporter than one 
that binds the ion directly.  Therefore, while ion binding by a receptor and ion recognition 
by a transporter may be rooted in the same principles, the goals for each field are distinctly 
different when considering the design and implementation of an optimal set of compounds. 
 
Supramolecular Interactions 
 
Interactions of Receptors and Transporters with Ions 
Reversible non-covalent interactions are of paramount importance in the fields of 
both ion binding and transmembrane ion transport. Electrostatic interactions are among the 
strongest non-covalent bonds, but depend significantly on the density of charge across the 
surface of the ionic species.  More diffuse charges, such as seen with iodide anions, or 
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sterically-hindered charges lead to weaker electrostatic attractions.  A chloride anion is 
attracted more strongly to a charge-dense sodium cation than it is to a tetrabutylammonium 
cation, which does not have a directly-accessible charge.   
Solvent also has an effect on electrostatic attractions.  The dearth of strong dipole 
moments in non-polar solvents such as methylene chloride and hexanes translates to a non-
competitive environment.  Assuming that both the anion and cation are completely soluble 
in this non-polar milieu, the only significant interaction is between the two ions.  However, 
the strength of electrostatic attractions is greatly diminished in polar solvent as the dipoles 
of solvent molecules (as previously described with aquated ions) interact with the charged 
ions, forming solvation shells.   
In either polar or non-polar solvent, host-guest interactions with these charged 
species can occur, given proper host or transporter binding geometries and strengths. These 
binding interactions, however, must at least be energetically and kinetically competitive 
with the counter ion and/or solvation shell if either is displaced. Whereas in non-polar 
solvents, binding competition comes mainly from the counter-ion, contact energies with 
the counter-ion are nearly negated in polar solvents, with competition from the ion’s 
solvation sphere dominating.  
 
Membrane Insertion 
Whereas most interactions in the cytosol or aqueous cell exterior are driven by 
charge-charge, charge-dipole, or dipole-dipole contacts, the non-polar interior region of the 
membrane bilayer is characterized by moieties that are energetically driven to minimize 
contacts with polar and charged species.  Other molecules that also have hydrophobic 
substructures, such as alkyl chains or arenes with minimal dipole moments, can insert into 
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membranes.  Amphiphilic compounds must insert and interact as the surrounding 
phospholipids do, with polar or charged moieties directed outward and lipophilic residues 
directed in toward the membrane interior. 
The hydrophobic residues of a membrane monomer or other amphiphiles are not 
inherently attracted to each other as cations are attracted to anions, but water is essentially 
repulsed by them—membrane insertion is entropy driven.  No favorable hydrogen-bonding 
interactions exist between polar solvating water and non-polar substructures, so proximate 
water molecules lose the energetic advantage of full hydrogen bonding capacity.  These 
water molecules, therefore, must maximize what favorable interactions are available to 
them by forming more rigid, “ice-like” contacts with surrounding water molecules, 
exacting a high entropic penalty in the process.   When the quantity of  rigid water contacts 
is minimized, the entropic energy penalty is proportionately diminished. 
The lipophilic-lipophilic forces themselves are extremely weak, allowing free 
movement and lateral diffusion of amphiphilic and hydrophobic species laterally 
throughout the bilayer, in much the same way that charged and polar species diffuse in 
polar solvents.  Given the proper conditions, amphiphiles that insert into one leaflet of the 
bilayer can flip to the other leaflet.  Gramicidin, a well-studied natural cation transporter,35 
takes advantage of both of these characteristics in biological membranes.  In fact, channel 
functionality is elicited by two monomers in each leaflet of the bilayer, diffusing across the 
face of its respective leaflet before aligning to form a transient pore.36   
 
Self-Aggregation and Stacking 
Another important aspect of weak-force binding that needs consideration is the 
energetic favorability of receptor and transporter molecules to aggregate in solution.  
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Aggregation of amphiphilic species in polar protic solvents is driven by the same forces 
that drive membrane insertion—minimization of contacts between hydrophobic moieties 
and solvent.  In utilizing a molecule to elicit activity in a membrane, self-aggregation of 
the molecule in solution can be counterproductive.37  Molecules that favor self-aggregation 
are less likely to insert into bilayer membranes—by definition, a necessary process for 
transmembrane ion transporters.  While the compounds may be membrane active, the 
concentration required to effect the desired activity may be significantly higher for those 
that prefer self-aggregation.   
One caveat to this self-aggregation concept is when the transporter is active 
because of self-aggregation, either in solution or in the membrane.  For example, 
molecules that are too small to span the membrane bilayer as a monomer would be more 
likely to transport as a channel with increasing concentration.   
 
Measuring Supramolecular Interactions 
Both the association energies and geometries of these various supramolecular 
interactions have been studied over the past several decades.  Structural information can be 
elucidated in the solid state by X-ray diffraction of grown crystals38 or in solution by 
NMR.39  Structural information can also be accurately modeled using computational 
methods.40  This technique is extremely useful when crystals are difficult to obtain, and 
when NMR does not, or could not, yield sufficient structural information. 
Relative binding strengths can also be modeled computationally41 and can yield a 
significant amount of information relatively quickly, especially in the context of 
optimizing leads (or targets) before synthesis and experimental analysis.  Quantitative 
characterization of interaction strengths, in the form of binding or association constants, 
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can be obtained using a variety of techniques, each with differing degrees of relevance or 
usefulness depending on the studied system and information gleaned. 
For example, binding constants can be derived from the isotherms of host-guest 
titrations, monitoring the change in chemical shift (Δδ) of binding protons by 1H NMR 
spectroscopy.42  Whereas in the case of anions, a set of hydrogen-bond donors should be 
present if any interaction exists, a cationic guest would not normally elicit a strong shift (if 
any) in a neutral host molecule.  Thus, while 1H NMR binding constants would be 
beneficial in measuring anion binding, it is often useless in measuring cation binding. 
 
Summary of Dissertation Work 
 
 The following studies were performed to further the understanding of a diverse 
array of novel and previously-studied synthetic molecules as membrane-active ion 
transporters.  In the process, important facets such as ion binding capacity, aggregation 
behavior, ion transport functionality, and antimicrobial activity are investigated.  While 
these studies yield structural and mechanistic insights into our own research group’s 
synthetic systems, they may also aid in understanding both other synthetic ion transporters 
as well as natural ion carriers and channels.   
 
Chapter 2: Synthetic Anion Receptors 
After completing an in-depth review of the synthetic anion receptor literature, a 
series of known uncharged anion receptors was modeled computationally to predict 
chloride-binding strengths.  Comparison with experimentally-derived values for the known 
molecules aided in developing the calculation methods for later use with novel compounds 
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designed to be chloride hosts. 
Upon completion of the method development, the known families of molecules and 
variations thereof, as well as novel families of uncharged molecules, were modeled and 
chloride-binding strengths were calculated.  These calculations were used as a predictive 
tool for determining the best families of compounds to target and to better understand 
structure-activity relationships within a family of compounds.  Such characteristics as 
number of hydrogen bond donors, proton acidity, and receptor flexibility were judged 
based on the calculated complexation energies, host and complex electrostatic potential 
maps, and analysis of host and complex geometries.  Using the accrued data for the most 
promising candidates, targets were determined for further study based on predicted activity 
and synthetic accessibility. 
Synthetic approaches were developed for all of the compounds studied, and efforts 
were made toward some of the more promising candidates.  While one family of 
compounds (dipicolinic dianilides) is detailed in Chapter 3, the synthetic work and 
characterization for the remaining attempts are detailed in Chapter 2. 
 
Chapter 3: Synthetic Anion Carriers and Channels 
Dianilides of 2,6-pyridine dicarboxylic acid (dipicolinic acid), a family of 
compounds modeled in Chapter 2, were synthesized, characterized, and studied for carrier 
and channel activity in biological systems and biological model systems.   
The first dipicolinic dianilides were made in a two-step synthetic process with 
overall yields of 40-70% and covered a range of substituent character from the electron-
donating para-methyl substituent to the electron-withdrawing para-nitro.  Initially, the 
compounds were investigated for chloride-binding activity in the context of chloride 
17 
receptor utilization.  1H NMR binding constants were derived in both polar DMSO-d6 and 
non-polar CD2Cl2, with the titrations showing that chloride binding activity was present 
even in the polar milieu of DMSO-d6.  These results were correlated with the previous 
molecular modeling studies, as well as with competitive electrospray ionization-MS 
studies performed by collaborators.  The same trend in chloride binding strength was seen 
across the studied range of substituents: with increased substituent electron-withdrawing 
character comes increased chloride binding strength. 
While elucidation of the solid-state structures of the host-guest complexes was 
attempted, molecular modeling and experimental work involving the measurement of the 
absorption spectra with increasing concentrations of a guest salt yielded significant insights 
into both the energetics and the geometries associated with the complexation. 
Favorable chloride binding results signaled that the compounds could conceivably 
act as chloride carriers in biological model systems.  Chloride influx into phospholipid 
vesicles was studied using a chloride-quenched internal fluorophore as an indicator of 
internal chloride concentration.  Fluorescence intensity was monitored as a function of 
time, showing fluorescence quenching and, by extension, chloride transport in a dynamic 
setting.  Again, the trend followed increased chloride transport activity with increasing 
substituent electron-withdrawing character. 
The rapid chloride transport rate seen in the vesicle study suggested that a channel 
mechanism, not simply a carrier mechanism, may be present for at least some of the 
transporters studied.  As stated previously, the simplest method to distinguish between the 
two mechanisms is the measurement of conductance between two aqueous environments 
electrically isolated by a bilayer membrane.  A colleague measured the presence of this 
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electrical conductance using the planar-bilayer conductance technique. The results 
indicated channel functionality in the form of distinct open-close behavior.   
A dipicolinic dianilide transporter monomer at its widest is approximately 15Å and 
is incapable of spanning the roughly 30Å of the hydrophobic region of the bilayer 
membrane.  Thus, unable to work alone, the monomers must somehow aggregate to elicit 
the exhibited channel functionality.  Using calculated geometries of stacked molecules, 
along with the concentration-dependent fluorescence profiles of the transporters, a stacking 
interaction was posited as the mechanism of channel formation. 
 
Chapter 4: Solvent Dependence of Solid-State and Nanoscale Structure 
Supramolecular interactions, are an extremely important part of understanding the 
morphology of aggregates of compounds and predicting the possible interactions of both 
monomers and aggregates in natural systems and biological model systems.  The solvent 
environment often plays a key role in how molecules aggregate and interact with other 
species.  Potential ion transporters, which are almost exclusively amphiphiles, can and will 
form aggregates of different morphologies under different solvent conditions. 
The work detailed in this chapter seeks to bring these solvent effects on aggregate 
and crystal formation to the forefront in the context of understanding these molecules as 
potential ion transporters.  The work presented in this chapter focuses on the solid-state 
and nanoscale morphologies of pyrogallol[4]arene macrocycles with branched sidechains.  
These compounds were analyzed for solid-state or “Angstrom-scale” geometry and 
morphology by X-ray crystallography and analyzed for nanoscale geometry and 
morphology by cryogenic transmission electron microscopy (cryo-TEM). 
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Both the crystallizations and EM sample preparations were performed in various 
solvent conditions—polar, non-polar, protic, aprotic—and in mixed solvents.  While 
crystallizations were unsuccessful in many cases, EM sample preparation by slow 
evaporation generally yielded usable specimens. These specimens reveal that nanoscale 
aggregates self-assemble in polar media.  Under 50000x magnification, these aggregates 
are shown to be formed from bundles of what appear to be short nanotubes of a diameter 
congruent with measurements taken from X-ray crystal structures. 
 
Chapter 5: Biological Activity of Synthetic Ion Carriers and Channels 
As stated previously, a major goal of a chemical biologist is to elicit biological 
activity from synthetic constructs.  In this vein, assays of these constructs in biological 
model systems are cursory studies leading to investigation in biological systems.  Pore-
forming compounds, such as cation-conducting hydraphile channels,43 as well as anion-
conducting synthetic anion transporters (SATs),25a,44 and dipicolinic dianilide channels45 
have the ability to conduct their respective ions rapidly across phospholipid membranes in 
biological model systems such as vesicles and planar bilayers.  If that activity is present in 
biological systems such as bacterial and fungal cultures or human red blood cells, 
therapeutic applications might emerge. 
The first of three projects associated with this chapter is an exploration of the 
antimicrobial activity for an array of novel ion transporters. In one part of this project, the 
family of compounds, known as hydraphiles, was investigated for activity with variation of 
growth culture pH.  The subset of compounds tested had amide moieties present instead of 
amines that are generally present in the family.  Additionally, both cation and anion 
transporters as well as suspected channel formers were studied using the minimum 
20 
inhibitory concentration (MIC) method in Gram-negative Escherichia coli. Only newly-
studied members of the hydraphile family of known antimicrobial agents exhibit any 
biological activity in the studied bacterium. 
The second project details the interaction between cation and anion transporters on 
antimicrobial activity was measured in Gram-positive Staphylococcus epidermidis using a 
co-application of two such compounds and comparing growth curves.  While alone, the 
diaza-18-crown-6 sodium transporter that is studied exhibits antimicrobial activity, when 
co-applied with a dipicolinic dianilide chloride transporter these effects are completely 
negated.  
The third and final project explored the development of antimicrobial resistance in 
E. coli to synthetic cation channel with known antimicrobial activity.    The antimicrobial 
resistance was studied with regular application of sub-lethal concentrations of the 
hydraphile cation channel over 12 days.  While resistance did develop over the time period, 
it plateaued after 6 days of growth, developing no further resistance.  
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CHAPTER 2 
 
Design and Computational Investigation of Novel Synthetic 
Anion Receptors for Use as Anion Transporters 
 
Summary and Contributions to this Work 
 
The work presented in this chapter focuses on the implementation of a 
computational method to design and optimize families of molecules as potential anion 
receptors with the goal of utilizing them as transmembrane chloride transporters.  40 
potential receptors of 5 different types were modeled and studied computationally at the 
density-functional level of theory.  Structural variations within families include the number 
and type of neutral hydrogen bond donor moieties, as well as substitutions in π-systems 
that are in conjugation with the hydrogen bond donors. 
After optimization of a computational method, the investigation yielded a number 
of insights into the design of anion receptors. First, the use of urea or thiourea in the 
binding cleft can lead to a significant complexation energy advantage over carbamates or 
amides.  In practical terms, however, the solubility of these compounds may limit their use 
as receptors.  Second, larger molecules with more hydrogen bond donor moieties may not 
be advantageous when considering the design of an anion receptor or transporter. 
Intramolecular hydrogen bonds would need to be broken to and complexation with an 
anion may not be as energetically favored.  Finally, electron-withdrawing substituents in a 
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π-system including anion-binding moieties dramatically lowers the binding energy of those 
systems due to increased proton acidity.  
One family of these compounds studied, the dipicolinic dianilides, was investigated 
further.  They are shown in Chapter 3 to bind chloride in polar solvent, transport chloride 
across phospholipid vesicles, and function as a synthetic anion channel. 
I performed all of the computational work, synthesis, and characterization 
described below. 
 
Introduction 
 
The essence of supramolecular chemistry has been, from its inception, weak force 
interactions.1 While some early work was devoted to the complexation of anions,2 initial 
studies focused primarily on host-guest interactions involving neutral hosts and cationic 
guests.  The field of anion binding remained only modestly active for many years, and 
work did not gain momentum until recently.  During the past decade, however, there has 
been a burgeoning interest in both anion binding and transport.3 The anion-binding and 
anion-transport fields have found utility in applications as diverse as the detection of 
chemical weapons4 and therapeutic value in mitigating the symptomatic manifestations of 
cystic fibrosis.5 
The most common complexation mode for such anions as fluoride and chloride is 
hydrogen bonding.  Amides, ureas and thioureas, alcohols and protonated amines have all 
proven to be effective hydrogen bond donor sources for these interactions,3b although the 
latter has found more use in anion receptor studies than ion transporter studies.  A 
successful ion carrier is dependent on at least three rates: the rate of binding the ion outside 
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the cell, the rate of diffusion across the membrane into the cytosol, and the rate of 
decomplexation—solvation of the ion by cytosolic water.6  Naturally, the former and latter 
rates are inversely related, and the effectiveness of a transporting agent is held to a true 
Goldilocks standard: a carrier that binds an ion too weakly prevents any meaningful host-
guest interaction; a carrier that binds an ion too strongly will not release the ion once in the 
cytosol.  Logically, the best ion carrier is one that binds a target ion at an intermediate 
magnitude of strength, being able to both bind an ion on one side of the membrane and 
release it on the other side.   
Incorporating a moiety with a charge opposite the target ion would render a carrier 
host too strongly bound to its guest.  The carrier must be uncharged but incorporate a series 
of dipoles that favorably interact with the target ion.  After such a molecule or aggregation 
of molecules meets these criteria, it must pass the final test—permeate the lipid bilayer, ion 
in tote.  
 
Results and Discussion 
 
Families of compounds modeled 
 As mentioned previously, numerous neutral and charged anion receptors have been 
developed recently.3b  Therefore, preliminary work consisted of identifying, as fully as 
possible, the range of novel synthetic molecules already used as ion hosts, specifically 
halide anion hosts.  A development process, detailed below, followed to determine likely 
combinations of anion-complexing moieties using readily available starting materials to 
identify likely anion host targets. 
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Figure 2.1 Examples of the five categories of transporter candidates modeled. 
 
From this process, a number of candidates were determined.  The candidate field 
was winnowed down by eliminating structures that might present solubility problems, that 
could not adopt a favorable complexation geometry, or were overly-large or complex to 
target synthetically.  The final candidates, therefore, were those that were synthetically 
accessible, smaller, easier to model computationally and easily modifiable in order to 
introduce a wide variety of compounds from a core or base structure.  These candidates fell 
into one of five distinct categories (examples given in Figure 2.1): 
 
1. Dianilides of dipicolinic acid (compound 2) and of the structurally-similar 
isophthalic acid—such as those discovered by Crabtree’s group7 and championed 
by Gale and co-workers,8 
2. Highly modified peptide chains akin to our group’s SCMTR9 (16), 
3. Metal-chelating poly-acids that have been amidated to bind anions (29), 
4. Alkyl and arylureas (35), and 
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5. Macrocycles incorporating some combination of o-phenylenediamine, dipicolinic 
acid and optional amino acids (38).  
 
Dipicolinic and isophthalic diamides 
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O O
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R R
N
O O
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R R
O O
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R R
R= 1 H; 2 NO2; 3 OCH3 R= 7 H; 8 NO2; 9 OCH3
R= 4 H; 5 NO2; 6 OCH3 R= 10 H; 11 NO2; 12 OCH3  
Figure 2.2 Synthetic anion receptors formed from the coupling of dipicolinic acid or 
isophthalic acid and a substituted/unsubstituted aniline or benzylamine. 
 
Method 
Version 
Conformer 
Search 
1st Geometry 
Optimization
2nd Geometry 
Optimization 
Energy 
Calculation 
I MMFF 10 of 10000 AM1 - B3LYP 
II MMFF 10 of 10000 PM3 - B3LYP 
III MMFF 20 of 10000 RM1 B3LYP B3LYP/MP2
Table 2.1 Summary of the study methodology as developed over three versions 
  
Using the set of molecules, 1-12 seen in Figure 2.2, the methodology for the study 
was developed and perfected over three iterations, summarized in Table 2.1.  In all three 
iterations, a subset of lowest energy conformers (LECs) as determined from a set of up to 
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ten thousand conformations generated at random and energy minimized using a low cost 
molecular mechanics level of theory.  Method versions I and II found ten such LECs, while 
version III found twenty LECs.  In all three versions, the optimized geometries of these 
LECs were found using a slightly more computationally-expensive semi-empirical method 
(AM110 in version I, PM311 in version II and RM112 in version III).  Version III included a 
further geometry optimization performed at the density functional level of theory (DFT) 
using the B3LYP method13 with a 6-31G* basis set.  B3LYP combines Becke's three-
parameter function14 with the non-local correlation provided by the correlation function of 
Lee, Yang and Parr,13 and finds common usage at this level of theory.   Finally, the single-
point energy was calculated for all versions using the B3LYP method and 6-31G* basis 
set.   Version III also attempted an electron correlated Möeller-Plesset MP215 calculation 
for most molecules, but a lack of computational resources prevented this calculation from 
being performed on all but the smallest molecules and complexes.   Thus, for comparison, 
both sets of values are listed where appropriate. 
The dipicolinic and isophthalic acid-derivatized receptors 1-12 were thus evaluated 
using all three versions of methodology.  Version III’s use of a second geometry 
optimization at the density functional level of theory proved worthwhile in evaluating the 
receptors, as the calculated LEC of the semi-empirically-optimized molecules in versions I 
and II were, at times, significantly inaccurate.   The calculated complexation energies of 
receptors 1-12, using each version, are shown in Table 2.2.  Of note is the significant 
difference in the calculated energies of compounds 1, 3, and 6 from version to version, as 
well as the comparatively high calculated chloride complexation energies of the para-nitro 
compounds. 
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Diacid Amine para Substituent 
Compound 
Number 
Version I 
(kcal/mol) 
Version II 
(kcal/mol) 
Version III 
(kcal/mol) 
H 1 -43.6 -9.8 -29.8 
NO2 2 -45.8 -45.7 -50.7 Aniline 
OCH3 3 -14.7 -16.8 -32.6 
H 4 -21.9 -18.6 -27.5 
NO2 5 -44.3 -41.8 -45.6 
2,6-Pyridine 
Dicarboxylic 
Acid 
Benzylamine 
OCH3 6 -2.6 -30.4 -33.6 
H 7 -34.7 -33.2 -30.3 
NO2 8 -48.9 -49.3 -49.7 Aniline 
OCH3 9 -33.5 -31.8 -35.0 
H 10 -21.8 -34.0 -39.4 
NO2 11 -39.6 -48.7 -48.5 
Isophthalic 
Acid 
Benzylamine 
OCH3 12 -25.8 -30.2 -35.8 
Table 2.2 Calculated chloride complexation energies for compounds 1-12 as calculated by 
each previously-described method.  Of note are the inaccurate early-version calculations 
of compounds 1, 3, and 6 (italicized in gray boxes) and the comparatively high calculated 
complexation energies of the para-nitro compounds 2, 5, 8, and 11 (bolded typeface).  
 
Figure 2.3 Left: Top-down view of geometry-optimized CPK structures of receptor 1 as 
calculated by version I (top), version II (middle) and version III (bottom) of the calculation 
method. Right: Geometry-optimized CPK structures of the chloride complexes 
corresponding to the receptors on the left. 
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Using compound 1 as an illustrative example of the limits of the first and second 
calculation method version, it can be seen in Figure 2.3 that different geometry 
optimizations can yield significantly different geometries.  Superficially, the results seem 
the same, as in all cases, the receptor adopts a syn-syn conformation as a native host and an 
anti-syn conformation to bind the chloride anion guest with one amide N-H moiety.  The 
top-down view, however, allows us to see that using version I, shows a higher-energy LEC 
host in a non-planar conformation (Figure 2.3 top left)—the amides are rotated 58° from 
the plane of the central pyridine and 13° from the plane of the side arm phenyls, 
eliminating any energy advantage gained from a fully planar, fully conjugated system.  
However, in the chloride complex (top right), planarity and conjugation exist in the syn-
conforming side arm.  The chloride-binding anti-conforming side arm, however, is rotated 
by 34° away from the central pyridine plane in order to favorably complex chloride.  
The version II geometry also shows a rotation away from planarity in the native 
host, though the rotation is less extreme than its version I counterpart.  As a result, an 
energy calculation yields a lower energy than that calculated with the former version.  The 
complexing host in version II, however, shows no amide-arene planarity in either the syn 
or anti side arm resulting in a higher complex energy and a lower energy advantage for 
complexation. 
 Version III, using two sets of geometry optimizations—the final at the density 
functional level—predicts a low energy fully conjugated, fully planar conformation in the 
native host and a 18° side-arm rotation in the chloride-binding host.  The inclusion of the 
density-functional level geometry optimization is the most important step in this 3rd 
version.  Other computational studies with anion receptors have used similar procedures 
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with geometry optimization performed at the DFT level of theory,16 so its use here is 
prudent.  
The design of receptors 1-12 was based on a proposed syn-syn binding mode 
making use of both amide protons for hydrogen bonding in an “internal cavity” between 
the two side arms.  The complex LECs for all receptors with substituted side arms show 
this behavior using all calculation method versions.  However, as seen in receptor 1 as well 
as in others with unsubstituted side arms (4, 7) a one hydrogen bond syn-anti mode is 
observed in the LEC optimized geometries of the first two calculation methods.  However, 
when geometry is optimized at the density functional level of theory as with Version III, 
all of the receptors bind chloride in a syn-syn fashion.  The dianilides, specifically, bind 
chloride out of the central arene plane, requiring a rotation of the amide moieties out of this 
plane as well.   
A closer investigation of the aniline derivatives 1-3 and 7-9, show an interesting 
relationship between the inductive strength of the para substituent and the chloride binding 
strength of the amide.  This trend, is explored more fully in Chapter 3 of this work, 
including a wider breadth of substituents used.   In addition, a computational investigation 
is conducted that studies the energetic advantages and penalties for a rotation out of the 
plane of the central arene to bind chloride. 
 
Modified peptide chains 
After optimization of the energy calculation process with compounds 1-12, method 
version III was applied to the remaining receptor candidates, starting with C- and N- 
capped peptide chains.  Taking experience and expertise from our similar, already-
established SAT anion transporters,9 such a synthetic thrust, involving peptide coupling 
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and modification seemed  reasonable.  With adequate computational study, the 
groundwork could be laid to properly direct such a foray. 
The first issue studied in this category of carrier candidates was the effect of 
substituting N-terminus capping moieties.  In our SAT family of compounds, the N-termini 
of the peptide chains are capped with a diglycolic acid anhydride derivative terminated 
with a dialkylamine lipophilic membrane anchor.  The C-termini are also protected and are 
implicated in a secondary anchoring capacity.17  A new approach to these peptide chains 
would be to reverse the function of the N- and C-termini, modifying the C-terminus with a 
main hydrophobic anchoring moiety and availing the N-terminus for additional anion 
complexation. 
Structure Compound 
B3LYP 
Ecomplexation 
(kcal mol-1) 
MP2 
Ecomplexation 
(kcal mol-1) 
13 -27.3 -41.0 
14 -26.2 -42.1 
15 -40.4 -49.1 
16 -45.9 -56.0 
17 -40.4 -50.8 
Table 2.3 Structures and calculated chloride complexation energies for Ala-Ala sequence 
compounds varying the N-terminal moieties. Energies shown are calculated using the 
B3LYP or MP2 method with the 6-31G* basis set. 
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In order to study the effects of varying the N-terminus capping moiety, a simple 
alanine-alanine dipeptide chain was modeled with an ethyl amidated C-terminus and a 
variably-capped N-terminus.  Compounds 13-17 include two commonly used N-protecting 
groups, carboxybenzyl (CBZ) and tert-Butoxycarbonyl (t-BOC), a phenyl urea, a 
phenylthiourea, and a phenylthiourea with an ortho-amino substituent.  The alanine-
alanine sequence was chosen to (1) preclude any backside amino NH···carbonyl O 
hydrogen bonding in the native host, (2) introduce chirality leaving open the possibility for 
a later chirality-based complexation study, and (3) produce models that are relatively easy 
to calculate using the more stringent MP2 method.  These structures, and the calculated 
chloride complexation energies are seen in Table 2.3. 
 
 
Figure 2.4 Top: Geometry-optimized space-filling structures of ortho-amino 
phenylthiourea receptor 17 (left) and phenylthiourea receptor 16 (right).  Bottom: 
Corresponding geometry-optimized CPK structures of the chloride complexes of the 
receptors above. 
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The addition of a fourth potential hydrogen bond donor in a switch from 
carbamates in 13 and 14 to ureas in 15, 16, and 17 lends an estimated 7 kcal mol-1 energy 
advantage using the MP2 method for energy calculation.  Substituting the urea for a 
thiourea yields an additional 7 kcal mol-1 in 16.  However, the addition of an ortho amino 
substituent to the phenylthiourea cap in 17 reduces this energy advantage to one 
comparable to the urea, 15. 
As seen in Figure 2.4, this latter phenomenon may have to do with the fact that, at 
most, only 4 N-H moieties bind the chloride anion in either geometry-optimized complex.  
The extra amino substituent in 17 replaces the non-binding N-H moiety, the first alanine 
backbone N-H which is geometrically unable to bind.   
The interplay between the addition of anion-binding moieties and intramolecular hydrogen 
bonding in the host is further investigated by lengthening the peptide to 3, 4 and 5 residues.  
The urea and thiourea N-capping moieties were used in a study of the effect of peptide 
length on chloride binding. A poly-alanine peptide sequence was thus used for this study 
with extension out to 5 amino acid residues.  Further extension of the chain would have 
raised the computational costs significantly, and as the results imply (Figure 2.5), 
additional amino acid residues past three would lend no significant change in complexation 
ability.   
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Intramolecular H-
Bonds N-Terminus 
Cap 
Alanine 
Chain 
Length 
Host 
B3LYP 
Ecomplexation 
(kcal mol-1) 
MP2 
Ecomplexation 
(kcal mol-1) Host Complex 
Complex 
NHּּּCl¯ 
Contacts 
1 18 -37.1 -46.2 1 0 3 of 3 
2 15 -40.4 -49.1 1 0 4 of 4 
3 19 -50.9 - 2 0 5 of 5 
4 20 -50.6 - 3 0 5 of 6 
N H 
O 
N H 
 5 21 -51.0 - 4 3 4 of 8 
1 22 -37.8 -46.7 1 0 3 of 3 
2 16 -45.9 -56.0 1 1 3 of 4 
3 23 -55.1 - 2 1 4 of 5 
4 24 -54.8 - 3 0 5 of 6 
N H 
S 
N H
 5 25 -56.0 - 4 0 6 of 7 
 
Figure 2.5 Tabular and graphical representations of complexation energies of urea (15, 
18-21) and thiourea (16, 22-25) N-capped poly-Alanine peptides of various length.  No 
additional complexation energy advantage is expected past three alanine residues. 
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The study suggests that for simplicity’s sake (both for calculations and synthesis), a 
tripeptide is the optimal length for chloride binding via the peptide backbone.  
Intramolecular hydrogen bonding is present in the smallest native hosts (18 and 22), and 
increases proportionately with the addition of each hydrogen bond donor past a peptide 
chain length of two.  The thiourea series shows an increasing degree of chloride 
complexation with increasing length.  In the 5-mer, 6 N-H···Cl¯ contacts are present of 7 
possible.  This compares to the same urea with 4 N-H···Cl¯ contacts of 7 possible and three 
intramolecular hydrogen bonds in the host molecule.  However, a closer examination of the 
5 lowest energy conformations for these two hosts shows that in both cases, the higher 
energy conformers (+ < 1.0 kcal mol-1) have variations in the amount of intramolecular 
hydrogen bonding and chloride coordination.  The trade-off between intramolecular 
hydrogen bonds and binding to the chloride guest is roughly the same when considering 
the degree of intramolecular hydrogen bonding present in the host.   
A final computational study in this area surveyed different amino acids used in 
urea-terminated dipeptides.  Once again, the compounds are compared to 15 as a standard 
to compare across the three discrete studies performed.   As seen in Table 2.4, four amino 
acids have been studied in this capacity.  In compounds 27 and 28, two additional 
hydrogen bond donors are present in the form of the serine and threonine residue side 
chains, respectively.   Compared to host 15, which contains only 4 hydrogen bond donors 
instead of 6, the calculated chloride binding energy of 27 and 28 is 5 to 8 kcal mol-1 better.  
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Intramolecular H-
Bonds R = Amino Acid Host 
B3LYP 
Ecomplexation 
(kcal mol-1)
MP2 
Ecomplexation 
(kcal mol-1) Host Complex 
Complex 
NHּּּCl¯ 
or 
OHּּּCl¯ 
Contacts 
H Gly 26 -40.5 -47.1 1 0 4 of 4 
CH3 Ala 15 -40.4 -49.1 1 0 4 of 4 
CH2OH Ser 27 -44.7 - 1 1 5 of 6 
CH(OH)CH3 Thr 28 -47.7 - 1 1 5 of 6 
Table 2.4 Structures and calculated chloride complexation energies for dipeptide 
compounds varying the amino acid composition. Energies shown are calculated using the 
B3LYP or MP2 method with the 6-31G* basis set. 
 
Examination of the geometries of the  27·Cl¯ and 28·Cl¯ complexes reveals that 
the geometries of the host peptides are essentially identical in the complex.  Both of the 
side-chain hydroxyl moieties bind the chloride guest along with both urea N-H protons and 
the first amino acid amide proton.  The N-H proton of the second amino acid residue is 
hydrogen-bonded to the oxygen atom of the urea in both complexes. 
The diglycine compound, 26, is predicted to be as good a host as the dialanine 
compound.  When compared to the dialanine compound, 15, it can be understood that the 
presence of a methyl side-chain has no disruptive effect on the calculated binding energy.  
Analysis of the host and complex geometries of 15 and 26 shows that they nearly overlap.  
As with the other receptors modeled, the lowest energy conformer of 26 has one 
intramolecular hydrogen bond present  in the native host.  When bound to chloride, 
however, this interaction is broken in favor of a fourth interaction with the guest molecule. 
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Amides of tri- and tetraacids 
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Figure 2.6 Structures of the computationally-modeled amidated metal-chelates.  
Compounds 29-33 are triamides of nitrilotriacetic acid, while 34 is the tetraethylamide 
ethylene diamine tetracetic acid. 
 
The third category of compounds (examples seen in Figure 2.6) studied are fully-
amidated multi-carboxylates normally used for metal chelation.  One of the most well 
known of these metal chelates is EDTA, ethylenediaminetetraacetic acid.  Amidation of the 
four carboxylic acids yields a tetraamide—four covalently-bound moieties capable of 
complexing a halide anion.  When the ethyltetraamide, 34, is subjected to the established 
calculation method, a tetracomplexation conformation is lacking in the twenty lowest 
energy conformers (LECs), with only two halide-amide interactions present in the overall 
LEC (Figure 2.7).  Although other low energy conformers have three binding amide 
moieties, presumably the energy-lowering backside amide to amide intramolecular 
hydrogen bonding negates any advantage gained by extra complexing interactions. 
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Host H-Bonds Contacts in Complex 
Host Chelate Acid 
B3LYP 
Ecomplexation 
(kcal mol-1) Intra- Extra- N-H···Cl¯ N-H···O 
29 NTA -44.2 2 - 3 0 
29·29 NTA -43.8 3 2 6 0 
34 EDTA -37.2 4 - 2 2 
Table 2.5 H-bonds and complexation energies of modeled ethylamides of metal-chelating 
agents nitrilotriacetic acid (NTA) and ethylenediaminetetraacetic acid (EDTA).  29 was 
modeled as a dimeric host as well. 
 
However, computational study of a tripodal receptor candidate, 29, shows that all 
three amide N-H moieties are in close contact with the chloride anion (<2.31Å) with the 
entire complex in C3 symmetry as seen in Figure 2.8.  The clockwise or counter-clockwise 
nature of the side chains (clockwise from the anion-binding face in Figure 2.8) could mean 
induced chirality in aggregates of molecules with larger alkyl or aryl side chains.  The 
short-chained compound 29 was modeled not as a real-world synthetic target, but as a 
computationally-friendly model of such targets.  The core of the investigation of this 
family of compounds is the central amide residues retained in all variations of this family. 
With compound, 29, yielding a -44.2 kcal mol-1 complexation energy advantage, a 
synthetic targeting of this receptor type seems prudent.  Lack of similar structures used as 
anion receptors and the relative ease of synthesis (see synthetic approach, below) further 
argued for this synthetic target.  Utilization of alkylamides can aid in optimization of the 
solubility and membrane permeability of this class of compounds.  The addition of amino 
acid moieties or peptide chains with N-termini coupled to the triacids can yield additional 
structural variability. 
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Figure 2.7 (Left) Lowest energy conformer of 33 exhibiting 4 intramolecular N-H···O 
contacts (Right) Lowest energy conformer of 33-Cl¯ complex.  Two amide N-H moieties 
bind chloride with close contacts as shown in the foreground, while the remaining amide 
N-H moieties are in close contact with the carbonyl oxygen atoms of the former. 
 
Figure 2.8 Lowest energy conformer of 29-Cl- complex.  All three amide N-H moieties 
bind chloride with close contacts on the same face of the receptor as the central nitrogen 
lone pair (hidden behind the chloride ion). 
 
During modeling and geometry calculations, an idea took hold for receptor 29 (and 
by extension any similar nitrilotriacetamide) binding in a 2:1 host to guest ratio with 
chloride.  This possibility was modeled in the gas phase and the relevant host and guest 
energies were calculated.  However, the drop in the complexation energy advantage 
expected from the addition of three complexing amide N-H moieties was not seen in the 
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final energy calculations.  In fact, the energy advantage was statistically even with a slight 
drop from -44.2 kcal mol-1 to -43.8 kcal mol-1. 
 
Figure 2.9 Orthogonal views of the tube model of the lowest energy conformer of 
29·29·Cl- complex with six amide N-H moieties binding chloride with close contacts.  The 
complex has a pseudo-octahedral geometry with an extended midsection.  The angles of 
the opposite N-H vertices, passing through the guest at the center average are offset 
between 8° and 12° from linearity.  Additionally, the central nitrogen atoms are offset 11° 
from linearity through the central guest ion. 
 
The optimized LEC of the 29·29·Cl- complex (Figure 2.9) shows, as expected, both 
hosts complexing the chloride anion with a total of 6 amide N-H residues, but the N-
H···Cl¯ distances have increased from <2.31 Å to between 2.42 Å and 2.44 Å.  In contrast, 
the N-H···Cl¯ bond angles have decreased from 27° to about 24°. The marginal bond angle 
decrease (3°) paired with a significant N-H···Cl¯ contact distance increase (>0.1 Å) leads to 
no significant change if both host molecules are taken separately.  Essentially, it is the 
interactions within the host molecule dimer in the gas phase that leads to the lack of 
change in the complexation energy.  Apart from the two intramolecular hydrogen bonds 
already present in the monomer, the two remaining non-interacting moieties on each 
monomer hydrogen bond intermolecularly as seen in the center of Figure 2.10.  This gas-
phase dimerization leads to an energy difference of -22.7 kcal mol-1 in the host dimer 
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(compared to two monomers) and no net energy advantage to using a 2:1 host to guest 
complex. 
 
Figure 2.10 Tube representation of the lowest energy conformer of the 29·29 homodimer.  
Extensive hydrogen bonding (3 intramolecular and 2 intermolecular) lowers the gas phase 
energy of the host and negates any energy complexation advantage from the three 
additional amide N-H moieties in the complex seen in Figure 2.9. 
 
While the modeling of 29 as a 2:1 dimer does not yield an additional complexation 
advantage, the geometry of the complex—which fully encapsulates the guest chloride 
ion—is intriguing.  This encapsulation strategy was used in the development of cryptands 
as cation binding agents18 and synthetic cation carriers.19  The 2:1 host to guest complex 
was modeled for para-substituted trinitrilotriacetanilides 30-34.  As seen below in Figure 
2.11, The rigid tris-anilide side-arms interdigitate in the complex at interatomic distances 
as close as 3.7 Å.   In all of the complexes, six N-H···Cl¯  are present at an average H···Cl¯  
distance below 2.17 Å and a bond angle that does not exceed more than an 11° deviation 
from linearity.  This information is summarized in Table 2.6. 
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Dimeric 
Host 
para-
substituent 
B3LYP 
Ecomplexation 
(kcal mol-1) 
Average 
N-H-Cl¯ Bond 
Angle (°) 
Average   
N-H···Cl¯ 
Distance (Å) 
N-H 
Electrostatic 
 Potential 
(kcal mol-1) 
30·30 CH3 -72.7 171.6 2.163 84.2 
31·31 H -77.8 171.7 2.163 87.7 
32·32 CN -104.3 171.1 2.160 113.4 
33·33 NO2 -106.3 169.9 2.169 115.7 
Table 2.6 Summary of the calculated energies and relevant geometric measurements  of 
the para-substituted trinitrilotriacetanilides, hosts  30-34 modeled as the 2:1 dimer 
complex.  
 
Figure 2.11 Orthogonal views of the 31·31·Cl¯ complex.   
 
While the geometry of each of these complexes is essentially identical, the most 
telling aspect gleaned from the calculations is the electrostatic potential of the chloride-
binding cleft.  The electrostatic potential is the measure of attraction or repulsion of a 
positive charge on an isodensity surface.20  This potential is negative (energetically 
favored) at more electron rich regions of the molecule such as the oxygen atom of a 
ketone.  Conversely, this potential is positive (energetically disfavored) at more electron 
45 
poor regions of the molecule, such as the carbon atom of a ketone, or in the present case, 
the hydrogen atom of an amide.  This calculated prediction of localized proton acidity 
correlates well with the calculated complexation energies. 
 
Alkyl- and arylureas 
The fourth of five categories of host candidates includes the urea non-peptidic 
compounds shown in Figure 2.11.  The favorable interactions of the urea and thiourea-
capped peptides led to the idea of extending the moiety to simple non-peptidic 
compounds—a 4-nitrophenyl alkyl urea (36) and an ortho-phenylene bis(4-
nitrophenyl)urea (35).  Both compounds have been made previously, with the former 
studied for antimicrobial activity21 and the latter used as an anion binding agent.22  
NH HN
NH
OO
HNO2N NO2
35
36
O2N
H
N
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Figure 2.12 Structures of the p-NO2 urea compounds 35 and 36.  
 
Compound 35, the chloride complex of which is seen in space-filling form in 
Figure 2.13, produces the largest calculated energy advantage from a 1:1 complexation of 
all of the compounds studied with -83.6 kcal mol-1. 
Unlike the dipicolinic and isophthalic acid receptors, the geometry of the native 
host is nearly planar while, upon rotation of one of the side arms, becomes completely 
planar in the complex.  The host forms four close contacts between urea N-H moieties and 
the chloride guest.  The anion receptor cleft is in such a geometry that the N-H···Cl¯ 
Compound N-H Donor(s) 
B3LYP 
Ecomplexation 
(kcal mol-1) 
35 (2x) Urea -83.6 
36 Urea -46.5 
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hydrogen bonds are very close to linearity (169.2° and 162.9°) and in close contact (2.27Å 
and 2.32Å) with no real deviation from the lowest energy conformation of the native host.  
While Gale and co-workers have shown that this compound does bind chloride in DMSO-
d6, 22 it has a preference for trigonal planar anions.  
 
Figure 2.13 (Left)Space-filling models of the lowest energy conformers of the native host 
35  (top) and the 35-Cl¯ complex (bottom).  The chloride-bound host is in a low energy 
fully-planar and fully-conjugated system, while the host deviates by < 7° from planarity.  
(Right) Structures of the lowest energy conformers of the native host 36  (top) and the 36-
Cl¯ complex (bottom).   
 
The alkylurea compound, 36, contains only one urea moiety.  Conjugation with the 
electron-withdrawing p-NO2 substituent creates a more acidic urea moiety. The chloride 
binding moieties deviate more from linearity than the interactions seen with 35 (N-H···Cl¯ 
angles = 164.9° and 156.2°), but are in closer contact (2.13Å and 2.28Å).  Observed in the 
lowest energy conformation of the complex, hydrogen atoms of the 3-,6-, and 8- carbons of 
the octyl chain are in close contact with the chloride anion (H···Cl¯ distance = 3.02Å, 
3.33Å and 3.00Å, for the 3-, 6-, and 8- carbons, respectively).  These C-H···Cl¯ interactions 
are normally seen with aromatic carbons (the hydrogen atom ortho to the urea substituent 
in 36 is at a contact distance of 3.32Å).  The limited energy that must be associated with 
these C-H···Cl¯ interactions could be roughly equal to the energetic penalty of the 
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methylene carbons rotating out of the all-gauche conformation.  All of the twenty lowest 
energy conformers have at least one non-gauche rotation, but the second lowest energy 
conformer has only one, signifying that the all-gauche conformation is energetically 
favorable as well. 
 
Dipicolinic acid / ortho-phenylene diamine macrocycles 
The fifth and final category of candidate receptors includes macrocycles 
incorporating ortho-phenylenediamine and dipicolinic acid.  The ortho-phenylenediamine 
moiety was chosen as it presents 2 hydrogen bond donors in close proximity to one 
another, as ureas and thioureas do.  The dipicolinic acid residue was used as the lone pair 
electrons of the pyridine nitrogen can pre-organize the amide N-H moieties to interact with 
anions.  The geometry of the two components also complement each other.   
The macrocyclic compound, 37, was targeted for its structural rigidity, as pre-
organized receptors do not have significant energetic penalties associated with rotation into 
the optimal guest-binding conformation. The leftmost half of Figure 2.14 shows the 
geometry-optimized structure of the native host.  The host is held rigidly in a puckered 
geometry with two adjacent arenes related by a dihedral angle of 36°. The dihedral angle 
between ortho-phenylenediamine and each amide C-N  bond is approximately 23° while 
the dihedral angle between each C-N bond and pyridine is approximately 13.°  The 
geometry of the host in the calculated complex, however, reverses these angles, with the 
amide moiety more closely aligned with the phenylene plane rather than the pyridine plane.  
The chloride binding strength of macrocycle 37 is comparable to the other reported 
hosts.  The binding geometry is not ideal, as the average N-H···Cl¯ bond angle deviates 
approximately 22° from linearity and the average H···Cl¯ distance is 2.57Å.  The rigidity 
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and pre-organization of the host is a key aspect in explaining the favorable chloride 
complexation energies.  However, a chloride ion of a diameter of 3.56Å is too large to fit 
into the pre-organized binding cavity which is approximately 1.6Å in diameter, when 
including the van der Waals radii of the binding amide protons.  Fluoride (d = 3.02Å) may 
be a better suited guest for this receptor. 
 
Dihedral Angle 
Structure  Pyridine/ 
Amide 
Amide/ 
Phenylene 
Pyridine/ 
Phenylene 
Average 
H···Cl¯ 
Distance
Average 
N-H···Cl¯ 
Angle 
B3LYP 
Ecomplexation 
(kcal mol-1)
37 13.1° 22.7° 35.8° - - 
37·Cl 33.5° 16.1° 50.6° 2.57Å 158.1° 
-42.5 
Figure 2.14 Orthogonal views of the the lowest energy conformer of the 37 host (left) and 
the 37-Cl- complex.  “Puckering” of the ring allows for a better chloride binding geometry 
in the complex, although the hydrogen bonds deviate by about 22° from linearity. 
 
49 
Unfortunately, macrocycle 37 was reported in the literature during the initial phase 
of this investigation.23 Therefore, a second type of macrocycle was envisioned that made 
use of a repeating sequence of ortho-phenylenediamine, amino acid, dipicolinic acid, and 
amino acid.  This larger macrocycle may better complement larger anion guests with a 
more favorable binding geometry.   
This second design approach also allows for the incorporation of either D- or L-, 
hydrophobic or hydrophilic, or natural or artificial amino acids to either aid in solubility or 
anion binding or resist biodegradation. Only macrocycles incorporating four arenes and 
four amino acids were modeled and binding energies were calculated.  Any larger 
macrocycles would require greater computational and synthetic resources and were ruled 
out.  However, the macrocycles present, at a minimum, 8 hydrogen bond donors available 
for chloride complexation.  Additional binding moieties can be integrated using 
appropriate amino acids such as serine and threonine (used previously with compounds 27 
and 28) or others such as asparagine, which have two hydrogen bond donors. 
Three of the two-repeat macrocycles have been modeled and analyzed—the 
tetraglycine version, 38, the tetraserine version, 39, and the tetraasparagine version, 40, all 
seen in Figure 2.15.  The latter two were modeled with the idea in mind of increasing the 
available hydrogen-bonding moieties, and in turn increasing binding strength while the 
former gives a good reference to the effects of adding different side chains into the mix.  
Compound 40 also lends an increase in side arm flexibility (from the added length) 
resulting in a high number of low energy conformers and increasingly difficult and 
computationally-expensive geometries to optimize. 
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Figure 2.15 Structures of the tetraarene, tetraamino acid macrocycles 38-40.  In 
compound 38, an array of 8 possible hydrogen bond donors are presented while 
compounds 39 and 40 present 12 and 16 donors, respectively.  Note that the amount of 
hydrogen bond acceptors also increases from 10 for 38 to 14 for 39 and 40. 
 
Focusing the discussion on the differences between compounds 38 and 39, we can 
see in the orthogonal views of the two chloride complexes (Figure 2.16) that host 39 nearly 
encapsulates the chloride ion from the back, front, and sides.  Notably, in the front, relative 
to viewpoints on the left-hand side of Figure 2.16, the serine side chain alcohol moieties 
are binding and better encapsulating the chloride anion.  Three of the four serine side 
chains are binding the chloride anion, yet they replace the same number of amide hydrogen 
bond donors, resulting in no net gain in close contacts.  While an intramolecular hydrogen 
bond is retained in the host molecule within the complex, host 39 starts out with eight 
intramolecular hydrogen bonds in its native form and thus must sacrifice seven of them to 
bind chloride.  In contrast, host 38 only has four intramolecular hydrogen bonds to 
sacrifice and a binding event involves the same number of hydrogen bond donors.  As a 
result, host 38 has a greater net complexation energy advantage than its serine counterpart 
(see Table 2.7 for full details) 
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Figure 2.16 Orthogonal views of the CPK model of the tetraglycine compound 38, top, and 
the tetraserine compound 39, bottom. In compound 38, six of eight amide hydrogen-bond 
donors are in close contact (H···Cl¯ <2.75Å) at reasonable ion-dipole interaction angles 
(>150°).  Two hydrogen-bond donors are geometrically forbidden from anion binding. A 
noticeable exposure to the outside environment is seen in the leftmost view. This exposure 
is somewhat diminished with 39 as host molecule in which three of the amide-chloride 
interactions are replaced with three serine side chain hydroxyl-chloride interactions, 
forming a more octahedral binding domain as seen in chloride complex of the dimer of the 
nitrilotriacetamide 29.  
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Contacts in Complex Intramolecular H-Bonds
Compound Amino Acid 
Complexation 
Energy 
(kcal/mol) N-H···Cl¯ O-H···Cl¯ Host  Complex  
38 Gly -58.0 6 - 4 0 
39 Ser -50.6 3 3 8 3 
40 Asp -52.3 4 - 9 9 
Table 2.7 Comparison of compounds 38 and 39. 38 is predicted to complex chloride more 
efficiently as the incorporation of the serine alcohol side chains in 39 affords no additional 
chloride-dipole close contacts and results in the breaking of seven intramolecular 
hydrogen bonds rather than four broken in 38 to bind chloride.  Close contacts and 
hydrogen bonds are defined as those with less than or equal to a 2.75Å hydrogen-
heteroatom or hydrogen-chloride distance, the presumed bifurcated hydrogen bonds 
observed in the dipicolinic diamide system are not counted as binding with the pyridine 
nitrogen lone pair. 
 
Synthetic approaches and synthesis of selected modeled anion receptors 
The receptors outlined in this study were designed and investigated for their 
simplicity and ability to be structurally-modified.  Both of these traits are highly desirable 
in the context of new applications—the former for minimizing the use of resources and the 
latter for optimizing a desired function.  The families outlined above make use of amino 
acid residues, alkyl or aryl moieties, or some combination of the three. 
The use of alkyl substructures in a family of compounds allows for the optimization 
of solubility and membrane permeability.  Ethyl substituents were used as a stand-in for 
any length alkyl chain in the modeling studies, as this minimized computational cost.  The 
exception to this is the octyl urea compound, 36.  Utilization of substituted aryls allows for 
the optimization of the strength of chloride interaction.  Insertion of amino acids into 
receptor molecules allows for further optimization of membrane permeability and chloride-
binding characteristics with variation of the amino acid side-chains. With these key aspects 
in mind, receptors 1-40 were targeted to both allow these structural variations and 
minimize the synthetic steps (and resources used) to access these compounds. 
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With 40 proposed synthetic receptors modeled computationally, the accessibility 
for all of the families were assessed by the development of a synthetic approach for each.  
The synthesis and characterization of the dianilides 1, 2, 7 and 8, as well as similar 
compounds not enumerated here, are detailed in Chapter 3 in the context of the full 
investigation of that family of compounds for anion binding, transport and channel 
functionality. 
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Scheme 2.1 Synthesis of modified peptides 13-16.  Peptide length can be varied by the use 
of extra peptide coupling steps while different amino acids can be used at any step to vary 
the side-chains, giving access to the remainder of the modified peptides outlined above. 
“EDCI” = 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; “HOBt” =  1-
hydroxybenzotriazole. 
 
The protected peptides 13-28, are similar to the SAT molecules studied in the 
Gokel lab, and are accessed through a similar synthetic approach.  Standard solution 
coupling methods would be used to prepare these modified peptides.  Scheme 2.1 shows 
the approach used to access the N-terminal-varied dialanine compounds 13-16.  This same 
approach can be used to access the remaining protected peptides, 17-28, and peptides of 
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the same class.  This is accomplished by variation of the amino acids used or the number 
of amino acids coupled (for longer chains). 
The approach consists of first coupling the alkylamine to the C-terminus of the 
peptide, accomplished in the first step using EDCI or 1-ethyl-3-(3-dimethylaminopropyl), 
a carbodiimide amide coupling agent24 and HOBt or 1-hydroxybenzotriazole, a 
racemization suppressor. 25  
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Scheme 2.2 Synthesis of nitrilotriacetanilides 30 and 31 and the proposed approach for the 
synthesis of the N,N’,N”,N’”-alkyl tetrakis(ethylenediaminetetraacetic)acetamide, 
(modeled by 34) from the corresponding tri- or tetraacid and the appropriate equivalents 
of aniline or alkylamine. “DCC” = 1,3-dicyclohexylcarbodiimide. 
 
A coupling agent is also used in the synthesis of nitrilotriacetanilides 30 and 31 as 
shown in Scheme 2.2. DCC, or 1,3-dicyclohexylcarbodiimide, is an older variety of the 
carbodiimide family of compounds.  As no stereocenters are present in the proposed 
receptors, a racemization suppressor is not utilized in this coupling interaction.  
Unfortunately, the yields for these two compounds are relatively low, and a different 
coupling reagent or different conditions may be used to optimize the synthetic efficiency if 
future work were to progress with this type of anion receptor.  Scheme 2.2 also shows a 
synthetic approach for the tetraamides of EDTA.  This methodology can be used for 
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compounds in both classes.  The poor solubility of the tri- and tetraacids in organic solvent 
necessitates a reaction performed in an aqueous environment, and this is accomplished 
using this procedure. 
The N-(4-nitrophenyl)-N’-octylurea, 36,21 and bis(4-nitrophenyl)urea, 35,22 have 
both been made previously.  However, a synthetic method developed by Barbiou and co-
workers26 was used to synthesize these receptors as seen in Scheme 2.3. The compounds 
were made in one step from commercially available material in quantitative or near-
quantitative yields. Variation of the substituents present on the phenyl isocyanate ring can 
be used to optimize the chloride binding strengths of both 35 and 36 while variation of the 
alkylamine (R) used in the synthesis of 36 can be used to optimize solubility and 
membrane permeability of this type of receptor. 
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Scheme 2.3 Synthesis of urea 36 and bis-urea 35 from 4-nitroisocyanate. 
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Scheme 2.4 Synthetic approach to macrocycle 38 from dipicolinic acid, glycine benzyl 
ester, and 2-nitroaniline.  While the acyclic receptor 41 was accessed, the later coupling 
with 2-nitroaniline was unsuccessful. “PyBrOP” = Bromo-tris(pyrrolidino)phosphonium 
hexafluorophosphate; “DIPEA” = N,N-diisopropylethylamine. 
 
 The tetraarene / tetraamide macrocycle, 37,  has been made previously,23 along 
with a number of other similar compounds,27 so the synthetic approach to this molecule is 
not outlined here.  However, the macrocycles incorporating amino acid residues, 38-40, 
have not, to our knowledge, been made previously.  The synthetic approach to access the 
tetraglycine compound, 38, is shown above in Scheme 2.4.  The first two steps include the 
coupling of dipicolinic acid to two equivalents of C-protected glycine through formation of 
the dicarbonyl chloride to yield the acyclic bis-glycine dipicolinamide, 41.  This compound 
was studied in Chapter 5 for antimicrobial activity.   
 After hydrogenolysis of the benzyl esters, attempts were made to couple the 
resulting diacid with 2-nitroaniline.  However, the electron-withdrawing nature of this 
substituent significantly decreases the nucleophilicity of the aniline amino moiety, 
resulting in no reaction.  While the coupling reagent, bromo-tris(pyrrolidino)phosphonium 
57 
hexafluorophosphate, or PyBrOP, is shown in Scheme 2.4,  EDCI was also used 
unsuccessfully as a coupling reagent. 
 A second strategy to access this class of compounds could make use of coupling N-
protected amino acid residues to 1,2-phenylenediamine through the C-termini.  After 
deprotection, the N-termini could be coupled to a dipicolinic acid that has been 
monobenzylated.  After hydrogenolysis and a cyclization coupling step, the desired 
marocycle could be achieved.  As detailed in Chapter 3, the success of the dipicolinic 
dianilides as anion receptors and transporters precluded further synthetic exploration of the 
tetraamino acid, tetraarene macrocycle family. 
 
Conclusions 
  
This survey of a vast number of novel structures has yielded better insight into 
which anion-binding moieties and how many should be used in a successful anion 
receptor.  Modeling of the N-capped peptides has shown that the use of urea and especially 
thiourea in the binding cleft can lead to a significant complexation energy advantage over 
carbamates or amides.   
The lengthening N-capped peptides, nitrilotriacetamide dimers, and the tetraamino 
acid tetraarene macrocycles has shown that larger, more complex molecules with more 
hydrogen bond donor moieties may not be advantageous when considering the design of an 
anion receptor or transporter.  Utilization of amides or ureas as hydrogen bond donors in a 
binding motif also presents hydrogen bond acceptors in the native host.  If a significant 
amount of intramolecular hydrogen bonding exists in the host because of this, then 
intramolecular host hydrogen bond would need to be broken and complexation may not be 
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as energetically favored as one would anticipate.  The best approach, therefore, would be 
one that considers just a few amide or urea residues rather than many.    
Modeling of the 2:1 host to guest complexes of 4,4’,4’’-substituted 
nitrilotriacetanilides and chloride has shown that that electron withdrawing substituents in 
a π-system including anion-binding moieties dramatically lowers the binding energy.  
Correlation with the calculated electrostatic potential maps reveals that this is caused by 
increasing proton acidity.  This characteristic is exploited more fully in the investigation of 
the dipicolinic dianilide chloride transporters in Chapter 3. 
These calculations give good predictions of actual molecules, yielding insight into 
what substructures should be incorporated and how variations of those structures can 
optimize the desired activity.  However, once a family is designed and leads are made, they 
must be correlated with experimental data to truly yield relevant information.  The 
calculations performed for the dipicolinic dianilides are further expanded upon in Chapter 
3 leading to work done with these compounds as synthetic ion channels.  A few of the 
other compounds modeled in this survey are approached synthetically, and the resulting 
compounds are tested for antimicrobial activity as detailed in Chapter 5.    
 
Experimental  
 
General.   
Reagents were the best (non-LC) grade commercially available and were distilled, 
recrystallized or used without further purification, as appropriate. CH2Cl2 was distilled 
from calcium hydride. Unless otherwise stated, all chemicals were purchased from Sigma-
Aldrich (St. Louis, MO).   
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Melting points were determined on a Thomas Hoover apparatus in open capillaries 
and are uncorrected. All 1H NMR spectra were recorded on a Bruker Avance 300 
spectrometer at 300 MHz and all chemical shifts are reported in ppm (δ), calibrated to 
literature values for internal solvent with integrated intensity (X H) and multiplicity (b = 
broad, s = singlet, d = doublet, t = triplet, q = quartet, bs = broad singlet, m = multiplet, 
etc.) and coupling constants in Hz.  13C-NMR spectra were obtained on a Bruker Avance 
300 spectrometer at 75.4 MHz and referenced to solvent literature values for chemical 
shifts. All Mass Spectrometry experiments were performed at high resolution on a JEOL 
MStation, JMS-700, double focusing high-resolution instrument using the fast-atom 
bombardment ionization technique in the positive ion detection mode.  Calculations were 
run using the Spartan 2006 software package on a Dell Dimension DXP061 desktop with a 
2.40GHz Intel® Core™2 Processor and 2.00GB of RAM.   
 
 
Molecular Modeling 
The following calculation method is the third such version as described in this 
method.  All calculations and visualizations are performed using Spartan ’06 software from 
Wavefunction Inc.  The Monte Carlo simulated annealing method was used to determine 
the twenty lowest energy conformations (LECs) from ten thousand conformations using 
the Merck Molecular Force Field, a molecular mechanics level of theory.  In some cases, 
fewer than twenty LECs are generated when conformational flexibility is limited. The 
geometry of these twenty LECs were then optimized first using the RM1 semi-empirical 
method and then at the density functional level of theory using the B3LYP method with a 
6-31G* basis set.  The final  single point, ground state energy calculations and electrostatic 
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potential mapping were performed with the B3LYP method and the 6-31G* basis set.  For 
a specific set of final energy calculations, the electron-correlating MP2 method was used. 
In every case, the conformer with the lowest calculated single point energy was 
used for the calculation of the complexation energy.  This calculation was performed by 
adding the energies of the host and guest, then subtracting the energy of the complex.  The 
complexation energy is listed as a negative value if the interaction is favorable, the more 
negative a value the more favorable an interaction. 
 
N,N’,N’’-tris(phenyl)nitrilotriacetamide, 31 
This compound was made previously by Greco and Schrock28 as an intermediate 
for a metal coordination complex.  The synthetic procedure from that work was used here.  
No melting point was reported, but the spectral data agrees with what was determined 
previously.  
 Aniline (1.84 g, 19.8 mmol) was added to a stirring suspension of nitrilotriacetic 
acid (1.25g, 6.5 mmol) in water (14.0 mL) and stirred until a solution is formed (complete 
proton exchange forming the salt).  To this solution is added a solution of 1,3-
dicyclohexylcarbodiimide (4.10 g, 19.9 mmol) in tetrahydrofuran (21.0 mL).  The reaction 
was stirred under N2 overnight. The resulting suspension was filtered over a glass frit, 
retaining the crude product as a white solid.  This was suspended and filtered with 
methanol (3x15mL) and diethyl ether (3x15 mL).  The white solid was suspended in 
dimethylformamide (4x25mL) and filtered over a glass frit, with the filtrate reduced in 
vacuo to yield an off-white solid.  This was suspended in a 2:1 mixture of diethyl ether and 
chloroform (50 mL) before filtering, retaining the white solid. Trace solvent was removed 
in vacuo to yield the pure product as a white solid (0.421 g, 16%, m.p. = 217°-220°C).  1H-
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NMR (DMSO-d6): 3.67 (6H, s, NCH2C(O)), 7.06 (3H, t, J = 7.3 Hz, Anil 4-H), 7.33 (6H, 
dd, J1 = 8.0 Hz, J2 = 7.3 Hz Anil 3/5-H), 7.66 (6H, d, J = 8.0 Hz, Anil 2/6-H), 10.47 (3H, 
s, C(O)NH-Anil).13C-NMR (DMSO-d6): 58.9  (NCH2C(O)), 119.4 (Anil 2/6-C), 123.7 
(Anil 4-C), 129.2 (Anil 3/5-C), 139.2 (Anil 1-C), 170.4 (CH2C(O)NH). FAB-MS: m/z calc 
for [M+H]+  417.1926, found: 417.1926. 
 
N,N’,N’’-tris(4-methylphenyl)nitrilotriacetamide, 30 
The synthetic method for of this compound is similar to that used for N,N’,N’’-
tris(phenyl)nitrilotriacetamide, above, using an approach developed by Greco and 
Schrock.28 p-Toluidine (2.18 g, 20.3 mmol) was added to a stirring suspension of 
nitrilotriacetic acid (1.28g, 6.7 mmol) in water (25.0 mL), heated to 58°C  and stirred until 
a solution is formed. To this solution is added a solution of 1,3-dicyclohexylcarbodiimide 
(4.21 g, 20.4 mmol) in tetrahydrofuran (15.0 mL).  The reaction was stirred under N2 
overnight. The remaining work-up is identical to above. Trace solvent was removed in 
vacuo to yield the pure product as a white solid (0.562 g, 18%, m.p. = 216°-218°C).  1H-
NMR (DMSO-d6): 2.25 (9H, s, Anil-CH3), 3.63 (6H, s, NCH2C(O)), 7.12 (6H, d, J = 8.3 
Hz, Anil 3/5-H), 7.53 (6H, d, J = 8.3 Hz, Anil 2/6-H), 10.21 (3H, s, C(O)NH-Anil).13C-
NMR (DMSO-d6): 20.4 (Anil CH3), 58.5  (NCH2C(O)), 119.1 (Anil 2/6-C), 129.1 (Anil 
3/5-C), 132.2 (Anil 4-C), 136.3 (Anil 1-C), 169.7 (CH2C(O)NH). FAB-MS: m/z calc for 
[M+H]+ 459.2396, found: 459.2379. 
 
N,N’-(1,2-Phenylene)bis([4-Nitrophenyl]urea), 35 
This compound was made previously by Gale and co-workers22 as a carboxylate 
receptor.  No melting point was reported, but the spectral data agree with what was 
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determined previously.   A synthetic procedure derived from the work of Barbiou and co-
workers26 was used. 
A solution of 1,2-phenylenediamine (0.2880g, 2.66 mmol) in acetonitrile (20 mL) 
is added dropwise to a stirring solution of 4-nitrophenylisocyanate (1.0163 g, 6.19 mmol) 
dissolved in acetonitrile (50 mL for 70 mL total).  The reaction was heated to reflux and 
stirred for 5 hours. After cooling, the resulting yellow suspension was filtered and washed 
with acetonitrile (1 x 10 mL) and dichloromethane (2 x 10 mL) before drying under high 
vacuum.  The resulting yellow solid is retained as the pure product (1.1088 g, 95%, m.p. = 
293°-297°C).  1H-NMR (DMSO-d6): 7.19 (2H, m, o-Phen 4/5-H), 7.71 (2H, m, o-Phen 
3/6-H), 7.78 (4H, d, J = 9.2 Hz, Isocyan 3/5-H), 8.19 (4H, d, J = 9.2 Hz, Isocyan 2/6-H), 
8.83 (2H, bs, Urea N-H), 9.32 (2H, bs, Urea N-H). 
 
N-(4-Nitrophenyl)-N’-octylurea, 36 
This compound was made previously by Micich.21 The observed melting point 
agrees with the literature value.  A synthetic procedure derived from the work of Barbiou 
and co-workers26 was used. 
A solution of octylamine (0.32g, 2.5 mmol) in acetonitrile (10 mL) is added 
dropwise to a stirring solution of 4-nitrophenylisocyanate (0.30 g, 1.8 mmol) dissolved in 
acetonitrile (10 mL for 20 mL total).  The reaction was heated to reflux and stirred for 5 
hours. After cooling, the resulting yellow suspension was filtered and washed with 
dichloromethane (2 x 10 mL) before drying under high vacuum.  The resulting yellow-
orange solid is retained as the pure product (0.53 g, 97%, m.p. = 110°-113°C, Lit.21 = 
113°-114°C).  1H-NMR (DMSO-d6): 0.86 (3H, t, -CH3), 1.25-1.28 (10H, pseudo-s, 
CH2CH2CH2), 1.55 (2H, m, -CH2CH3), 3.47 (2H, bdt, J = 5.7 Hz, NHCH2CH2), 7.84 (2H, 
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d, J = 9.2 Hz, Isocyan 3/5-H), 8.16 (2H, d, J = 9.2 Hz, Isocyan 2/6-H), 8.38 (1H, bt, 
NHC(O)NHCH2), 10.21 (1H, bs, ArNHC(O)NH). 13C-MR (DMSO-d6): 14.0 (CH2CH3), 
22.1 (CH2CH2CH3), 26.5 + 28.1 + 28.7 + 28.7 + 31.3 (CH2CH2CH2), 43.9 (NHCH2CH2), 
120.2 (Isocyan 2/6-C), 124.5 (Isocyan 3/5-C), 141.9 (Isocyan 4-C), 147.1 (Isocyan 1-C), 
179.9 (NHC(O)NH). 
 
N2,N6-bis(glycine benzyl ester)pyridine-2,6-dicarboxamide, 41 
2,6-pyridinedicarbonyldichloride (3.24 g, 15.88 mmol) was dissolved in 
dichloromethane (40 mL) and was added dropwise to a stirring solution of the tosyl salt of 
glycine benzyl ester  (12.81 g, 37.8 mmol) and triethylamine (20.0 mL, 143.6 mmol) in 
dichloromethane (60 mL additional for 100 mL total) held at 0°C in an ice bath.  Upon 
completion of the addition, the system was returned to room temperature and stirred for 4 
hours. The reaction was quenched with the addition of 100 mL of 5% (w/w) ammonium 
chloride in water.  The organic layer was washed with 5% sodium carbonate (2 x 50 mL) 
and water (2 x 25 mL), dried over magnesium sulfate and filtered before removing solvent 
in vacuo to yield the crude product as a dark red oil.  The crude was chromatographed over 
silica with 1:1 hexane to ethyl acetate  ethyl acetate  methanol to yield the pure 
product as a light orange oil (7.18 g, 73%, oil).  1H-NMR (CDCl3): 5.18 (4H, s, OCH2Ar), 
4.16 (4H, d, J = 5.9 Hz, NHCH2C(O)), 7.29-7.37 (10H, m, Bn-H)  7.89 (1H, t, J = 7.8 Hz, 
Pyr 4-H), 8.16 (2H, d, J = 7.8 Hz, Pyr 3/5-H), 8.43 (2H, bt, J = 5.8 Hz, C(O)NHCH2). 13C-
NMR (CDCl3): 41.7 (NHCH2C(O)), 67.6 (OCH2Ar), 125.4 (Pyr 3/5-C), 128.7 + 128.9 + 
129.1 (Bn 2/3/4/5/6-C), 136.0 (Pyr 4-C), 139.4 (Bn 1-C), 148.5  (Pyr 2/6-C), 164.1 (Pyr-
COCH2), 171.0 (CH2C(O)O). FAB-MS: m/z calc for [M+H]+ 462.1665, found: 462.1658.  
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CHAPTER 3 
Chloride Binding, Transport, and Channel Functionality of   
Dianilides of Dipicolinic Acid and Isophthalic Acid  
 
Summary and Contributions to this Work 
 
Dianilides of 2,6-pyridine dicarboxylic acid (dipicolinic acid), a family of 
compounds modeled in Chapter 2, were synthesized, characterized, and studied for carrier 
and channel activity in biological systems and biological model systems.   
The first dipicolinic dianilides were made in a two-step synthetic process with 
overall yields of 40-70% and covered a range of substituent character from the electron-
donating para-methyl substituent to the electron-withdrawing para-nitro.  Initially, the 
compounds were investigated for chloride-binding activity in the context of chloride 
receptor utilization.  1H NMR binding constants were derived in both polar DMSO-d6 and 
non-polar CD2Cl2, with the titrations showing that chloride binding activity was present 
even in the polar milieu of DMSO-d6.  These results were correlated with the previous 
molecular modeling studies, as well as with competitive electrospray ionization-mass 
spectrometry studies performed by collaborators.  Amide proton acidity and chloride 
binding strength both increase with increasing anilide substituent electron-withdrawing 
character. 
A fluorescence-quenching assay was used to monitor chloride influx mediated by 
this series of compounds into phospholipid vesicles over time.  These studies show that 
dianilides with more acidic protons attain approximately 80% of chloride transport, while 
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those with less acidic protons elicit approximately 20% of chloride transport.  In both 
cases, the maximal chloride transport is achieved within 600 s of application.    
Using the planar bilayer conductance technique, a collaborator, Saeedeh Negin, 
confirmed channel functionality, showing that one of the highly-active chloride 
transporters exhibits classic open-close behavior. A dipicolinic dianilide transporter 
monomer at its widest is approximately 15Å and is incapable of spanning the roughly 30Å 
of the hydrophobic region of the bilayer membrane.  Thus, unable to work alone, the 
monomers must somehow aggregate to elicit the exhibited channel functionality.  Using 
calculated geometries of stacked molecules, along with the concentration-dependent 
fluorescence profiles of the transporters, a stacking interaction was posited as the 
mechanism of channel formation. 
I performed all calculations, syntheses and characterization, proton NMR binding 
studies, chloride transport studies, and optical spectroscopy detailed here.  A fellow Gokel 
research group member, Alex Carasel of Washington University, along with Joseph 
Kramer and Dr. Rudolph Winter of the University of Missouri-St. Louis, performed the 
electrospray-ionization mass spectrometry studies.  Saeedeh Negin, another member of the 
Gokel research group and a graduate student at the University of Missouri-St. Louis, 
performed the planar bilayer studies.  
A portion of this work is included in a paper published in Chemical 
Communications in 2010. 1 
 
Introduction 
 
The transport of anions is limited by the same constraints that are common to all 
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transport processes.2 Similar to the demands of ion receptors, selectivity is dictated by a 
binding or complexation interaction. These complexation forces must be strong enough so 
that recognition can occur but, unlike receptors, weak enough to maintain a dynamic 
system in order to effect transport.  Once this dynamic characteristic is established, a 
successful transporter may elicit functionality through one of two mechanisms—carrier or 
channel.  
The carrier mechanism is often likened to a boat ferrying passengers back and forth 
across a river, while a channel is analogous to a bridge spanning the river, allowing the free 
and continuous passage of anyone wishing to cross. The metaphorical comparison extends 
to the rate of transport observed with the two separate mechanisms. An ion-carrier 
molecule first binds an ion on one side of the membrane barrier, diffuses across the 
membrane, and releases the ion on the far side of the barrier, repeating until equilibrium is 
established. Potassium transport by valinomycin, one of the best known ion carriers, 
reaches a level of 104 ions per second3 while a functional pore such as gramicidin may 
conduct ions at a rate of 108 or even 109 ions per second.4  
The roughly thousand-fold difference in transport rate is attributable to the rate-
limiting diffusion process required of a carrier.5  Since a protein channel, at the very least, 
spans the width of the hydrophobic bilayer domain, no diffusion is required for the channel 
to elicit transport activity.  
However, the size of the channel is another issue, as only a certain number of ions 
can pass a confined space at any given time. Like a draw bridge, the channel may open and 
close at intervals, with no ions or current passing across the barrier when the channel is 
closed. If two channels are open simultaneously, the current will be double that of a single 
channel. 
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Many of the particulars of binding interactions for various anion hosts have been 
obtained from binding constant determinations and X-ray crystal structure studies.6 While 
the latter can yield valuable insights into static binding arrangements, the geometries and 
stabilizing interactions of the solid-state may be altered in the presence of solvent 
molecules.  Binding constants can gauge the strength of the interactions in solution, but ion 
transport is a dynamic process that cannot truly be verified without the use of dynamic 
tools in biological model systems.   
Several techniques have been developed over the past decades to assess ion 
transport functionality.  These methods range from the U-tube technique using a water-
organic partitioning to gauge carrier functionality7 to vesicle-based systems that monitor 
intra- or extravesicular ion concentration levels.8   
The complexation of anions was explored nearly concurrently with the 
development of cation complexation by crown ethers.9 Examples include studies reported 
by Simmons,10 Schmidtchen,11 Lehn,12 de Mendoza,13 Newcomb,14 and others.6 Great 
interest and activity in this area burgeoned only recently, however. By far, the most 
common complexation mode for such anions as fluoride and chloride has been hydrogen 
bonding, particularly by amides or protonated amines. Characterization of anion complexes 
has often been accomplished by X-ray crystallographic methods, although solution 
studies15 and much more rarely, dynamic transport studies16 have also been reported.  
In 1999, Crabtree and coworkers reported a much emulated isophthalic acid 
dianilide anion host.17  This isophthalic dianilide bound Br¯ in the solid state and Cl¯ in 
CHCl3 solution. Since these first reports, the family of studied isophthalic acid dianilides 
has been greatly expanded by Gale and coworkers,18 the receptor has been incorporated as 
an anion-binding subunit into ion-pair hosts,19 while isophthalamides have been reported 
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that replace the aniline subunit with other aromatics such as aminoindoles20 or with 
alkylamines.16e Numerous pyridine-2,6-dicarboxylic acid dianilides are known as well 
although most were prepared for study in a context other than anion complexation.21 
Dipicolinamides have been incorporated as subunits into structures such as Lehn's helices22 
and Anslyn's cyclophane receptor for trigonal planar anions.23  
For a potential new chloride channel or carrier to transport its quarry, either must 
recognize and bind chloride or at least organize solvent molecules to indirectly bind the 
anion.  For the most part, compounds that are thought to form channels or pores are of a 
length at sufficient to penetrate a single leaflet of a bilayer membrane, while most span 
both leaflets of the bilayer.  An exception exists in the system developed by Sakai, Matile 
and coworkers that appears to stack dendritic folate rosettes within the bilayer.24 Using 
planar bilayer conductance studies, transport of various cations was demonstrated for this 
assembly. The arrangement of multiple individual elements in an organized membrane-
spanning stack seems unlikely from an energetic point of view but essential in the light of 
the experimental evidence. That transport occurs is unequivocal, so some type of organized 
assembly that mediates transport must form.  
While several synthetic chloride ion channels have been prepared,25 only one 
example of channel function by an isophthalamide, and none by a dipicolinamide, has 
appeared before completion of the current work.1  Li et al. showed that a bis(α-
aminoxyamide) derivative of isophthalic acid can form Cl¯-conducting channels in 
phospholipid bilayers.26  This is remarkable because the isophthalamides are small 
molecules that seem incapable of spanning a bilayer membrane and would require both 
aggregation and organization to function as a channel. Li et al. have offered no structural 
suggestion to account for pore formation.  
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Recent work published by Yang and co-workers26b has expanded upon the 
biological and biophysical effects of their chloride channels in living cells, but have yet to 
offer an explanation for the mechanism of chloride channel formation. The goals of this 
study of the dipicolinic dianilides were therefore twofold: to compare the chloride-binding 
abilities of these dipicolinamide compounds, and to determine the efficacy and mechanism 
of chloride transport activity.  
 
Results and Discussion 
 
Compounds prepared for the current study 
Compounds 1-4, 7 and 8 were prepared as outlined in Scheme 3.1 by converting 
2,6-pyridinedicarboxylic acid into the corresponding dichloride using SOCl2, followed by 
coupling with two equivalents of amine in the presence of triethylamine.27 Compounds 9-
12 were prepared in one step from the commercially-available 2,6-pyridinedicarbonyl 
dichloride. The well known isophthalamide, 5,17b was used as a control in the ion-binding 
studies.  Previously-unstudied 628 was prepared as a comparison to the deeply-investigated 
compound 4.  Both of these compounds were prepared in one step from commercially-
available isophthaloyl dichloride. All products were characterized by 1H- and 13C-NMR 
and mass spectrometry.  Structural data were as expected, and agreed with published 
values where available. 
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Compound Y = X = Yield m.p. (°C) 
1 N: 4-CH3 42% 223-224 
2 N: H 86% 277-278 
3 N: 4-CN 34% 304-306 
4 N: 4-NO2 52% > 330 
5 CH H 67% 291-294 
6 CH 4-NO2 40% > 330 
7 N: 4-NHC(O)CH3 72% 195-196 
8 N: 4-C(O)CH3 76% >330 
9 N: 3- CH3 78% 211-214 
10 N: 3-CN 37% 260-261 
11 N: 3- CF3 41% 288-291 
12 N: 3-Cl 70% 245-247 
Scheme 3.1. Synthesis of compounds 1-12 with yields reported over one or two steps as 
appropriate.  Compounds 5, 6, and 9-12 were made in one step from the appropriate 
commercially-available dicarbonyl chloride.  Compounds 1-4 and 7-8 were made in two 
steps. 
 
Comparison of calculated and solid state structures 
Much of the work with dipicolinamides and isophthalamides has focused on solid-
state structures and anion binding.  Accordingly, there are a number of crystal structures 
and binding constants of these hosts or closely related molecules available in the literature.  
To give us a sense of chloride-binding strength we can model these hosts and their 
complexes and calculate their associated energies (see the “Calculated gas-phase chloride-
binding energies” section below), but the structures themselves yield insights into host and 
complex geometries outside of the solid-state and the influence of crystal-packing forces.  
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Comparison of solid-state and calculated gas-phase structures, therefore, seemed a 
necessary step in developing of our binding models. 
Figure 3.1 shows calculated gas-phase structures for the related isophthalic and 2,6-
dipicolinic acid dianilides. The geometries of the unbound host molecules are significantly 
different from one another. The dipicolinamide adopts a syn-syn conformation of side-
arms, with amide protons directed inward, while the isophthalamide host adopts a syn-anti 
side-arm conformation with only one amide proton directed inward. All of the dipicolinic 
dianilide hosts were calculated to be planar in their unbound forms, maintaining an 
extended conjugated π-system while minimizing molecular dipoles. The pyridyl lone pair 
offers little or no steric hindrance of the type the 2-hydrogen does in isophthalic acid.  
While the solid-state structure of the 4-CH3 isophthalamide (CSD:ATIQAV) reported by 
Nimmanpipug et al.29 confirms this syn-anti conformation, the unsubstituted 
isophthalamide (CSD: PULHUZ)27b adopts the syn-syn conformation seen in the calculated 
gas-phase and experimental solid-state structures of dipicolinamides. This difference may 
be attributable to a more favorable crystal packing geometry arising from the syn-syn 
conformation. 
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Figure 3.1. Structural comparison of dianilides of isophthalic acid (left) and dipicolinic 
acid. Space filling models are of the DFT energy-minimized conformer of the unsubstituted 
dianilides 
 
Figure 3.2.Orthogonal depictions of the solid-state structure of the DMSO pseudo-
polymorph of 4, as determined by X-ray analysis. 
 
Solid-state structures of 1 (CSD: RABZUK),30 2 (CSD: PULJAH), 27b and of 4 have 
previously been reported. The latter was crystallized by Yin et al.31 from several different 
solvents but not in the presence of Cl¯. The study rather described the formation of 
pseudo-polymorphs in which 4 was solvated by DMSO (CSD: NEDSAR), DMF (CSD: 
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NEDRUK), or MeCN (CSD: NEDROE). In that work, the oxygen atom of a single DMSO 
molecule in 4DMSO was coordinated to the amide hydrogen atoms of the dipicolinamide.  
Along with the original report by Kavalleratos et al. of the isophthalamideBr¯ 
complex,17b structures have been reported by Gale and coworkers32 of compounds related 
to 4, namely N1,N3-bis(3-nitrophenyl)isophthalamide co-crystallized with Bu4NPF6 (CSD: 
QAGFAG) and N1,N3-bis(3,5-dinitrophenyl)isophthalamide with Bu4NF (CSD: 
QAGFEK).  The existence of these structures led to our desire to deduce a complex of the 
more biologically-relevant chloride ion with receptor 4. Numerous attempts to co-
crystallize 4 as a chloride complex (in DMSO with NBu4Cl or NaCl) afforded only the 
uncomplexed receptor.  Therefore, the previously published structure with DMSO (CSD: 
NEDSAR)31 was compared with the calculated host 4 geometry. No direct solid-state 
comparison could be made with the calculated 4 Cl¯ complex. 
 
Figure 3.3. (A) Solid state structure of 4 viewed from above, derived from the work of Yin 
et al.31  The top molecule is represented as sticks and the lower in the space-filling 
metaphor. The two molecules are offset by ~60o and the interplanar distance is ~3.4 Å. (B) 
The gas-phase calculated electrostatic potential map (DFT/B3LYP/6-31G*) of receptor 4 
with a capped-stick structural overlay depicting the underlying geometry.  The more 
electronegative portions (amide and nitro oxygen atoms) are shown in red on the map with 
the electropositive chloride-binding cleft (amide protons) shown in darker blue.  Regions 
of intermediate potential are shown spanning the spectrum from red to blue. 
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Of particular interest is the orientation of the adjacent (i.e. stacked) molecules of 4. 
The left panel of Figure 3.3, derived from the crystal structure of 4 by Yin et al.31 shows 
that two receptors in the unit cell are stacked at van der Waals distances (~3.4 Å) and 
rotated by ~60o with respect to one another. The DMSO molecules have been omitted for 
clarity. The right panel of Figure 3.3 shows the calculated electrostatic potential map for 4. 
The color scale runs from blue (most positive) to red (most negative). Four areas that are 
relatively negative owing to the presence of electronegative oxygen are found at the 
termini of the inverted V and proximate to pyridine’s 2- and 6-positions. The most 
electropositive regime is comprised of two amide protons surrounding the pyridyl nitrogen. 
A comparison of the calculated electron densities and the crystal structure (above) suggests 
that the orientation of the two molecules of 4 is determined primarily by the overlap of this 
most electropositive region with one of the electronegative carbonyl oxygen atoms.  
However, in agreement with crystal structures of similar complexes,17b,33 the 
geometry-optimized dipicolinic dianilide hosts adopt a non-planar conformation with 
rotation about the pyridine-CO bond to bind chloride and other anions above the pyridine 
plane. This rotation leads to an energetically unfavorable conformation that breaks the π-
conjugated system. Thus, an energy trade-off is required to maximize chloride binding and 
minimize the energy of the complex.  Calculations investigating this energetic relationship 
are detailed below. 
 
Calculated gas-phase proton acidities, chloride-binding energies and complex 
geometries  
As seen in the left panel of Figure 3.4, an analysis of electrostatic potential maps 
calculated at the density-functional level of theory reveal that the electrostatic potential at 
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the amide protons closely correlate (R2 =0.881) to the Hammett σp and σm constants for the 
substituents modeled.  The electrostatic potential is the measure of attraction or repulsion 
of a positive charge on an isodensity surface.34  This potential is negative (energetically 
favored) at more electron rich regions of the molecule such as the oxygen atom of a 
ketone.  Conversely, this potential is positive (energetically disfavored) at more electron 
poor regions of the molecule, such as the carbon atom of a ketone, or in the present case, 
the hydrogen atom of an amide. 
This measure of acidity can also be correlated to experimentally-derived data.  In 
the right panel of Figure 3.4, the calculated electrostatic potentials are plotted against the 
observed chemical shifts (ppm) of the amide protons of dipicolinic dianilides 1-4 and 7-10 
in DMSO-d6.  The straight line fit to these data shows a good correlation (R2 =0.897) 
between calculated and experimental values. 
Figure 3.4: (Left) Linear correlation (R2 =0.881) between Hammett  values35 of 
dipicolinic dianilide substituents and the DFT-calculated electrostatic potential at the N-H 
amide protons.  (Right)   Linear correlation (R2 =0.897) between the calculated N-H 
amide electrostatic potential and the observed chemical shift of the same moiety in DMSO-
d6.  
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Binding energies were also calculated for chloride complexation by nine of the 
para-substituted dipicolinic dianilides at the density-functional level of theory (DFT-
B3LYP)36 using the 6-31G* basis set. Likewise, the calculated binding energies (1:1 
host:Cl¯) obeyed a Hammett relationship,37 with the strongest Cl¯ binding calculated to 
occur when the 4,4’-substituents were most electron withdrawing. The plot shown in 
Figure 3.5 includes data for compounds 1-4 (black dots), which were examined 
experimentally as well as by computational methods. The calculated energies for those 
compounds that were not further studied are shown as gray, rather than black, points. The 
range of substituents and their Hammett p constants35 were CH3, -0.14 (1); OCH3, -0.12; 
H, 0.00 (2); F, 0.15; Br, 0.26; COCH3, 0.47; CF3, 0.53; CN, 0.70 (3); and NO2, 0.81 (4). A 
graph of the calculated data produced a straight line having R2 =0.96. 
Two phenomena are observed with increasing substituent electron withdrawing 
nature: increased acidity (and H-bond donor ability) of the amide proton as well as better 
facilitation of rotation away from planarity and full conjugation with decreased electron 
density over the rotating π-bonds.  The latter observation was investigated by measuring 
the energy penalty associated with rotating away from co-planarity in the unbound host.   
The energetic effects of this non-planarity were studied in further computational 
detail for the p-NO2 variant 4 by incrementally and symmetrically rotating the pyridine-CO 
bond in the unbound host, freezing the host geometry and optimizing the geometry of the 
complex with an unconstrained chloride guest, calculating energies at each step. With no 
rotation, there is no direct N-H···Cl¯ interaction, so a rotation must occur to yield a binding 
event. 
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Figure 3.5: DFT-calculated binding energies plotted against the Hammett para35 for each 
para-substituent modeled in the survey (R2 =0.965). 
 
Figure 3.6 Energy penalty of rotation away from the central arene plane in host 4 (“Opt 
Rot”), compared to the rotation of each bond.  The significantly higher energy penalty of 
rotating the C-N amide bond precludes any rotation of this angle above 11°. 
 
In rotating away from the central arene, two of the three interarene bonds (those 
proximal to the central arene) result in decreased steric repulsion and better geometry for 
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binding chloride by the amide hydrogen bond donors.  However, rotation of the distal 
Namide-Carene bond has no effect on geometry of the amide proton moieties and yields little 
to no steric advantage.  Thus, this distal bond is neglected in considering the rotation of the 
side-arm arenes to bind halides. 
For compound 4, the optimum bond angles for the two proximal bonds were 
established by calculating the DFT energy of the host resulting from each 5° rotation (up to 
90°) of either the Carene-Camide (proximal) bond or the Camide-Namide (middle) bond.  These 
energy distributions were fit to polynomial functions then related to predict the lowest 
energy combination of rotations for both bonds to yield a total 5° rotation from the central 
arene plane.  The energy of each optimized rotation was then calculated and compared to 
the lowest energy conformation of 0° rotation.  These results are graphically summarized 
in Figure 3.6. 
After these host geometries were established at each 5° interval, the host was 
frozen and an unfrozen chloride anion was added to the structure before geometry 
optimization (essentially optimizing the host-guest interactive distances and geometry).  
The energy for each optimized complex was calculated by comparing the energy of the 
host and guest separately to the energy of the complex.  Finally, the total relative energy 
was calculated by adding the energy advantage from complexation to the energy penalty 
from bond rotation. 
As summarized graphically in the relative energy profile seen in Figure 3.7, this 
conformational change incurs an energetic penalty (squares) to the unbound host, but 
yields an optimized binding geometry. Whereas the energetic penalty is due primarily to 
the disruption of the conjugated π-system, steric interactions and the intramolecular 
pyridine nitrogen—amide hydrogen bonds play minor roles.  The advantage of binding Cl¯ 
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ion is greatest at between a 50° and 60° rotation (circles). Closer examination of the 
calculated geometries of the host-guest complexes show that with increased pyridine-CO 
bond rotation, the N-H···Cl¯ angle gradually approaches 180° while simultaneously 
shortening the H···Cl¯ distance until only one amide proton can bind the guest chloride ion. 
However, the summation of the rotation energy penalty and the binding energy advantage 
(diamonds) shows that a shallow energy trough between 20° and 40° yields the best 
combination of minimized π-system disruption and optimized N-H···Cl¯ binding geometry. 
 
Figure 3.7 Total relative energies for each conformation of host 4 rotated at 5° intervals 
from the central arene plane.  The energy penalty arises from the breaking of planar 
conjugation in the π-system whereas the energy advantage is gained from more favorable 
halide complexation geometry.  Note that the overall greatest energy advantage occurs at 
around 55°, but is negated by a higher energy penalty.  As a result, the lowest total relative 
binding energy is present at around 30°. 
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Figure 3.8 Energy advantage for conformation of host 4 optimally rotated at 5° intervals 
from the central arene plane compared with the N-H…Cl- bond distance (top panel) and 
N-H…Cl- bond angle (bottom panel). The increased energy advantage appears more 
dependent on a lower angle of deviation from linearity in the H-bond, as the conformation 
with the smallest such angle corresponds to the conformation with the greatest energy 
advantage.   
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While the energy penalty of rotation increases as rotation away from the central 
arene plane occurs, a large energy advantage is gained by creating a better complexation 
geometry through a closer N-H···Cl- contact and a bond geometry closer to 0° through the 
three atoms.  A survey of these interactions (Figure 3.8) in these optimized geometries 
show that, while close contact reaches its peak at 40° with a 2.27Å H-bond distance (upper 
panel), optimum bond geometry occurs at 55° with a bond angle of 8.6° (lower panel).  
The energy calculations show that indeed it is at this latter angle that the lowest energy is 
achieved (greatest energy advantage), predicting that bond geometry trumps contact 
distance when considering a difference of less than 0.1Å. 
 
Binding constants determined by 1H-NMR.  
The chloride association constants (Ks) of compounds 1-6 and  were determined by 
1H NMR spectroscopy in DMSO-d6 and CD2Cl2 by titration of a solution of 10:1 Bu4NCl 
guest to dianilide host into a solution of host only, monitoring the chemical shift change 
(Δδ) of the amide N-H peak.  In all cases, the amide N-H peak shifts downfield upon 
addition of chloride guest.  Donation of electron density from the anionic guest to the 
unfilled N-H σ* antibonding orbitals leads to less N-H bonding character and a downfield 
shift.  Job plots38 were constructed for each determined binding constant and with a 
maximal N-H amide shift at χHost= 0.5, a 1:1 binding stoichiometry is indicated for all 
complexes.   Using this 1:1 host to guest complex stoichiometry, constants were 
determined at [host] = 1.8 mM. The data points, derived from three independent titrations 
each, were fit to eq. 1,17b where “[H]0” is the initial host concentration, “[G]0” is the initial 
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guest concentration, “Δδ” is the change in chemical shift of the proton peak of interest, and 
“Ka” is the association constant. 
   (Eq. 1) 
 
Host DMSO-d6 CD2Cl2 
No. Y = X = Ks (M-1)a Ks (M-1)a 
1 N: p-CH3 NBb 63 ± 5 
2 N: H 26 ± 8 222 ± 14 
3 N: p-CN 50 ± 7 Insolc 
4 N: p-NO2 44 ± 4 Insolc 
5 CH H 16 ± 1 NPd 
6 CH p-NO2 46 ± 8 NPd 
Table 3.1: Chloride association constants Ks (M-1) and maximal amide N-H shifts for 1-6.    
a[Host] = 1.8 mM. Guest Cl¯ (as NBu4Cl) up to 18.0mM in DMSO-d6 and CD2Cl2 at 298 
K. bNB = no binding cInsol = the host is insoluble. dNot Performed. 
 
Direct comparison of binding by 1-4 was complicated by differing solubilities. 
Compounds 1 and 2 were soluble in CD2Cl2, but hosts 3 and 4, were not. Although 1-4 
were all soluble in DMSO-d6, its polarity diminishes the binding to such an extent that an 
encompassing comparison could not be completed in that solvent. As shown in Table 3.1, 
the isophthalamide receptor 5 bound chloride significantly better than its dipicolinamide 
counterparts 1 and 2 in non-polar CD2Cl2. However, in the more polar milieu of DMSO- 
d6, 3 and 4 bound chloride more strongly than 2 and far more strongly than 1, which did 
not yield a fittable curve.   
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Job Plots and titration curves leading to the values seen in Table 3.1 can be seen in 
Appendix A of the dissertation. 
 
 
Figure 3.9: Representative 1H NMR spectra showing the shift of the amide proton peak of 
4 upon addition of Bu4NCl guest.  The uppermost panel is the spectrum with no guest 
present (δ NH = 11.438 ppm).  The lower panel is the spectrum acquired with 16 
equivalents of guest present (δ NH = 11.933 ppm).   
 
Competitive chloride binding assayed by electrospray mass spectrometry  
 As noted above, our desire to directly compare binding in a single solvent was 
thwarted. Alex Carasel, Joseph Kramer, and Dr. Rudolph Winter thus undertook an 
electrospray ionization mass spectrometry (ESI-MS) study that would permit comparison 
of all of the compounds under similar conditions. Although mass spectrometry is a gas 
phase technique, the electrospray method gives data that are reflective of the solution at the 
time of ionization and limits or eliminates fragmentation.39 The electrospray study of 1-6 
was conducted in CH3OH, using Bu4NCl as the Cl¯ source.  Methanol is not identical to 
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either solvent system used in the 1H NMR studies, but it permits a uniform evaluation for 
all of these receptors. 
In each experiment, competing hosts were present in equimolar concentrations (50 
µM) and chloride (as NBu4Cl salt) was kept sub-stoichiometric (5 µM) so that competition 
for the guest would be obvious. The excess neutral host molecules are not observed in 
mass spectrometry unless they are complexed by Cl¯, so excess neutral host could be 
ignored. The ratios shown in Table 1 were calculated from the total integration of relevant 
M/z peaks for host-Cl¯ adducts. Five charged adducts were observed at significant 
abundances: [hostACl]¯, [hostBCl]¯, [(hostA)2Cl]¯, [(hostB)2Cl]¯, and 
[hostAhostBCl]¯. In each case, the lowest relative abundance was normalized to 1.  
Errors are the calculated standard deviations of ratios from at least three independent 
experiments. 
Host 1H NMR Ratio ESI-MS Ratio 
No. Compound vs. Control (5)a vs. Control (5)b 
1 Dipic p-CH3 NBc 0.14 ± 0.01 
2 Dipic unsub 1.63 ± 0.56 0.13 ± 0.02 
3 Dipic p-CN 3.13 ± 0.44 3.27 ± 0.26 
4 Dipic p-NO2 2.75 ± 0.25 2.82 ± 0.07 
5 Isophth unsub 1.00 1.00 
6 Isophth p-NO2 2.88 ± 0.51 5.44 ± 0.65 
Table 3.2: Comparison of ratio of chloride association constants to ESI-MS competitive 
ratio.  aKA (M-1) in DMSO-d6 at 298 K normalized to KA of  5   bCompetitive complexation 
with host 5 [Host] = 50 µM, 10% DMSO in MeOH. cNB = no binding. 
 
Table 3.2 shows that Cl¯ binding by dipicolinamides 3 (p-CN) or 4 (p-NO2) was 
similar. The KS values obtained in DMSO-d6 were 50.2 ± 7.3 and 44.0 ± 3.8, respectively 
with a ratio of binding constants equal to 1.14:1. The results of mass spectrometric 
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competition experiments for these two hosts were similar, with a ratio of 1.2:1 obtained by 
ESI-MS.  
When 3 and 4 were used as hosts, they behaved in a relatively similar manner 
showing roughly equal abilities to bind chloride. When either 3 or 4 was compared with 
control 5, each showed a much higher affinity for chloride. When all three compounds 
were mixed together, again 3 was slightly better than 4, and both were much better than 5 
with a ratio of the adducts of 3 to 4 (~1.2:1) preserved, even in the presence of 5. When 3, 
4 or 5 were compared all at once with compounds 1 and 2, no chloride adducts of 1 and 2 
were observed, indicating very weak binding. These data are in accordance with the 
calculated binding energies and provides further support for our findings. 
 
Chloride transport through vesicular phospholipid bilayers 
Compounds 1-4 and 6 as well as the control 5 were tested for mediation of chloride 
influx into dioleoylphosphatidylcholine (DOPC) vesicles as indicated by quenching of a 
vesicle-entrapped chloride-sensitive fluorescent indicator.   
N
N
N,N'-Dimethyl-9,9'-bisacridinium nitrate
Lucigenin
NO3
NO3
N
S
O
O
O
O
6-Methoxy-N-(3-sulfopropyl)quinolinium
SPQ
 
Phospholipid vesicles were prepared as previously described40 to obtain liposomes 
of a uniform 200 nm size. The indicator 6-methoxy-N-(3-sulfopropyl)quinolinium, or SPQ, 
has been used in previous chloride-transport studies using synthetic transporters26a but was 
unsuitable in the present context because the excitation and emission bands of 4 were 
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found to overlap with SPQ.  While the fluorescence and absorption profiles of 4 were 
further investigated (see the “Absorbance and fluorescence of the p-NO2 derivative” 
section), an alternative chloride-sensitive dye, N,N’-dimethyl-9,9’-bisacridinium nitrate, or 
lucigenin, was used.  This fluorescent probe was also used in previous transport studies40,41 
and was found to be optimal with no excitation and emission overlap with any of the 
compounds to be tested.  Lucigenin’s use requires it to be trapped in the Cl¯-free interior 
of vesicles where it fluoresces (λexc = 368 nm, λem = 506 nm).  However, if an agent 
mediates the passage of Cl¯ through the bilayer from the external buffer, the fluorescence 
intensity decreases due to collisional quenching. After a specified time, Triton X-100 is 
added to lyse the vesicles, and a baseline intensity for complete quenching is established. 
This baseline fluorescence intensity value is subtracted from the raw fluorescence intensity 
data and fractionally normalized to F0, the unquenched fluorescence value.  Thus, a value 
of 0.2 indicates 80% chloride influx. 
Figure 3.10 compares Cl¯ transport mediated across dioleoylphosphatidyl choline 
(DOPC) vesicles over the course of 600 s by 1-6 at a host concentration of 10 µM. 
Transport mediated by weak chloride binders 1 and 2, was far less effective than transport 
mediated by the stronger binders 3 and 4.  In direct correlation with the molecular 
modeling predictions, the experimental binding constants and the mass spectrometry 
competition experiments, receptors 3, 4, and 5 exhibited the highest levels of chloride-
transport activity with ~80% chloride influx after 600 s, respectively. Receptors 1 and 2 
and the control, 5, showed diminished activity under the same conditions.  The ideal 
chloride transporter (carrier or channel) needs to bind the ion strongly enough for 
recognition to occur but weak enough to maintain a dynamic system.  While 1, 2, and 6 
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can be considered to bind chloride too weakly in a polar environment, the stronger 
interactions observed for 3, 4 and 5 are weak enough that a dynamic system is maintained. 
 
Figure 3.10. Chloride transport through DOPC vesicles mediated by dianilides 1-4 and 
isopthalamides 5 and 6 as determined by lucigenin quenching.42  All hosts are added as 
DMSO solutions with a final concentration of 10 µM.  Maximal quenching is reached 
within 10 minutes in all cases. Data points for all replications are within 7% of the mean. 
 
The relatively rapid chloride influx rate, observed at low micromolar 
concentrations of receptors 3 and 4, suggests that a channel mechanism versus a carrier 
mechanism is responsible for transport. Thus, a definitive test for channel activity, a 
planar-bilayer conductance study, was performed to confirm the theory (see the “Planar 
bilayer conductance” section). 
While the lucigenin quenching experiment characterizes chloride transport activity 
at a given transporter concentration, variation of the transporter concentration can yield 
insights into the aggregation mechanics of transport activity. Systems using vesicles at a 
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fixed lipid concentration of 0.31 mM and transporter 4 in a range of concentrations from 
20 µM to 50 nM were used to study the concentration dependence of chloride transport 
activity. The results, shown in Figure 3.11, can be used to construct a Hill Plot43 (Figure 
3.12) to determine the concentration dependence of the active channel or carrier.  
 
Figure 3.11. The concentration dependence of the p-NO2 dianilide, 4, on 
chloride transport. 
 
Originally used in the study of enzyme kinetics, Hill plots are constructed to 
analyze the velocity of a measurable reaction or activity (in the present case, the initial rate 
of chloride transport) at different concentrations of enzyme or other agent (our chloride 
transporter).  As these velocities are limited to some maximum value (Vmax) at a 
theoretically infinite concentration of activity-inducing agent, an asymptotic relationship is 
observed.  The data are linearized by plotting on a log-log scale for the Hill plot with a line 
of slope 1 indicating a direct ideal linear relationship between activity-inducing agent and 
activity velocity.  If the slope is greater than 1, a cooperative relationship is indicated, as 
91 
the activity velocity increases at a greater than linear rate.  If the slope is less than 1, a 
competitive or non-cooperative relationship is indicated, as the presence of more activity-
inducing agent leads to less activity per molecule of agent present. 
 F0/F = 1 + KD [Q]     (Eq. 2) 
Application of the Stern-Volmer equation (Eq. 2)44 to the acquired fluorescence 
data yielded chloride concentrations for each half-second recording. Using the literature 
Stern-Volmer quenching constant for lucigenin with chloride (KD = 390 M-1) and the 
experimentally-determined F0/F values (the inverse of the dependent values in Figure 
3.10), intracellular chloride concentrations are derived for each observed point in time, 
ultimately yielding ion transport velocities. 
 
Figure 3.12. A Hill plot derived from the data 
presented in Fig. 3.11 (variation of [4]) via 
application of the Stern-Volmer equation.  
 
Examination of the Hill plot seen in Figure 3.12 shows that when plotted on a log-
log scale to linearize the transport velocity and concentration terms, a non-linear 
dependence is observed.   If all 5 points were fit to a single straight line (full line), as 
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normally done with a Hill plot, a slope of 0.66 is the result, indicating a competitive 
concentration dependence.  However, if the plot were divided into two parts, the first with 
the two lowest concentrations and the second with the three remaining, two straight lines 
result: the first half yielding a slope of 0.13 and the second a slope of 1.98, indicating a 
competitive and cooperative concentration dependence, respectively.  Presumably, these 
two straight lines are a simplification, and a non-linear relationship is truly at work (dashed 
curve), but with only 5 data points, this is an assumption at this time. 
However, while measuring membrane potential polarization rate in their work,   
Yang and co-workers also observe a non-linear concentration dependence with their α-
aminooxyacid class of synthetic chloride transporters.26b  These observations with other 
synthetic chloride transporters incapable of spanning a membrane may complement our 
own studies with similar compounds.  The non-linear dependence may be based on a 
minimum concentration threshold that is required for these transporters to function as 
anion channels.  At any given concentration, both the carrier and channel mechanism may 
be active, with more channel character present at higher concentrations. 
 
Planar bilayer conductance 
The planar bilayer conductance technique45 (KCl, 0.45 M, pH 7.0, soybean 
asolectin) was used to probe for channel formation in experiments conducted by Saeedeh 
Negin.  In this experiment, two potassium chloride buffer solutions (0.45M, pH 7.0) were 
separated by a phospholipid membrane (asolectin from soybean) painted onto a ~200 μm2 
aperture between the two buffer chambers. To this system, a DMSO solution of 4 was 
added to one buffer chamber (the cis chamber) yielding a final transporter concentration of 
7 μM. A potential difference was then applied across the membrane and channel activity 
was observed by measurement of current in the trans buffer chamber. The distinctive open-
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close behavior exhibited by the current measurements seen in Figure 3.13 is indicative of 
functional ion-channel formation in the bilayer.45 
 
Figure 3.13. (Left) The current observed at applied voltages of (Top) -60 mV and (Bottom) 
60 mV elicited upon the addition of transporter 4 at 7 μM. (Right) I-V Plot, a plot of 
observed current vs. applied potential correlating to the major conductance state. 
 
When the experiments were conducted for durations as long as 3 hours after 
addition of transporter, a variety of “open” currents could be observed at the same voltage, 
meaning that multiple conductance states are present.  Data for the major conductance state 
are shown in Figure 3.13. The conductance value determined from the graph in Figure 3.13  
is 117 pS.  
To estimate the pore diameter of this channel, Hille’s equation45 can be applied to 
the derived conductance value. A channel exhibiting a conductance of 117 pS in a 35Å 
thick bilayer has an estimated pore diameter of ~8Å. An unsolvated Cl- ion with a 1.81Å 
van der Waals radius46 ion would need a pore with a diameter of at least 3.6Å to transport 
ions and the calculated structures of the dipicolinamides show a binding cavity in a single 
receptor with a diameter of ~4.1Å. A pore of ~8Å would mean that at least two of these 
receptors would form the sides of the pore with their binding cavities directed inward.  
Unsolvated Cl¯ has a diameter of ~3.6 Å47 but fully aquated Cl¯ is estimated to be ~6.5 
Å,48 which is close to the calculated pore size 
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  Unsubstituted dipicolinamide, 2, and isophthalamide, 5, were also tested for 
channel functionality using the same procedure shown above.  Tests were run for 
durations of 3 hours showing no conductance behavior  for either of these compounds at a 
final transporter concentration of 7 μM. 
 
Absorbance and fluorescence of the p-NO2 derivative, 4 
  The formation of a transmembrane channel by 4 would require aggregation of 
the monomers. One possibility is that the triarenes self-assemble, stacking upon one 
another. To span the 30-35 Å insulator regime of a bilayer membrane, 8-10 molecules 
would be required to stack at the van der Waals distance of 3.4 Å. Such an arrangement 
would have a significant entropic cost in the bilayer but this type of stacking is 
apparent in the solid state structure.31  
 Inferential evidence for stacking was obtained from fluorescence studies. Nitro-
substituted dipicolinamide (4) showed no fluorescence emission when excited at various 
wavelengths in DMSO solution. Compound 4 is soluble in DMSO but not in water. 
However, when a small amount of a concentrated DMSO solution of 4 is added to an 
aqueous solution (1% DMSO v/v), fluorescence is readily observed. The emission spectra 
seen in Figure 3.14 are from an excitation wavelength of 280 nm.  The only peak observed 
at a receptor concentration of 50 μM was the peak having a maximum near  400 nm as 
seen in Figure 3.14.  In subsequent studies varying the excitation wavelength (270-600 nm 
in 10 nm increments), it was determined that an excitation wavelength of 280 nm yielded 
the highest fluorescence intensity.  
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Figure 3.14. Fluorescence in 4 in 1% DMSO / water at (Top) 2-20 µM host concentration 
(Center) 10-90 µM concentration and (Bottom) 10-90 µM with 0.17mM DOPC vesicles. 
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The top panel of Figure 3.14 shows the fluorescence spectra obtained for 4 in 1% 
DMSO/H2O over a concentration range of 2-20 µM, in 2 µM increments—concentrations 
relevant to eliciting chloride transport, from concentration dependence studies (Figure 
3.11). Molecules of 4 aggregate under these conditions and the fluorescent emission is 
presumably due to the formation of excimers. Similar, but more intense spectra, were 
obtained at concentrations between 10-90 µM as shown in the middle panel of Figure 3.14. 
As the concentration increases, the peak intensifies while shifting from its first observable 
maximum of 372 nm to a final maximum of 403 nm.  
The maximal emission intensity fluorescence excitation wavelength of 280 nm 
does not correlate with the maximal absorbance wavelength of 338 nm seen in Figure 3.15 
(uppermost curve). However, when the same DMSO-water solution of 4 is titrated with a 
10 equivalent mixture of NaCl and host 4, an isosbestic point in the absorbance spectrum is 
observed near  the aforementioned 280 nm wavelength. 
The lower absorption at the longer wavelength (338 nm) upon addition of NaCl is 
most likely attributable to the disruption of the extended conjugated π-system of the planar 
receptor molecule. We speculate that with increasing NaCl concentration, the receptor 
anilide side-arms rotate to bind its Cl- guest as seen previously in the calculated structure 
(Figure 3.15).  While the absorbance at this higher wavelength is decreased, the absorbance 
intensity at 275 nm (and presumably lower wavelengths) increases proportionally. 
Unfortunately, the absorbance spectra below 275 nm is not able to be obtained due to 
instrumental limitations. 
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Figure 3.15. (Top) Absorbance of host 4 in 1% DMSO/water at a concentration of 10mM.  
NaCl guest is added (0-70 equivalents) resulting in the lowered absorbance at the 
maximum at 338 nm and an increased absorbance for a species with a maximum below 
275nm.  (Bottom) The calculated geometry of a 4·Cl¯ complex.  Presumably, the species 
absorbing at 338 nm is the planar host whereas the species absorbing at the shorter 
wavelength is a combination of the three discrete π-systems present in the complex. 
 
Conclusions 
In this study, we have examined the chloride binding properties of hosts 1-4 using 
three independent methods—DFT-level gas-phase calculations, 1H NMR binding constants 
in both polar DMSO- d6 and non-polar CD2Cl2, and electrospray ionization MS in a polar 
methanol microenvironment. We observed the same general trend across the methods: the 
more electron-withdrawing p-NO2 and p-CN dianilides (4 and 3, respectively) were better 
chloride binders than the unsubstituted and electron-donating p-CH3 dianilides (2 and 1, 
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respectively). 3 and 4’s chloride binding capabilities—even in polar environments—
proved a boon in their ability to transport chloride across phospholipid membranes, an 
ability not displayed by their more weakly-binding counterparts. The rapid chloride 
transport evidenced by 4 was explored more fully, with its open-close behavior exhibited 
in planar-bilayer conductance tests proving its channel functionality. 
The observation that compound 4 exhibits channel behavior may be surprising at 
first glance. While each molecule of 4 is at most 14.5 Å in length, the hydrophobic 
insulator regime of a bilayer is ~35 Å thick49 meaning 4 and members of its structural 
family, 1-3, would not span the bilayer in a typical unimolecular fashion as would natural 
ion channels45 or many designed single-molecule synthetic channels.50 Certainly, other 
channel modalities could be in play, such as a two-molecule, two-leaflet modality seen in 
gramicidin.51 However, a vertically-stacked assembly of receptors such as seen in cartoon 
form in Figure 3.16 could be another possible mechanism. The formation of channels from 
stacked monomers has been proposed previously for cyclic peptides,52 rosettes,53 cyclic 
ureas54 and for oligoamide macrocycles55 even though π-π stacking has been the subject of 
controversy in recent years.56 
Observation of the fluorescence of 4 in water leads us to believe that this stack is 
rapidly organized in the aqueous milieu by exclusion of water contacts at the hydrophobic 
arene faces. Examination of calculated gas-phase models argues that this pre-organized 
stack most likely organizes solvent water, binding the electronegative water oxygen. The 
exposed water protons in turn weakly (but dynamically) complex chloride in a water-and-
ion filled pore. 
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Figure 3.16. (Left) CPK representation of a stack of molecules of receptor 4 with solvent 
water molecules in light blue and chloride ions in green. (Center) DFT-calculated 
structure of host 4 with two molecules of water.  (Right) DFT-calculated structure of host 4 
with four molecules of water and a chloride anion. 
 
The multiple conductance states seen in the planar-bilayer tests show that different 
channel sizes are possible. While a minimum of 8 to 10 transporters would be needed for a 
single stack, further lateral aggregation over time might form larger and larger pores 
leading to those of the size seen in the planar-bilayer conductance studies.  The formation 
of channels by such small molecular species may have implications in the design of drugs, 
especially since the aminoxyisophthalamides described recently alter biological 
function.26b  
The regulation of ion concentrations—maintaining gradients across ion-
impermeable cellular membranes—is of paramount importance in living, functioning cells. 
Disruption of the regulation of the chloride ion gradient is implicated in the symptomatic 
manifestation of cystic fibrosis in humans,57 a result of malfunctioning natural chloride 
channels.58 While many commercially successful synthetic therapeutics are small, limiting 
the costs in an industrial process, they are tailored to interact with naturally-occurring 
100 
proteins, rarely affecting activity on their own. However, compounds such as transporters 3 
and 4 that are small and easily made while independently eliciting a desired effect at a low 
concentration, could find many potential therapeutic uses. 
 
Experimental 
  
General.   
All NMR spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz 
and all chemical shifts are reported in ppm (δ), calibrated to literature values for internal 
solvent in reference to TMS  with integrated intensity (X H) and multiplicity (b = broad, s 
= singlet, d = doublet, t = triplet, q = quartet, bs = broad singlet, m = multiplet, etc.), and 
coupling constants in Hz.  13C-NMR spectra were obtained at 75.4 MHz and calibrated to 
literature values for chemical shift in reference to TMS. Melting points were determined on 
a Thomas Hoover apparatus in open capillaries and are uncorrected. Reagents were the 
best (non-LC) grade commercially available and were distilled, recrystallized or used 
without further purification, as appropriate. CH2Cl2 was distilled from calcium hydride. 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO).   
All Mass Spectrometry experiments were performed on a JEOL MStation, JMS-
700, double focusing high-resolution instrument using either the fast-atom bombardment 
ionization technique in the positive ion detection mode at high resolution (FAB-MS), or 
the elesctrospray ionization technique in the negative ion detection mode (ESI-MS).   All 
fluorescence spectra and fluorescence quenching data were recorded on a Perkin Elmer 
LS50B Luminescence Spectrometer. Planar bilayer conductance measurements were 
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performed with a Warner bilayer clamp instrument. All UV-Vis absorbance spectra were 
recorded on a Beckman Coulter DU 7400 Spectrophotometer.  Calculations were run using 
the Spartan 2006 software package on a Dell Dimension DXP061 desktop with a 2.40GHz 
Intel® Core™2 Processor and 2.00GB of RAM.   
 
Gas-phase binding calculations and molecular modeling.  
A lowest energy conformation search was performed using the Monte-Carlo 
simulated annealing method with the MMFF force field to yield the ten lowest energy 
conformers for each host and complex modeled. The geometry of each of these conformers 
were optimized by the density-functional B3LYP method using the 6-31G* basis set. 
Single-point energy calculations were performed using the same method and basis set to 
determine the overall lowest energy conformer (LEC). Binding energies were determined 
for each complex by adding the calculated energies of the host LEC and guest then 
subtracting the calculated energy of the complex LEC.  
  
Synthesis and characterization of hosts 1-12, general procedure.  
All solvents used were freshly distilled and all reactions were performed under an 
inert nitrogen or argon atmosphere and vapor condenser.   
The commercially-available diacid (2,6-pyridinedicarboxylic acid for 1-4, 
isophthalic acid for 5 and 6) was dissolved in acetonitrile or dichloromethane (~2mmol in 
7mL) and added drop-wise to a stirring solution containing an excess of the appropriate 
aniline in the same solvent (~7mmol in 7mL in acetonitrile or dichloromethane) and 
triethylamine (3mL) held at 0°C in an ice bath.  After addition, the mixture was returned to 
room temperature and then heated to reflux for 3h.  After returning to room temperature, 
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the solid was filtered and washed with the reaction solvent (acetonitrile or 
dichloromethane) and dried under high vacuum yielding the final product.   
 
2,6-Pyridinedicarbonyl dichloride 
The commercially-available diacid, 2,6-pyridinedicarboxylic acid (4.00 g) was 
added to a stirring mixture of thionyl chloride (15.80 g) and 1,4-dioxane (24.0 mL) and 
heated to reflux for 4 hours.  After cooling to room temperature, solvent, excess thionyl 
chloride and hydrogen chloride gas are removed in vacuo.  Toluene (2 x 50 mL) is added 
to the concentrate and removed in vacuo to ensure removal of all traces of thionyl chloride 
and hydrogen chloride.  The resulting brown solid (4.88 g, quantitative, mp = 61-62 °C, lit. 
59 = 60 °C) is used immediately in the subsequent amide coupling reactions. 1H-NMR 
(CD2Cl2): 8.18 (1H, dd, J1 = 8.3 Hz, J2 = 7.3 Hz Ar 4-H), 8.38 (2H, d, J = 7.8 Hz Ar 3/5-
H), 13C-NMR (CD2Cl2): 129.9, 140.3, 149.7, 169.8. 
 
N2,N6-bis(4-Methylphenyl)pyridine-2,6-dicarboxamide, 1 
This compound was made and reported previously. Spectral data and the melting 
point match literature values.60 2,6-Pyridinedicarbonyl dichloride (0.44 g, 2.2 mmol) was 
dissolved in acetonitrile (5.0 mL) and was added dropwise to a stirring solution of 4-
toluidine (0.82 g, 7.7 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (7.0 mL 
additional for 12.0 mL total) held at 0°C in an ice bath.  Upon completion of the addition, 
the system was returned to room temperature and stirred for 24 hours.  The resulting white 
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 
mL) and refiltered after each suspension before drying under high vacuum.  The resulting 
white solid is retained as the pure product (0.33 g, 42%, mp = 223-224 °C, lit.60 = 224 °C).  
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1H-NMR (DMSO-d6): 2.32 (6H, s, Anil-CH3), 7.25 (4H, d, J = 8.4 Hz, Anil 3/5-H), 7.80 
(4H, d, J = 8.4 Hz, Anil 2/6-H)  8.29 (1H, dd, J1 = 8.6 Hz, J2 = 6.9 Hz, Pyr 4-H), 8.38 (2H, 
d, J = 7.6 Hz Pyr 3/5-H), 11.03 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6): 20.6 (Anil-
CH3), 121.2, (Anil 2/6-C), 125.2 (Pyr 3/5-C), 129.1 (Anil 3/5-C), 133.4 (Anil 4-C), 140.2 
(Pyr 4-C), 135.6 (Anil 1-C), 149.0 (Pyr 2/6-C), 161.5 (Pyr-C(O)NH). ESI-MS: m/z calc for 
[M+Cl]¯ 380, found: 380. 
 
N2,N6-bis(Phenyl)pyridine-2,6-dicarboxamide, 2 
This compound was made previously.  Spectral data and the melting point match 
literature values.61 2,6-pyridinedicarbonyl dichloride (0.42 g, 2.1 mmol) was dissolved in 
acetonitrile (5.0 mL) and was added dropwise to a stirring solution of aniline (0.63 g, 6.8 
mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (7.0 mL additional for 12.0 
mL total) held at 0°C in an ice bath.  Upon completion of the addition, the system was 
returned to room temperature and stirred for 24 hours.  The resulting white suspension is 
filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 mL) and 
refiltered after each suspension before drying under high vacuum.  The resulting white 
solid is retained as the pure product (0.56 g, 86%, mp = 277-278 °C, lit.61 = 278 °C).  1H-
NMR (DMSO-d6): 7.19 (2H, t, J = 7.4 Hz, Anil 4-H), 7.45 (4H, t, J = 7.9 Hz, Anil 3/5-H), 
7.94 (4H, d, J = 7.5 Hz, Anil 2/6-H) 8.31 (1H, dd, J1 = 8.7 Hz, J2 = 6.6 Hz, Pyr 4-H), 8.41 
(2H, d, J = 7.7 Hz Pyr 3/5-H), 11.09 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6): 121.1 
(Anil 2/6-C), 124.4 (Anil 4-C), 125.3 (Pyr 3/5-C), 128.8 (Anil 3/5-C), 138.1 (Anil 1-C), 
140.0 (Pyr 4-C), 148.9 (Pyr 2/6-C), 161.7 (Pyr-C(O)NH). ESI-MS: m/z calc for [M-H]¯ 
316, found: 316; m/z calc for [M+Cl]¯ 352, found: 352. 
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N2,N6-bis(4-Cyanophenyl)pyridine-2,6-dicarboxamide, 3 
This compound was made previously.  Spectral data and the melting point match 
literature values.62 2,6-Pyridinedicarbonyl dichloride (0.42 g, 2.1 mmol) was dissolved in 
acetonitrile (5.0 mL) and was added dropwise to a stirring solution of 4-aminobenzonitrile 
(0.82g, 6.9 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (7.0 mL 
additional for 12.0 mL total) held at 0 °C in an ice bath.  Upon completion of the addition, 
the system was returned to room temperature and stirred for 24 hours.  The resulting white 
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 
mL) and refiltered after each suspension before drying under high vacuum.  The purified 
product is isolated as a white powder (0.26 g, 34%, mp = 304-306 °C, lit.62 = 304-306 °C).  
1H-NMR (DMSO-d6): 7.92 (4H, d, J = 8.6 Hz, Anil 3/5-H), 8.19 (4H, d, J = 8.6 Hz, Anil 
2/6-H)  8.34 (1H, t, J = 7.7 Hz, Pyr 4-H), 8.43 (2H, d, J = 8.0Hz  Pyr 3/5-H), 11.34 (2H, s, 
C(O)NH-Anil). 13C-NMR (DMSO-d6): 106.0 (Anil 4-C), 119.0 (Anil-CN), 120.7 (Anil 
2/6-C), 126.0 (Pyr 3/5-C), 133.2 (Anil 3/5-C), 140.3 (Pyr 4-C), 142.3 (Anil 1-C), 148.3 
(Pyr 2/6-C), 162.1 (Pyr-C(O)NH). ESI-MS: m/z calc for [M-H]¯ 366, found: 366; m/z calc 
for [M+Cl]¯ 402, found: 402. 
 
N2,N6-bis(4-nitrophenyl)pyridine-2,6-dicarboxamide, 4 
This compound was made previously.  No spectral data were recorded, but the 
melting point matches the literature value.63 2,6-Pyridinedicarbonyl dichloride (1.65 g, 8.1 
mmol) was dissolved in acetonitrile (20.0 mL) and was added dropwise to a stirring 
solution of 4-Nitroaniline (2.44g, 16.2 mmol) and triethylamine (9.0 mL, 64.6 mmol) in 
acetonitrile (25.0 mL additional for 45.0 mL total) held at 0 °C in an ice bath.  Upon 
completion of the addition, the system was returned to room temperature and stirred for 24 
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hours.  The resulting yellow-brown suspension is filtered, resuspended with acetonitrile (2 
x 25 mL) and diethyl ether (1 x 10 mL) and refiltered after each suspension before drying 
under high vacuum.  The resulting yellow-beige solid is retained as the pure product (1.70 
g, 52%, mp > 330°C, lit.63 >300°C).  1H-NMR (DMSO-d6): 8.13 (4H, d, J = 9.2 Hz, Anil 
3/5-H), 8.24 (4H, d, J = 9.6 Hz, Anil 2/6-H)  8.23 (1H, [buried], Pyr 4-H), 8.34 (2H, d, J = 
8.1 Hz Pyr 3/5-H), 11.48 (2H, s, C(O)NH-Anil).13C-NMR (DMSO-d6): 120.4, (Anil 2/6-
C), 124.9 (Anil 3/5-C), 126.2 (Pyr 3/5-C), 140.4 (Pyr 4-C), 143.0 + 144.3 (Anil 4-C +Anil 
1-C), 148.2 (Pyr 2/6-C), 162.3 (Pyr-C(O)NH). ESI-MS: m/z calc for [M-H]¯ 406, found: 
406; m/z calc for [M+Cl]¯ 442, found: 442.  
 
N1,N3-bis(phenyl)isophthalamide, 5 
This compound was made previously.  Spectral data64 and the melting point65 
match literature values. Isophthaloyl chloride (0.498 g, 2.45 mmol) was dissolved in 
acetonitrile (7.0 mL) and was added dropwise to a stirring solution of aniline (0.780 g, 8.38 
mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (8.0 mL additional for 15.0 
mL total) held at 0 °C in an ice bath.  Upon completion of the addition, the system was 
returned to room temperature and stirred for 24 hours.  The resulting white suspension is 
filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 mL) and 
refiltered after each suspension before drying under high vacuum.  The resulting white 
solid is retained as the pure product (0.521 g, 67%, mp = 280-281 °C, lit.65 = 279-281 °C).  
1H-NMR (DMSO-d6): 7.13 (2H, t, J = 7.3 Hz, Anil 4-H), 7.38 (4H, t, J = 7.2 Hz, Anil 3/5-
H), 7.70 (1H, t, J = 7.7 Hz, Isophth 5-H), 7.81  (4H, d, J = 8.1 Hz, Anil 2/6-H), 8.15 (2H, 
d, J = 7.7 Hz, Isophth 4/6-H), 8.54 (1H, s, Isophth 2-H), 10.44 (2H, s, C(O)NH-Anil). 13C-
NMR (DMSO-d6): 120.4 (Anil 2/6-C), 123.8 (Anil 4-C), 127.0 (Isophth 2-C), 128.4 
106 
(Isophth 5-C), 128.7 (Anil 3/5-C), 130.6 (Isophth 4/6-C), 135.2  (Isophth 1/3-C), 139.1 
(Anil 1-C), 165.1 (Isophth-C(O)NH). FAB-MS: m/z calc for [M+H]+ 317.1290, found: 
317.1285. ESI-MS: m/z calc for [M+Cl]¯ 351 found: 351.   
 
N1,N3-bis(4-Nitrophenyl)isophthalamide, 6 
This compound was made previously. No spectral data were recorded, but the 
melting point agrees with the literature value.66 Isophthaloyl chloride (1.199 g, 5.90 mmol) 
was dissolved in acetonitrile (15.0 mL) and was added dropwise to a stirring solution of 4-
nitroaniline (2.478g, 17.94 mmol) and triethylamine (10.0 mL, 71.7 mmol) in acetonitrile 
(15.0 mL additional for 30.0 mL total) held at 0 °C in an ice bath.  Upon completion of the 
addition, the system was returned to room temperature and stirred for 24 hours.  The 
resulting brown-yellow suspension is filtered, resuspended with acetonitrile (2 x 25 mL) 
and diethyl ether (1 x 10 mL) and refiltered after each suspension before drying under high 
vacuum.  A yellow-beige solid is isolated as the pure product (0.951 g, 40%, mp > 330°C, 
lit.66 = 377°C).  1H-NMR (DMSO-d6): 7.76 (1H, t, J = 7.4 Hz, Isophth 5-H), 8.13 (4H, t, J 
= 7.7 Hz, Anil 2/6-H), 8.22 (2H, d, J = 7.8 Hz, Isophth 4/6-H), 8.30 (4H, d, J = 7.7 Hz, 
Anil 3/5-H), 8.67 (1H, s, Isophth 2-H), 11.22 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-
d6): 119.9 (Anil 2/6-C), 124.8 (Anil 3/5-C), 127.8 (Isophth 5-C), 131.5 (Isophth 4/6-C), 
134.4 (Isophth 1/3-C), 139.5 (Isophth 2-C), 142.6 (Anil 4-C), 145.3 (Anil 1-C), 165.6 
(Isophth-C(O)NH). ESI-MS: m/z calc for [M-H]¯ 405, found: 405; m/z calc for [M+Cl]¯ 
441, found: 441.  
 
N2,N6-bis(4-Aminoacetylphenyl)pyridine-2,6-dicarboxamide, 7 
2,6-Pyridinedicarbonyl dichloride (1.10 g, 5.4 mmol) was dissolved in acetonitrile 
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(20.0 mL) and was added dropwise to a stirring solution of 4-aminoacetanilide (1.78 g, 
11.9 mmol) and triethylamine (9.0 mL, 64.6 mmol) in acetonitrile (20.0 mL additional for 
40.0 mL total) held at 0 °C in an ice bath.  Upon completion of the addition, the system 
was returned to room temperature and stirred for 24 hours.  The resulting white suspension 
is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 mL) and 
refiltered after each suspension before drying under high vacuum.  The resulting off-white 
(slight pink) solid is retained as the pure product (1.77 g, 76%, mp > 330°C).  1H-NMR 
(DMSO-d6): 1.49 (6H, s, C(O)CH3), 7.08 (4H, d, J = 8.9 Hz, Anil 3/5-H), 7.25 (4H, d, J = 
8.9 Hz, Anil 2/6-H)  7.73 (1H, dd, J1 = 8.8 Hz, J2 = 6.5 Hz, Pyr 4-H), 7.82 (2H, d, J = 7.5 
Hz Pyr 3/5-H), 10.00 (2H, s, Anil-NHC(O)), 10.98 (2H, s, C(O)NH).13C-NMR (DMSO-
d6): 24.0 (COCH3), 119.3 (Anil 3/5-C), 121.8, (Anil 2/6-C), 125.2 (Pyr 3/5-C), 133.08 
(Anil 1-C), 136.0 (Anil 4-C), 139.4 (Pyr 4-C), 148.9 (Pyr 2/6-C), 161.5 (Pyr-C(O)NH-), 
168.2 (NHC(O)CH3). FAB-MS: m/z calc for [M+H]+ 462.1665, found: 462.1658.  
 
N2,N6-bis(4-Acetylphenyl)pyridine-2,6-dicarboxamide, 8  
2,6-Pyridinedicarbonyl dichloride (0.44 g, 2.2 mmol) was dissolved in acetonitrile 
(7.0 mL) and was added dropwise to a stirring solution of 4’-aminoacetophenone (0.92 g, 
6.8 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (5.0 mL additional for 
12.0 mL total) held at 0 °C in an ice bath.  Upon completion of the addition, the system 
was returned to room temperature and stirred for 24 hours.  The resulting white suspension 
is filtered, resuspended and refiltered with acetonitrile (2 x 25 mL) and diethyl ether (1 x 
10 mL) before drying under high vacuum.  The resulting off-white (slight pink) solid is 
retained as the pure product (0.63 g, 72%, mp = 195-196 °C).  1H-NMR (DMSO-d6): 2.58 
(6H, s, C(O)CH3), 8.04 (4H, d, J = 8.7 Hz, Anil 3/5-H), 8.18 (4H, d, J = 8.7 Hz, Anil 2/6-
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H)  8.32 (1H, dd, J1 = 8.6 Hz, J2 = 6.7 Hz, Pyr 4-H), 8.42 (2H, d, J = 7.2 Hz Pyr 3/5-H), 
11.33 (2H, s, C(O)NH).13C-NMR (DMSO-d6): 26.5 (COCH3), 120.2, (Anil 2/6-C), 125.8 
(Pyr 3/5-C), 129.3 (Anil 3/5-C), 132.5 (Anil 4-C), 140.1 (Pyr 4-C), 142.6 (Anil 1-C), 148.7 
(Pyr 2/6-C), 162.2 (Pyr-C(O)NH), 196.7 (Anil-C(O)CH3). FAB-MS: m/z calc for [M+H]+ 
402.1454, found: 402.1448.  
 
N2,N6-bis(3-Methylphenyl)pyridine-2,6-dicarboxamide, 9 
2,6-Pyridinedicarbonyl dichloride (0.426 g, 2.09 mmol) was dissolved in 
dichloromethane (6.0 mL) and was added dropwise to a stirring solution of 3-toluidine 
(0.743 g, 6.93 mmol) and triethylamine (5.0 mL, 35.9 mmol) in dichloromethane (9.0 mL 
additional for 15.0 mL total) held at 0 °C in an ice bath.  Upon completion of the addition, 
the system was returned to room temperature and stirred for 24 hours.  The resulting white 
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 
mL) and refiltered after each suspension before drying under high vacuum.  The resulting 
white solid is retained as the pure product (0.564 g, 78%, mp = 211-214 °C).  1H-NMR 
(DMSO-d6): 2.34 (6H, s, Anil-CH3), 7.01 (2H, d, J = 7.5 Hz, Anil 4-H), 7.31 (2H, t, J = 
7.8 Hz, Anil 5-H), 7.65 (2H, d, J = 8.0 Hz, Anil 6-H), 7.70 (2H, s, Anil 2-H),  8.28 (1H, 
dd, J1 = 8.7 Hz, J2 = 6.6 Hz, Pyr 4-H), 8.37 (2H, d, J = 7.3 Hz Pyr 3/5-H), 11.00 (2H, s, 
C(O)NH-Anil). 13C-NMR (DMSO-d6): 21.5 (Anil-CH3), 118.9 (Anil 6-C), 122.2, (Anil 2-
C), 125.2 +125.6  (Pyr 3/5-C + Anil 4-C), 129.0 (Anil 5-C), 138.0 + 138.4 (Anil 1-C + 
Anil 3-C), 143.5 (Pyr 4-C), 149.2 (Pyr 2/6-C), 162.1 (Pyr-C(O)NH). FAB-MS: m/z calc 
for [M+H]+ 346.15555, found: 346.1555. ESI-MS: m/z calc for [M+Cl]¯ 380, found: 380.  
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N2,N6-bis(3-Cyanophenyl)pyridine-2,6-dicarboxamide, 10 
2,6-Pyridinedicarbonyl dichloride (0.423 g, 2.07 mmol) was dissolved in 
acetonitrile (7.0 mL) and was added dropwise to a stirring solution of 3-aminobenzonitrile 
(0.785g, 6.64 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (11.0 mL 
additional for 18.0 mL total) held at 0 °C in an ice bath.  Upon completion of the addition, 
the system was returned to room temperature and stirred for 24 hours.  The resulting white 
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 
mL) and refiltered after each suspension before drying under high vacuum.  The resulting 
white solid is retained as the pure product (0.311 g, 41%, mp = 288-291 °C).  1H-NMR 
(DMSO-d6): 7.62-7.68 (4H, m, Anil 4-H + Anil 5-H), 8.21 (2H, dt, J1 = 6.5 Hz, J2 = 2.5 
Hz Anil 5-H), 8.32 (1H, dd, J1 = 8.8 Hz, J2 = 6.6 Hz, Pyr 4-H), 8.37 (2H, s, Anil 2-H), 
8.42 (2H, d, J = 7.4 Hz Pyr 3/5-H), 11.31 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6): 
111.9 (Anil 3-C), 118.8 (Anil-CN),  124.1 (Anil 2-C), 126.1 + 126.2 (Anil 6-C + Pyr 3/5-
C), 128.3 (Anil 4-C), 130.6 (Anil 5-C), 139.2 (Anil 1-C + Pyr 4-C), 148.6 (Pyr 2/6-C), 
162.5 (Pyr-C(O)NH). FAB-MS: m/z calc for [M+H]+ 368.1148, found: 346.1132. ESI-MS: 
m/z calc for [M+Cl]¯ 402, found: 402.   
 
N2,N6-bis(3-Trifluorophenyl)pyridine-2,6-dicarboxamide, 11 
2,6-Pyridinedicarbonyl dichloride (0.423 g, 2.07 mmol) was dissolved in 
acetonitrile (7.0 mL) and was added dropwise to a stirring solution of 3-
trifluoromethylaniline (1.083 g, 6.72 mmol) and triethylamine (5.0 mL, 35.9 mmol) in 
acetonitrile (11.0 mL additional for 18.0 mL total) held at 0 °C in an ice bath.  Upon 
completion of the addition, the system was returned to room temperature and stirred for 24 
hours.  The resulting white suspension is filtered, resuspended with acetonitrile (2 x 25 
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mL) and diethyl ether (1 x 10 mL) and refiltered after each suspension before drying under 
high vacuum.  The resulting white solid is retained as the pure product (0.346 g, 37%, mp 
= 260-261 °C).  1H-NMR (DMSO-d6): 7.55 (2H, d, J = 7.7 Hz, Anil 4-H), 7.71 (2H, t, J = 
7.8 Hz, Anil 5-H), 8.19 (2H, d, J = 7.9 Hz, Anil 6-H), 8.34 (1H, t, J = 7.9 Hz, Pyr 4-H), 
8.44 (4H, m, Anil 2-H + Pyr 3/5-H), 11.25 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6): 
117.0 (Anil 2-C), 120.7 (Anil-CF3), 124.6 (Anil 4-C), 125.7 (Anil 6-C), 129.3 (Pyr 3/5-C), 
130.8 (Anil 3-C + Anil 5-C),  138.9 (Anil 1-C), 140.3 (Pyr 4-C), 148.4 (Pyr 2/6-C), 162.1 
(Pyr-C(O)NH). FAB-MS: m/z calc for [M+H]+ 454.0990, found: 454.0995. ESI-MS: m/z 
calc for [M+Cl]¯ 488, found: 488.   
 
N2,N6-bis(3-Chlorophenyl)pyridine-2,6-dicarboxamide, 12 
2,6-Pyridinedicarbonyl dichloride (0.426 g, 2.09 mmol) was dissolved in 
acetonitrile (5.0 mL) and was added dropwise to a stirring solution of 3-chloroaniline 
(0.861 g, 6.75 mmol) and triethylamine (5.0 mL, 35.9 mmol) in acetonitrile (10.0 mL 
additional for 15.0 mL total) held at 0 °C in an ice bath. Upon completion of the addition, 
the system was returned to room temperature and stirred for 24 hours.  The resulting white 
suspension is filtered, resuspended with acetonitrile (2 x 25 mL) and diethyl ether (1 x 10 
mL) and refiltered after each suspension before drying under high vacuum.  The resulting 
white solid is retained as the pure product (0.561 g, 70%, mp = 245-247 °C).  1H-NMR 
(DMSO-d6): 7.25 (2H, d, J = 7.9 Hz, Anil 4-H), 7.48 (2H, t, J = 8.1 Hz, Anil 5-H), 7.90 
(2H, d, J = 7.9 Hz, Anil 6-H), 8.16 (2H, s, Anil 2-H),  8.31 (1H, t, J = 7.7 Hz, Pyr 4-H), 
8.41 (2H, d, J = 8.2 Hz Pyr 3/5-H), 11.19 (2H, s, C(O)NH-Anil). 13C-NMR (DMSO-d6): 
119.5 (Anil 6-C), 120.4 (Anil 2-C), 124.1 (Anil 4-C), 125.7 (Pyr 3/5-C), 130.5 (Anil 5-C), 
133.0 (Anil 3-C), 139.6 (Anil 1-C), 140.1 (Pyr 4-C), 148.6 (Pyr 2/6-C), 161.9 (Pyr-
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C(O)NH). FAB-MS: m/z calc for [M+H]+ 386.0463, found: 386.0463. ESI-MS: m/z calc 
for [M+Cl]¯ 420, found: 420.   
 
Chloride binding constants from 1H-NMR titrations.  
Solutions of the receptor molecule in DMSO-d6 or CD2Cl2 were prepared at a 
concentration of 1.8 mM. A 1 mL solution thus prepared was transferred to a glass NMR 
tube and titrated with a solution containing both 1.8 mM of host and 18 mM solutions (10 
equiv.) of NBu4+Cl-. The chemical shifts of the NH protons were monitored as a function 
of the anion concentration until saturation was reached. Using data accrued from a 
minimum of three independent determinations, the association constants were calculated 
using a nonlinear regression analysis (GraphPad) with a curve fit for 1:1 binding originally 
used by Kavallieratos et al.17b  
 
Competitive chloride binding assayed by electrospray mass spectrometry, as 
performed by I. Alexandru Carasel, Joseph Kramer and Dr. Rudolph Winter.   
In each experiment, competing hosts were present in equimolar concentrations (50 
μM) and chloride (as NBu4Cl salt) was kept sub-stoichiometric (5 µM) so that competition 
for the guest would be obvious. The excess neutral host molecules are not observed unless 
complexed by Cl¯, so excess host could be ignored. The ratios shown in Table 3.2 were 
calculated from the total integration of relevant m/z peaks for host-Cl¯ adducts. Five 
charged adducts were observed at significant abundances: [hostACl]¯, [hostBCl]¯, 
[(hostA)2Cl]¯, [(hostB)2Cl]¯, and [hostAhostBCl]¯, and total relative abundances were 
calculated for both hosts.  In every case, the total relative abundance of the unsubstituted 
isophthalamide, 5, was normalized to 1, with a value established for the competing 
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compound.  Errors are the calculated standard deviations of ratios from at least three 
independent experiments.  
 
Preparation of phospholipid vesicles.  
3.6 mL of a 25 mg mL-1 chloroform solution of dioleoylphosphatidylcholine 
(DOPC, from Avanti Polar Lipids; Alabaster, AL), was distributed equally to 6 test tubes 
before evaporating the solvent in vacuo for 4 hours to yield dry films of 15 mg each. For 
each vesicle preparation, a dry film sample was dissolved in a mixture of Et2O (375 μL) 
and aqueous 1 mM lucigenin – 225mM NaNO3 (375 μL). The combined mixture was 
sonicated for 30 s yielding a yellow suspension. The diethyl ether was removed under low 
vacuum at 30 °C for 2 to 2.5 hours. The resulting mixed micellar, vesicular, and aggregate 
aqueous suspension was extruded through a 200 nm pore-size membrane filter 5 times. 
The filtered suspension was passed through a Sephadex G25 size exclusion column that 
was previously equilibrated with a 225 mm NaNO3 external buffer, collecting the first 
translucent fractions. This process effectively eliminated undesired extra-vesicular 
lucigenin as well as micelles and vesicles of a smaller-than-desired size. The size of the 
resulting purified vesicles was confirmed by light-scattering analysis, and the sample was 
diluted to the appropriate concentration using the 225 mm NaNO3 external buffer. 
 
Lucigenin quenching assay.  
A 1900 μL aliquot of 0.31 mM vesicles in external buffer was placed in a quartz 
cuvette to be used for the lucigenin quenching experiment. The excitation wavelength was 
set to 368 nm and the emission wavelength to 506 nm, with both slits set to 5 nm. After a 
brief initial equilibration phase, 100 μL of a 4 M NaCl solution were added in order to 
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create a chloride gradient between the outside (190 μM) and the inside (0 μM) of the 
vesicles. When the fluorescence intensity stabilized, 2 μL of the desired compound at the 
appropriate concentration (10 mM stock solution for studies with 10 μM concentrations) in 
DMSO were added. At the end of each experiment the vesicles were lysed with 100 μL of 
a 2% Triton X-100 solution to establish the level of baseline fluorescence.  The traces 
shown are an average of at least 3 independent trials. 
 
Planar bilayer conductance as performed by Saeedeh Negin.  
Membranes were formed by painting lipid solutions (asolectin from soybean 
dissolved in n-decane, 25mg mL-1, from Avanti Polar Lipids; Alabaster, AL) over a 200 
m aperture separating two chambers containing 3.000 mL buffer solutions (450 mM KCl, 
10 mM HEPES, pH = 7.00).  21L of a DMSO solution of the appropriate transporter was 
then added into the cis chamber (the side of the membrane that hosts the input electrode) to 
yield a final concentration of 7 M. Working in a Faraday cage (Warner Instruments) at 
room temperature, specific potentials were applied between two electrodes immersed in the 
two buffer solutions. The resulting currents were amplified (amplifier BC-525 D, from 
Warner Instruments), filtered with a 4-pole Bessel filter at 1 kHz, digitized by Digitizer 
(Digidata 1322A from Axon Instruments), sampled at 100 Hz amplifier filter frequency 
and collected using Clampex 9.2 (Axon Instruments). The data were analyzed later using 
Clampfit 9.2 (Axon Instruments). 
 
Fluorescence of compound 4.  
Fluorescence emission intensity was found to be maximal for all wavelengths with 
λex = 280 nm when both slits were set to 5 nm.  The fluorescence emission spectrum was 
114 
recorded while titrating a solution of host in 1% DMSO/Water into a solution of either 1% 
DMSO/Water or 1% DMSO/Water with 0.31 mM DOPC vesicles.  In all cases, the 
recorded spectra are the average of 10 scans per concentration per trial with a minimum of 
three independent trials totaling a minimum of 30 scans.   
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CHAPTER 4 
Solvent Dependence of Solid-State and Nanoscale Structures of 
Branched-Chain Pyrogallol[4]arenes 
 
Summary and Contributions to this Work 
 
The work presented in this chapter focuses on the solid-state and nanoscale 
morphologies of pyrogallol[4]arene macrocycles with branched sidechains.  These 
compounds were analyzed for solid-state or “Angstrom-scale” geometry and morphology 
by X-ray crystallography and analyzed for nanoscale geometry and morphology by 
cryogenic transmission electron microscopy (cryo-TEM). 
Solid-state structures show that within a family of branched-chain 
pyrogallol[4]arenes, one in particular self-assembles into unique hexameric nanotubes.  
Further analysis reveals that while the phenolic “head-group” is identical for all 
pyrogallol[4]arenes, sidechain-sidechain interactions dominate the self-assembly, and a 
unique intermolecular hydrogen bonding motif exists. 
Both the crystallizations and electron microscopy sample preparations were 
performed in various solvent conditions—polar, non-polar, protic, aprotic—and in mixed 
solvents.  While crystallizations were unsuccessful in many cases, EM sample preparations 
by slow evaporation generally yielded usable specimens. These specimens reveal that 
nanoscale aggregates self-assemble in polar media.  Under 50000x magnification, these 
aggregates are shown to be formed from bundles of what appear to be short nanotubes of a 
diameter congruent with measurements taken from X-ray crystal structures. 
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The solid-state X-ray crystal structures of these compounds were solved at the 
University of Missouri – St. Louis by Dr. Nigam Rath using crystals grown by Dr. 
Kulikov.   My contributions to the solid-state work are confined to the analysis of the 
structures and the associated DFT-level calculations. 
With the exception of the first set of specimens examined (seen in Figure 4.8, 
below), I prepared samples of compound 2 for analysis by transmission electron 
microscopy, which was performed with the assistance of Dr. Dan Zhou and David Osborn 
at the University of Missouri – St. Louis. 
A portion of this work is included in a paper1 published in Chemical 
Communications in 2009.  
 
Introduction 
 
While covalent and ionic bonds are the strongest of interatomic forces and are thus 
key factors in the formation of structures on the nanometer scale, weaker forces such as 
hydrogen bonding, dipole-dipole, and van der Waals’ (or London dispersion) forces can 
play prominent roles as well.  Solid-state and nanoscale morphologies are of utmost 
importance when considering the activity of a compound in a biological membrane. 
Aggregates visible on the nanoscale using techniques such as transmission electron 
microscopy (TEM) may be indicative of a propensity for a compound to self-aggregate.  
Self-aggregation may preclude membrane insertion in some cases or may lead to 
unexpected characteristics in other cases.  This paradox is seen in the two synthetic 
chloride channels that have been developed in our lab—the peptidic SAT transporters and 
the dipicolinic dianilide triarenes detailed in Chapter 3. 
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With the SAT molecules, self-aggregation of those family members with long alkyl 
chains at either the N- or C-terminus anchors leads to a decrease in chloride transport 
activity at a given applied concentration.2  A large proportion of these specific SAT 
molecules form large, stable aggregates in the aqueous media.  As a result, the effective 
concentration—the fraction of the total concentration that inserts into the membrane and 
transports chloride—is decreased.  Generally, with increasing alkyl chain length and, by 
extension, hydrophobic character, the effective concentration decreases and overall 
chloride transport activity decreases. 
Hydrophobic character was designed into the amphiphilic SAT system, as it was 
believed that it was necessary for membrane insertion.  Indeed, it is true that for SAT 
molecules with alkyl chains that are too short, chloride transport rate is significantly 
diminished due to lack of membrane insertion and a lowered effective concentration.  
Thus, the hydrophobic character of a potential ion transporter must be balanced to both 
allow membrane insertion and minimize unwanted self-aggregation. 
With dipicolinic dianilides, however, self-aggregation in aqueous solution leads to 
increased chloride transport activity as, with higher concentration, more aggregation 
occurs.  A stacked aggregate is capable of spanning the phospholipid bilayer and 
transporting chloride via a channel mechanism.3  This aggregation is explored in full detail 
in Chapter 3 of this work. 
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Figure 4.1. Structures of branched-chain pyrogallol[4]arenes 1-4, investigated in this 
work.  As variation is present only in the aldehyde-derived side chains, they can be 
distinguished in future reference as 2-propyl (compound 1), 3-pentyl (2), 4-heptyl (3) and 
5-nonyl (4).  In the same crystallization conditions, 1, 3 and 4 form the bilayer (example in 
bottom left panel) while 3 forms a unique hexameric nanotube (bottom right). 
 
Another family of compounds known as pyrogallol[4]arenes have been made and 
characterized by a colleague in our research group, Oleg Kulikov.  The hydroxyl-rich 
tetrarenes are formed from the 4+4 condensation of pyrogallol (1,2,3-trihydroxybenzene) 
and an aldehyde under acidic conditions.4 The reaction proceeds through an electrophilic 
aromatic substitution at the 4 and 6 positions of the arene, ultimately resulting in 
cyclization.  Variation of the aldehyde used in the condensation allows for modification of 
the four “legs” or “sidechains” of the macrocycle.  Pyrogallol[4]arenes with sufficiently 
lipophilic sidechains are amphiphilic in nature, owing to the hydroxyl-rich “upper rim” of 
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the macrocycle seen in Figure 4.2.  Work performed by another colleague, Megan 
Daschbach, indicates that this amphiphilic behavior extends to pyrogallol[4]arenes with 
sidechains as short as three carbons.5  
 
 
Figure 4.2. Orthogonal perspectives of the calculated lowest energy gas-phase 
conformation of the 3-pentyl branched chain pyrogallol[4]arene,  2. 
 
The pioneering work of Atwood and collaborators with these pyrogallol[4]arenes 
has explored a wide variety of straight-chain alkane and alkene sidechains, among 
others.4,6  While many of the solid-state structures of these macrocycles exhibit a bilayer 
morphology that is typical of amphiphiles,7 a number of these compounds have been 
shown to self-assemble under the proper solvent conditions to form hydrogen-bonded 
dimeric8 and  hexameric9 nanocapsules.  Additionally, one pyrogallol[4]arene has been 
shown to assemble, in the presence of an ancillary molecule, into a solid-state nanotube 
formed from stacks of hydrogen-bonded rings of four macrocycles each.6b 
In the present work, Dr. Kulikov was able to isolate crystals of compounds 1-4 
grown from the polar solvent systems 1:1 ethanol to ethyl acetate and 1:1 acetonitrile to 
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ethyl acetate.  These crystals were characterized by X-ray analysis and the resulting 
structures were studied further to elaborate structural detail and solid-state geometry. 
One pyrogallol[4]arene, the 3-pentyl compound, 2, was found to form nanotube 
structures in the solid state, while the remainder form a typical bilayer morphology.  The 
nanotubes formed by 2 appear to pack tightly with one another, leaving open the 
possibility of forming nanostructures, which are shown to form on a carbon coated copper 
grid after slow evaporation of solvent.   
The nanoscale characterization is extended in the current work to investigate the 
variation in nanoscale morphologies based on the evaporation of solvent, as well as to 
determine the presence of and analytically compare the crystallinity and order in the 
solvent-evaporated specimen.  If different solvents yield different nanoscale morphologies, 
and if diffraction patterns are present, a comparison of patterns can be made.  If the same 
diffraction pattern and lattice spacings arise from different nanoscale morphologies, it 
supports the argument that both morphologies form from the same supramolecular 
structure—the nanotube, for example.  If the diffraction patterns are different, it lends 
credence to the argument that different nanoscale morphologies arise from different 
supramolecular structures. 
Diffraction patterns of soft materials—most notably carbon nanotubes10—have 
been acquired and used to differentiate varying molecular structures from similar or nearly-
identical nanostructure morphologies.  In another previous study, calix[4]arenes, which are 
similar in structure to the pyrogallol[4]arenes used in this study, were deposited on a 
particular face of a gold crystal, self-organizing into a flat crystalline overlayer.11  This 
supramolecular organization was determined by the combined use of scanning tunneling 
microscopy and low-energy electron diffraction.   In both of these previous studies, low 
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energy-electron diffraction (LEED) was used to garner structural information on the 
molecular level—a strategy that may be used with normal energy electron diffraction to 
simply reveal differences in molecular/supramolecular structure, if not the structures 
themselves.  Unfortunately, these techniques were not available for our efforts, so TEM 
visualization of nanostructures and analysis of polycrystalline diffraction rings are the 
techniques used to garner as much information as possible herein.  
 
Results and Discussion 
 
Solid-state structure of branched-chain pyrogallol[4]arenes 
The synthetic efforts of Dr. Kulikov, further characterized as presented here, were 
targeted at understanding the effects of branched sidechains on the self-assembly of 
pyrogallol[4]arenes in solution and in the solid-state.  Four branched-chain 
pyrogallol[4]arenes were prepared for the present study. The acid-catalyzed reaction of 
pyrogallol with isobutyraldehyde, 2-ethylpropanal, 2-propylbutanal, or 2-butylpentanal 
gave, respectively, pyrogallol[4]arenes 1, 2, 3 and 4 shown in Figure 4.1.  With one of 
these sidechain variations, macrocycle 2, a self-assembled hydrogen-bonded nanotube has 
been shown to form in the solid-state.  The nanotube consists of an infinite stack of rings 
of six hydrogen-bonded macrocycles. Conversely, under identical crystallization 
conditions, pyrogallol[4]arenes 1, 3, and 4 crystallize in the more common bilayer 
morphology. 
Samples suitable for X-ray crystal structure determination were obtained for 
compounds 1, 2, 3, and 4 by crystallization from 20:19:1 (v/v/v) EtOAc:EtOH:H2O. Solid-
state structural analysis confirmed the bilayer structures for 1, 3, and 4.  In all three cases, 
126 
the pyrogallol[4]arene molecules align face-to-face with the phenolic hydroxyls 
participating in a significant amount of intermolecular and interfacial hydrogen bonding.  
Simultaneously, the branched hydrocarbon sidechains align tail-to-tail, maximizing polar 
solvent exclusion and minimizing void space.  Although none of these bilayer structures 
had been previously described, the observed bilayer organization is similar to that reported 
for related compounds with straight alkyl chains. 
 
Figure 4.3. Orthogonal perspectives of a single hydrogen-bonded hexameric ring of 
molecules of compound 2 formed in a 20:19:1 (v/v/v) EtOAc:EtOH:H2O solvent mixture.  
Molecules directly opposite one another in the ring are related by Ci symmetry, with the 
inversion point located on the tube axis.  Solvent molecules and side-chains are omitted for 
clarity. 
 
In contrast, when 3-pentylpyrogallol[4]arene, 2, was crystallized, either from 
20:19:1 (v/v/v) EtOAc:EtOH:H2O (“form A”) or 1:1 (v/v) EtOAc:MeCN (“form B”), 
identical structures of the hexameric nanotube morphology were obtained. The 
organization of a single hexameric ring is shown in Figure 4.3 as a cross-section of the 
solid-state structure obtained from the ethanol-ethyl acetate solvent system.   
Form A, which crystallized from 20:19:1 (v/v/v) EtOAc:EtOH:H2O, has an 
empirical formula C152H238O52 and a molecular weight of 2897.4 g/mol that is consistent 
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with half of a hexameric ring (i.e., a trimeric “half-ring”). This corresponds to 3 
pyrogallol[4]arene subunits, 4 EtOH, and 12 H2O molecules. This repeating structure 
comprises one half of a hexameric nanotube ring, with the other half-ring related by 
reflection through a single inversion point that lies on the nanotube axis (Ci symmetry). A 
full ring is held together by two direct hydrogen bonds between each neighboring subunit 
and direct solvent-bridging interactions involving 2 EtOH and 6 H2O molecules. Rings are 
linked by 18 subunit-to-subunit hydrogen bonds — 2 per subunit plus 6 additional H-bonds 
between specific subunits. These interactions are shown in Figure 4.4. Note that no solvent 
molecules participate in direct ring-to-ring bridging, and no organized ethyl acetate 
molecules are present. 
Form B of 2, crystallized from 1:1 (v/v) EtOAc:MeCN and has the empirical 
formula C162H229N5O43 (mw 2934.5 g/mol). The molecular weight corresponds to 3 units 
of 2, 3 EtOAc, 5 MeCN, and 3 H2O molecules. As in form A, this comprises half of the 
hexameric ring. The internal and external dimensions of Forms A and B are not identical 
but differ by less than 1 Å in any direction. The direct subunit-to-subunit hydrogen bond 
network is identical in Forms A and B, although additional interactions occur with either 
EtOH (Form A) or EtOAc (Form B). 
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Figure 4.4. A depiction of the supramolecular interactions involved in a hexameric ring 
derived from the ethanol-ethyl acetate system (Form A). The depiction is a “Mercator-
like” projection from the outside of the tube looking towards the tube axis running 
vertically and is not drawn to scale. The sixth subunit (C’) is not shown as its interactions 
are identical to those between the C subunit and its neighbors B and A’. The A’ subunit of 
the ring below and the B subunit of the ring above are shown for clarification of inter-ring 
interactions. Bridging waters are shown as red spheres while bridging ethanol molecules 
are shown as red spheres connected to black ellipses. Relevant hydrogen bonds are 
depicted as blue dashed lines. 
 
Figure 4.5. (Top) Side view of a stack of six hexameric rings composed of 
pyrogallol[4]arene 2. For clarity, the 3-Pentyl side chains and solvent molecules are not 
depicted. (Bottom) A cartoon representation of tube formed by the stacked rings, showing 
the tube axis and the cylinder formed.  The dimensions of the elliptical tube are measured 
within the plane that is normal to the tube axis. 
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Analysis of Form A shows that the hexameric rings that form the nanotubes are 
elliptical and tilted by about 30° with respect to the tube axis normal, as presented in 
Figure 4.5. Using measurements of atoms that are coplanar with the tube axis normal, the 
nanotubes themselves are shown also to be elliptical with short and long axis internal 
dimensions of 16 Å x 22 Å between hydroxyl oxygen atoms and external dimensions of 26 
Å x 33 Å measured between distal side-chain carbon atoms.  
The nanotube formed in this structure is much larger than related predecessors. 
Approximately 60% of the crystal's volume is an intra-annular, solvent-filled void. This 
compares with previously reported internal volumes of 38% for Atwood’s 
pyrogallol[4]arene tetrameric ring nanotubes,6b and 6% for the resorcin[4]arene inverted 
hexameric ring nanotube characterized by Rissanen and co-workers.12 The larger void 
volume in the present case may explain the higher R-factor (R1) of 16.5% (form A) and 
18.2% (form B) compared to R1 values of 9.4%,6b 11.8%,6b and 9.0%12 for the previously 
reported nanotubes.  These void volumes are compared visually in Figure 4.6. 
In the previous cases of nanotube formation from resorcin[4]arene or 
pyrogallol[4]arene, a compound such as pyrene, 1-bromopyrene,6b or a diammonium salt12 
was present as an ancillary to the nanotube. In the current work, ordered solvent molecules 
appear in the crystal lattice, but the H-bond network does not appear to require them.  In 
contrast to the previous nanotubes and the other branched-chain solid-state structures, the 
3-pentyl sidechains appear to interlock like the teeth (or cogs) of gears to tightly join 
adjacent nanotubes and exclude solvent from the interannular domain. This interaction and 
the excellence of the fit are apparent in the top panel of Figure 4.7, which shows a top-
down view of three closely packed nanotubes.  
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Intertube side-chain carbon-carbon distances are often between 3.5Å and 4.5Å – at 
or near the sum of the van der Waals radii.  These contacts have been measured and 
enumerated for all four of the solid-state structures derived from branched chain molecules 
crystallized from 20:19:1 (v/v/v) EtOAc:EtOH:H2O.  When normalized to the unit cell 
composition (crystals of 1, 3 and 4 have two pyrogallol[4]arenes present in the unit cell, 
while 2 has three monomers), a direct comparison of contact distances can be made. The 
counts are portrayed in relation to carbon-carbon distances, with values binned to 
maximum cut-off points (0.05 Å, 5 pm).  The data binning is cumulative, meaning that a 
contact of 3.71 Å would be included in the 3.75Å count and counts for all higher values 
(3.80Å, 3.85Å, etc.). 
The number of close contacts present in these solid state structures suggests that the 
unique hexameric nanotube morphology formed by 2 is energetically advantageous.  The 
high number of close contacts (< 3.75 Å) formed in the solid-state as well as the high 
number of total contacts less than 4.10 Å is a manifestation of this energetic advantage, 
underscoring the possibility that these structures form spontaneously in polar 
environments. 
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Figure 4.6. Comparison of tube size and volume of Rissanen’s trimeric ring 
resorcin[4]arene tube  (Panel A), Atwood’s tetrameric ring pyrogallol[4]arene tube 
(Panel B), and the current hexameric ring pyrogallol[4]arene tube (Panel C).  All 
projections are along the tube axis, and no ordered intraannular solvent molecules are 
shown.   Polar interannular solvent molecules (present only in the resorcinarene nanotube, 
Panel A) are depicted in blue, macrocycle oxygen atoms are depicted in red, macrocycle 
carbon atoms in yellow, and lipophilic solvent molecules/co-crystallents shown in orange.    
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Figure 4.7. (Top) End-on perspective of three rings of three adjacent nanotubes (carbon 
atoms in green, blue or orange for each ring) showing the cogged or interlocked nature of 
the branched side chains in the interannular space. (Bottom) Cumulating histogram of 
interannular carbon-carbon contacts binned to the maximum contact distance. 
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Nanoscale morphologies of 3-pentyl pyrogallol[4]arene, 2  
The tight interlocking of pyrogallol[4]arene sidechains between nanotubes provides 
a mechanism for bundling of nanotubes and formation of discrete identifiable 
nanostructures.  Previous transmission electron microscopy (TEM) work by Oleg Kulikov 
shows that when specimens are prepared by evaporation of solutions or sonicated 
suspensions of these pyrogallol[4]arenes, nanoscale morphologies are evident.  His 
specimen was taken from a sample of 2 that had crystallized as form A and was 
resuspended in 20:19:1 (v/v) EtOAc:EtOH:H2O.  When this mixture was evaporated on a 
copper-continuous carbon support, nanowires composed of what are presumably bundles 
of tens to thousands of nanotubes are seen by transmission electron microscopy.  The 
specimen, as seen in Figure 4.8, exhibits small bundles forming in amorphous areas of the 
sample and larger bundles in the more ordered areas of the sample. As the solvent 
evaporates, the nanotube bundles could form more quickly or thoroughly in one area 
versus another.   
Detailed examination of TEM images acquired for the sample of compound 
2 revealed that the smallest dark lines typically have a width of 9-10 nm. The 
thinnest lines that are visible have a width of 6-7 nm. If the microfiber bundles are 
exclusively nanotubes, then each individual nanotube is a cylinder of approximate 
dimension 30 Å. Four coaxial tubes would have an external dimension of 60-70 Å 
(6-7 nm). 
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Figure 4.8: Bright-field images of a single specimen prepared by Dr. Oleg Kulikov  from 
the evaporation of a solution of pyrogallol[4]arene in a 1:1 mixture of ethyl acetate and 
acetonitrile.  Images are taken at a magnification of 2500x.  Larger, thicker rhomboidal 
cylinders with diameters between 270 nm and 13 nm are seen in panel A in a more 
amorphous, thicker “field” of presumably disordered pyrogallol[4]arene.  Panel B shows 
a more extensive and numerous “web” of nanotube bundles with fewer areas of 
amorphous “fields.” 
 
 Dr. Kulikov’s work has proven that these compounds can form nanostructures 
when evaporated from solution.  However, only one solvent system—a 1:1 mixture of 
ethyl acetate and acetonitrile has been used to form nanostructures.  Variation of the 
solvent systems used to prepare the specimen may yield different nanostructures. 
Four solvent systems were investigated for the current work—the original 1:1 ethyl 
acetate to acetonitrile mixture, a 1:1 ethyl acetate to ethanol mixture, a 99:1 water to 
ethanol mixture, and a pure ethanol mixture.  The 99:1 water to ethanol mixture yielded the 
most interesting results and will be discussed at length.  Nanostructures derived from the 
other solutions were all varied, and comparisons will be made following the discussion on 
the specimen prepared from the 99:1 water to ethanol suspension. 
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Particle size analysis of the post-sonication 99:1 water to ethanol suspension by 
dynamic light scattering showed that aggregates were non-spherical, with a wide 
distribution of average diameters.  Using the TEM at 2500x magnification, large particles 
of what appeared to be crystalline powder were seen, as shown in Figure 4.9.  However, 
under higher magnification (10000 x) the large aggregates appeared as large cylinders of 
diameters varying from 900 nm to 150 nm.  These large cylinders displayed ordered 
texture, spaced at about 25 to 26 nm, running the length of the cylinder, as seen in Figure 
4.10.  Also evident at this magnification were smaller nanowire-like structures that 
appeared to emanate from the surface of the larger cylinders, as seen in Figure 4.11.  These 
also varied in diameter with a range of about 80 nm to 20 nm, and may have been 
deposited by solvent in an ordered manner at the cylinder surfaces during the evaporation 
process.  As thickness cannot be easily judged using phase-contrast imaging, it is unknown 
whether these structures are 3-D nanowires or 2-D nanobelts.  Presumably, a large 
proportion of the pyrogallol[4]arene monomers in the sonicated solution remained as the 
large cylindrical aggregates that form, immediately.  However, a smaller proportion 
becomes solvated in the sonication process and the solvated monomers deposited at the 
ordered cylinder surfaces. 
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Figure 4.9: Phase contrast image (2500x magnification) of the specimen, taken from an 
evaporated, sonicated solution of pyrogallol[4]arene in 99:1 water to ethanol.  The larger, 
thicker cylinders are between 900 nm and 150 nm in diameter, while the smaller 
nanowires are between 80 nm and 20 nm in diameter. 
 
 
137 
 
Figure 4.10: Phase contrast image of a large cylindrical aggregate taken at 10000x 
magnification.  Ordered texture is seen running the length of the cylindrical aggregate, 
with thickness, and thus transmission loss, increasing near the center of the cylinder. 
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Figure 4.11: Phase contrast image (10000x magnification) of the same cylindrical 
aggregate seen in Figure 4.10. Bundles of nanotubes (8-20 nm diameter) are seen 
radiating from the circular edge, or “top,” of the cylinder.  This phenomenon is seen 
throughout the specimen.   
 
This ethanol-water post-sonication specimen was investigated further for possible 
crystallinity and order.  When a large cylindrical aggregate is isolated by the selective-area 
aperture, a polycrystalline-like diffraction ring is seen, but the wide bands indicate that the 
nanostructure is too amorphous to be considered polycrystalline.  Polycrystalline can be 
differentiated from crystalline in that the latter is organized into a single crystal lattice (or 
relatively few crystal lattices) while the former consists of crystallites that can be of 
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various sizes and different orientations.  Rings are formed in the diffraction patterns of 
polycrystalline materials due to their random orientations, while crystalline materials 
diffract at distinct points. 
 
  
Figure 4.12: (Top left) Phase contrast image taken at 2500x magnification of three larger 
cylindrical aggregates.  The area of the image under the beam-stop tip is selected for using 
the SAD aperture to produce the diffraction rings (top right).  Image (bottom left) and the 
derived ring pattern (bottom right) of a “web” of smaller bundles of nanotubes not 
associated with a large aggregate. 
 
The aggregate examined and the resulting diffraction pattern can be seen in the 
upper left and upper right panels of Figure 4.12, respectively.  The observed ring pattern is 
the same when examining a “web” of smaller bundles of nanotubes as seen in lower left 
panel of Figure 4.12.  A direct comparison can be made between the rightmost panels.  
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Nanostructures formed from the evaporation of the other three solvents were 
dramatically different.  The 1:1 ethyl acetate to acetonitrile solution originally used to 
prepare the specimen seen in Figure 4.8 was used once again, nearly three months later, to 
determine if the nanostructures morphology remains stable over time.  The more recent 
transmission electron micrograph, seen in Figure 4.13, is dramatically different.  The 
sample exhibits the same “fields” of presumably amorphous disordered pyrogallol[4]arene, 
yet the visible nanostructures formed are spherical outcroppings, or “buds,” from the 
amorphous fields.  Attempts to examine fine structure at higher magnification showed that 
no fine structure was apparent (Figure 4.13, Right) 
 
Figure 4.13: (Left) Phase contrast image (5000x) magnification of spherical “buds” or 
outcroppings from the amorphous pyrogallol[4]arene fields present in this specimen, 
prepared from evaporation of a solution of monomer in 1:1 ethyl acetate to acetonitrile. 
(Right) An image (10000x) magnification revealing no additional insights into fine 
structure or nanostructure order.  
 
The nanostructures seen in the specimens prepared from evaporation of absolute 
ethanol and 1:1 ethyl acetate to ethanol possessed the most similar nanostructure 
morphologies.  Side-by-side comparison of the two—seen on the left and right panels, 
respectively—was made at 25000x magnification (Figure 4.14) and 50000x magnification 
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(Figure 4.15).  The similarities were striking at both magnifications, particularly at 50000x, 
and one can reasonably assume that these solvent systems form the same nanostructures 
upon evaporation.  This observation, coupled with the observation that crystallization of 
this pyrogallol[4]arene from 1:1 ethyl acetate to ethanol shows no ordered ethyl acetate 
molecules in the solid-state crystal structure, supports the argument that even though there 
is a difference in polarity between the two solvents, ethyl acetate has no effect in both 
supramolecular and nanoscale structure formation when ethanol is involved. 
   
Figure 4.14: (Left) Phase contrast image (25000x magnification) of a specimen prepared 
from evaporation of a solution of monomer in 1:1 EtOAc to EtOH. (Right) An image 
(25000x magnification) of a specimen prepared from absolute EtOH.  
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Figure 4.15: (Left) Phase contrast image (50000x magnification) of the same 1:1 ethyl 
acetate to ethanol specimen seen in the left panel of Figure 4.14. (Right) An image (50000x 
magnification) of the absolute ethanol specimen seen in the right panel of Figure 4.14.  
 
Evident at the higher magnification (50000x) seen in Figure 4.15, are distinct 
rectangular and ordered “tiles” measuring about 25 to 35 Å in diameter.  This is roughly 
the size of a single nanotube in the solid state structures.  These “tiles” are closely packed 
in 2-D space, as one sees in the solid-state crystal structure.  These nanostructures could 
perhaps be large aggregates or bundles of short nanotubes, but the amorphous environment 
of the surrounding material and the difficulty in studying a given particle at high 
magnification for long periods of time makes this statement a supposition. 
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Figure 4.16: (Left) Phase contrast image 
taken at 100000x magnification of the same 
absolute EtOH specimen seen in the right 
panels of Figure 4.14 and 4.15.  
 
Attempts to image the material at high magnification were made, but were futile.  
As seen in Figure 4.16, specimen drift and degradation of the sample prevented the capture 
of a high-resolution image, and no additional information could be gleaned. Unfortunately, 
at high magnifications (>50000x), specimen degradation and shift is significant in all of 
the studied samples.   
  
Conclusions 
 
 The formation of the hexameric nanotube morphology by compound 2 is 
surprising.  No ancillary or solvent molecules are present to aid in ordering the sidechains 
or filling void space in the hydrophobic domain of the crystal.  Enthalpically, the only 
energetically favorable supramolecular interactions exist at the interfaces of the 
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hydrophilic phenolic regions of the macrocycle.  As the pyrogallol[4]arenes are structurally 
identical in this region, one would expect the supramolecular interactions to also be 
identical in solution and the solid-state.  As with the “hydrophobic interactions” mentioned 
previously, the variation in solid-state morphology is derived from the geometry that 
minimizes supramolecular hydrophobic-hydrophilic contacts and increases solvent 
entropy.   
This entropy is easily exemplified in the void space that is present in the crystal.   
The interannular portion of the crystal is roughly 60% of the crystal lattice by volume.  A 
layer of polar protic solvent molecules (water and ethanol) are organized by the phenolic 
hydroxyls lining the nanotube interior (or pore).  However, significant disorganization of 
the space between this first layer of solvation signifies that a favorable solvent entropic 
situation exists. 
 The tight interlocking between the 3-pentyl sidechains of pyrogallol[4]arene 2 
appears to be the dominant force in the crystal lattice.  This “gearing” interaction 
completely excludes water or other solvent molecules from the hydrophobic region of the 
crystal and perfectly minimizes void space in this intraannular domain.  The larger 
branched-chain pyrogallol[4]arenes 3 and 4, have 12 and 24 extra methylenes per 
macrocycle, respectively.  In an extended geometry, the extra carbon atoms expand the 
radius of the hydrophobic domain beyond the radius encompassed by the phenolic upper 
rim of the macrocycle.  With too much steric bulk to accommodate between the rings, the 
cogged, hexameric ring geometry of 2 is not the entropically-preferred morphology and a 
bilayer is formed.  Presumably, the shorter-chained pyrogallol[4]arene 1 would yield too 
much void space in the cogged nanotube morphology, as the steric bulk of 12 methylenes 
per macrocycle would be absent.  While studies at the air-water interface1,5 suggest that 
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some entropically-favored interaction occurs between macrocycle monomers, only the 
bilayer morphology is observed in the solid state. 
 Specimens prepared by evaporation of pyrogallol[4]arenes in four different solvent 
systems were studied and imaged by transmission electron microscopy.  The 
nanostructures morphologies were different for each solvent system, indicating that the 
solid-state crystallized nanotubes of compound 2 can form different nanostructures out of 
different solutions.  However, all nanostructures appear to be spontaneously-formed in 
polar solution, with the 1% ethanol in water solution yielding the only structures formed 
from evaporation.  
 The specimens formed from solutions of pyrogallol[4]arene 2 in ethanol or 1:1 
ethanol to ethyl acetate show ordered aggregates that exhibit fine structure.  At 50000x 
magnification, these aggregates are shown to be composed of structures approximately 25 
to 35 Å in diameter, the same dimensions as the nanotube observed in the solid state.  This 
observation confirms the nanotube supramolecular morphology.  In this solvent system, 
however, the rings do not form into infinite stacks—a trait which may only be present in 
the sonicated 1% ethanol in water specimens. 
 
Experimental 
 
Compounds Studied 
 
Compounds 1-4 
These compounds were synthesized by Dr. Oleg Kulikov and were used as received.  
Synthetic details are reported in the literature.1 
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X-Ray Analysis 
 Crystallographic data for compound 2 crystallized from the mixture 20:19:1 (v/v/v) 
EtOAc:EtOH:H2O in nano-tubular motif (form A). C152H238O52, M = 2897.42, triclinic, a = 
12.5581(17), b = 29.097(5), c = 30.504(7) Å, U = 9743(3) Å3, µ = 0.074 mm-1, T = 100(2) 
K, space group P-1, Z = 2, GOF = 1.129, final R-indices (R1 = 0.1645, wR2 = 0.3740), 
103521 reflections collected, 33806 unique (Rint = 0.186), CCDC 729499.  
              Crystallographic data for compound 2 crystallized from the mixture 1:1 
(v/v)EtOAc:MeCN in nano-tubular motif (form B). C162H229N5O43, M = 2934.50,               
triclinic, a = 12.546(2), b = 29.291(6), c = 29.804(5) Å, U = 9564(3) Å3, µ = 0.073               
mm-1, T = 100(2) K, space group P-1, Z = 2, GOF = 1.619, final R-indices (R1 =              
0.1820, wR2 = 0.4672), 155193 reflections collected, 32525 unique (Rint = 0.1644),              
CCDC 729498.  
Data for both crystal structures were collected on a Bruker Kappa Apex II CCD 
detector single crystal X-ray diffractometer.  
 
Transmission Electron Microscopy 
Four solvent systems were investigated for this study—the original 1:1 ethyl 
acetate to acetonitrile mixture, a 1:1 ethyl acetate to ethanol mixture, a 99:1 water to 
ethanol mixture, and a pure ethanol mixture.  The 99:1 water to ethanol specimen yielded 
large extended aggregates that were easily visible with the naked eye and thus too large for 
TEM work.  This mixture was sonicated for 15 minutes to give a stable suspension usable 
for specimen preparation.  In all cases, a copper/continuous carbon support grid was 
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dipped in a given pyrogallol[4]arene solution with a concentration of 600µM and left to air 
dry for 30 minutes.   
Specimens were examined and imaged primarily with the JEOL 2000 FX 
microscope with an electron acceleration voltage of 120kV.  CryoTEM conditions are 
achieved using a suitable specimen holder that cools the specimen using liquid nitrogen.   
A digital CCD camera was used to capture all images with this microscope.  However, for 
the images and associated diffraction patterns shown in Figure 4.12, the more powerful 
Phillips EM 430 microscope (acceleration voltage of 300kV) was used with a film camera 
for image/pattern collection.  The film negatives were developed and digitized by David 
Osborn. 
Images were taken primarily at 25000 x magnification or lower, as the 
nanostructures of interest were easily visible at these magnifications.  However, in a few 
cases, images were taken at 50000 x and 100000 x magnifications in an attempt to 
investigate the fine structure of nanostructures.  In many cases, specimen degradation and 
drift under the electron beam rendered images of low clarity and resolution, though these 
are examined. 
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CHAPTER 5 
Antimicrobial Activity and the Development of Antimicrobial 
Resistance to Synthetic Ion Carriers and Channels in Bacteria 
 
Summary and Contributions to this Work 
 
The work presented in this chapter focuses on the characterization of antimicrobial 
activity of novel compounds as well as an investigation into the development of 
antimicrobial resistance to a known novel synthetic cation channel in Escherichia coli.  27 
compounds were tested for their activity in Gram negative E. coli, revealing that only 
cation transporters of the known hydraphile family of compounds1 are active in the 
bacterium.  The other compounds studied, including known cation and anion transporters, 
did not elicit growth inhibition in E. coli.   
Growth curve measurements of Gram-positive Staphylococcus epidermidis were 
used to study the effects of co-application of a diaza-18-crown-6 antimicrobial cation 
transporter with one of two dipicolinic dianilide (Chapter 3) anion transporters.  The 
activity of the diaza-crown was monitored at both lethal and sub-lethal concentrations.  
While alone, the diaza-18-crown-6 that is studied affects antimicrobial activity, when co-
applied with a dipicolinic dianilide chloride transporter the effects are completely negated.  
The third and final project explored the development of antimicrobial resistance in 
E. coli to synthetic cation channel with known antimicrobial activity.    The antimicrobial 
resistance was studied with regular application of sub-lethal concentrations of the 
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hydraphile cation channel over 12 days.  While resistance did develop over the time period, 
it plateaued after 6 days of growth, developing no further resistance. 
Compounds 1-12 (structures below) were made and chemically characterized by 
Dr. Wei Wang, a former collaborator.  Compounds 13 and 14 were made and chemically 
characterized by Dr. Lei You, compounds 15-17 were made and chemically characterized 
by Dr. Oleg Kulikov, and compounds 18-27 were made and chemically characterized by 
me, as outlined in Chapters 2 and 3.  The 24-hour growth curves were measured for the last 
6 hours by an undergraduate researcher, Jason Atkins.  Otherwise, I performed all of the 
sample preparation, specimen storage, and microbiological assays reported here. 
A portion of this work is included in a paper published in Heterocycles in 2007.2 
 
Introduction 
 
 The development of resistance to first-, second-, and even third-line antibiotics is 
an alarming upward trend, prevalent in both the developing and developed world.3  
Overuse and misuse of antibiotics—antibacterial soaps for the general population, 
prophylactic antibiotic use in livestock, doctors wrongly prescribing antibiotics for the flu, 
patients not completing their prescribed regimen after they feel healthy—can all further the 
development of resistance.4  Application of antibiotics at sub-lethal concentrations—an 
end result of scenarios such as these—inevitably kills the weakest, least resistant 
phenotypes of a given bacterial strain, while the strongest and most resistant survive.5  This 
acceleration of evolution, coupled with the twenty minute average generation time for E. 
coli, exacerbates a problem (from a human perspective) that arises naturally, without 
antibiotics.6 
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Resistance to antibiotics can develop for many different reasons and through many 
different mechanisms.7  Eons before the pharmaceutical industry existed, a molecular arms 
race began between organisms small and large, simple and complex.  Over the millennia, 
multi-cell eukaryotic organisms have developed a myriad of defenses against their distant 
prokaryotic relatives.  Whereas humans have their own immune systems to fight off 
infection, other organisms have developed their own methods and molecules to do the 
same.   
At the same time, the prokaryotes have developed ways to circumvent these 
eukaryotic defenses, as well as put themselves at an advantage against other prokaryotes.  
As evolution continues, the organisms that can exploit their genetic advantages will go on 
to procreate and multiply—while those that cannot go by the wayside.  
While modern science has allowed us to isolate, characterize, improve, and use 
what antibiotic defenses nature has provided, we are only now beginning to see the effects 
of harnessing and improving nature on the organisms that we target for elimination.  Many 
of these natural molecules and synthetic analogues, such as the β-lactam antimicrobial 
agents, that have been cornerstones in antibiotic regimens, have been showing a marked 
increased of tolerance in pathogenic organisms.8 Only in the past few decades have we 
come to understand the many mechanisms and modes of antibiotic resistance.9  Once we 
are able to fully elucidate all of these mechanisms, efforts to target antibiotics in order to 
circumvent these prokaryotic defenses can come about at full steam. 
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Figure 5.1 Common drugs of “last resort” include the glycopeptide, vancomycin, the first 
oxazolidinone, linezolid, and the broad-spectrum beta lactam, imipenem. 
 
 The third-line of antibiotic defense, or “drugs of last resort,” include antibiotics 
such as vancomycin, imipenem, and linezolid that are prohibitively expensive, broad-
spectrum (adversely affecting ones natural gastric flora), relatively toxic to the host, or 
some combination of the three.10  While these have been used quite successfully against 
bacterial strains such as methicillin-resistant Staphylococcus aureus (MRSA)11 that are 
resistant to older drugs, some of these newer antibiotics are inciting resistance themselves, 
as evidenced by the appearance of vancomycin-resistant S. aureus (VRSA).12 
 At some point in the future, medical practitioners facing an outbreak of bacterial 
infections resistant to multiple antibiotics may have to release these drugs of last resort for 
broad use.   If this nightmare scenario comes to pass time and time again, our existing 
stockpile of novel antibiotics may run out.  To circumvent this future problem, an obvious 
solution is better handling and use of the antibiotics already in the field.  However, it might 
also be wise to find a proverbial über-drug—an antibiotic that is not only active against 
drug-resistant strains, but is immune to the development of resistance in bacteria. 13 
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 This über-drug may be found in the realm of novel synthetic molecules that have 
no significant structural basis in natural materials and do not interact directly with enzyme 
active sites or genetic material—areas where mutations could quickly lead to the 
development of resistance.14 Compounds derived from abiotic materials may be less likely 
to be metabolized by either the host or the target organisms.  “Foreign” structures and 
uncommon chemical moieties may have no “molecular predators”—enzymes with active 
sites that can bind with and break down the molecule.  Such a substance has a two-fold 
therapeutic advantage in vivo: (1) molecules that have diffused to the infection site will be 
broken down only slowly by the bacterial colonies, if at all and (2) bioavailability, or the 
proportion of the original dosage available where needed, is higher if the host cannot 
metabolize the substance.  This second advantage could be a drawback if the host cannot 
eliminate the foreign substance, inevitably becoming toxic if a build-up occurs. Such 
considerations must be weighed during pre-clinical in vivo testing with mammals, but this 
is beyond the scope of knowledge gleaned in a chemical biology laboratory. 
 The application of sub-lethal concentrations of antimicrobial agents has been 
employed previously to understand what fraction of the total may survive contact with the 
agent, and what changes may take place.15 However, it is now well known that the 
presence of sub-lethal concentrations of antimicrobial agents leads to multi-drug 
resistance, 16 specifically in nosocomial infections where both different strains of bacteria 
and different antimicrobial agents are present. 
 Our group’s studies in the biological realm consist primarily of assaying 
functionality in both natural and biological model systems.  In this regard, we have 
developed a number of membrane-active ion transporters, many of which display channel 
functionality.  Earlier work with diaza-18-crown-6 synthetic cation carriers showed that 
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channel functionality is not a requirement for  antimicrobial activity.17  Therefore, a broad 
range of ion transporters—anion or cation transporters with carrier or channel 
mechanisms—have been assayed for antimicrobial activity in the present work. 
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 Previous work in our laboratory group has yielded a well-studied membrane-
spanning, ion-conducting family of compounds known as hydraphiles.18  Aside from 
showing ion channel activity, many of the hydraphiles have exhibited antimicrobial 
activity, with efficacy against Gram negative Escherichia coli, Gram positive Bacillus 
subtilis, and eukaryotic Saccharomyces cerevisiae.17  The best characterized, and one of 
the most biologically-active members of this family is the C12 benzyl channel hydraphile, 
compound 1, used for a further study into the development of antibiotic resistance in E. 
coli.  
 
Results and Discussion 
 
Antimicrobial activity of novel compounds 
Drawn from various research projects carried out in our group, a collection of 
known, membrane-active ion transporters and suspected transport agents was gathered and 
assayed for antimicrobial activity.   
Minimum inhibitory concentration (MIC) assays are performed in liquid culture 
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with bacteria grown over time in a liquid nutrient-rich growth media.  A set of cultures 
with varied concentrations of the compound of interest is grown in an incubator-shaker at 
37°C for 24 h.  Cultures with low enough concentrations of an antimicrobial compound 
show growth in the form of visual turbidity.  Cultures in the presence of high enough 
concentrations of an antimicrobial compound show no visual turbidity and thus no growth.  
The lowest concentration at which no growth is seen is the MIC.  More active 
antimicrobial agents would therefore have a lower MIC.  This method yields quick 
quantitative results that are sufficient for this broad-range study.  
For the sake of comparison, many common antimicrobial agents, such as penicillin 
and erythromycin, are active at concentrations less than 20 μM.19  Novel compounds that 
prove to be inactive in a bacterial species at concentrations of 100 μM or lower are deemed 
inactive and in most cases not worthy of further study in the use against the respective 
organism. 
The first set of compounds tested for antimicrobial activity was a subset of the 
previously mentioned hydraphile family of synthetic cation channels.  This subset was 
synthesized and chemically characterized by a collaborator, Wei Wang, and is unique in 
that they feature amide moieties at specific diazacrown-alkyl chain interfaces (outlined in 
Figure 5.2) rather than tertiary amines which are typical for the hydraphile family.  Due to 
the predicted variation of nitrogen basicity and molecular geometry in tertiary amides and 
tertiary amines, it was believed that pH could play a determining role in the cation 
transport effectiveness and antimicrobial activity of the hydraphile channels. 
Dr. Wang’s work with the compounds focused on the cation transport activity of 
the hydraphiles in phospholipid vesicles, while my portion of the project entailed 
characterizing variations in antimicrobial activity in E. coli at various pH conditions.   
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Under normal circumstances, the pH of the unadulterated growth media is around 7.0.  
When used for all microbiological tests, the pH of the media is maintained using HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), a common, biologically-inert buffer.  
For the more acidic growth cultures, malonic acid was added until a pH of 6.5 was 
indicated by a pH meter. 
 
Compound X = Y = Z =  MIC (μM) at pH 7 
MIC (μM) 
 at pH 6.5 
2 H2 H2 H2 4 1 
3 H2 H2 O >32 4 
4 H2 O H2 32 2 
5 O H2 H2 >32 16 
6 O O H2 >32 >32 
7 O H2 O >32 >32 
8 H2 O O >32 >32 
9 O O O >32 >32 
Figure 5.2 Amide hydraphile channels tested for microbial activity at pH 7 and 6.5.  
Compounds 3-9 containing amide moieties have a gray shaded box at the appropriate 
position, highlighting the presence of the carbonyl moiety. 
 
Hydraphiles 2-9 were dissolved in ethanol and serially-diluted in two-fold steps to 
yield a range of concentrations from 32 to 0.5 μM.  While ideally ranges up to 100 μM are 
desired, solubility issues prevented exploration of activity at these higher concentrations.  
Therefore, as seen in Figure 5.2, where an MIC is reported as >32, no activity is seen in the 
culture with the highest concentration of hydraphile present.  Note that this is distinct from 
a reported MIC of 32 μM (Compound 4 at pH 7). 
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A second set of compounds that were made and characterized by Wei Wang, called 
aplosspan or “simple span,” were found to elicit sodium transport and channel activity in 
biological membranes.  As with hydraphiles, these compounds, seen in Figure 5.3, were 
thought to be able to exhibit antimicrobial activity and were thus tested for this 
characteristic.  The limited solubility of these aplosspans in ethanol led to the use of 
dimethyl sulfoxide as a solvent.  As with ethanol, all assays using test compounds were 
compared to cultures grown in the presence of solvent alone.  The solutions were prepared 
to yield a high end 64 μM concentration in-culture, with dilutions down to 1 μM.  Limited 
solubility precluded the preparation of a 128 μM in-culture concentration for any of the 
compounds. 
 
Figure 5.3 Aplosspan molecules tested with antimicrobial activity in E. coli shown.  
 
Unfortunately, none of the aplosspans effected growth inhibition in E. coli.  To 
confirm the negative results, the experiment was repeated using compound 1 as a positive 
control, with the same conditions used in the assay.  Additionally, the optical density at 
600 nm (OD600, discussed in greater detail below) was measured for each of the cultures to 
ensure that no degree of growth inhibition occurred at the higher end of the concentration 
range.  If growth is present in a culture, any differences in the amount of growth are 
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indiscernible to the naked eye, so visible light spectroscopy is necessary to ensure that no 
antimicrobial activity is observed. With the exception of the first set of compounds (2-9), 
which includes the known internal positive control compound, 2, this confirmation 
procedure is used for all of the antimicrobial assays performed. 
While 10-12, like hydraphiles, have cation transport and channel functionality, the 
lack of antimicrobial activity can be attributed to the inherent solubility issues.  Unaided, 
the compounds may not be able to pass both of the bilayer membranes present in E. coli.  
If they are able to insert into both the cell wall and plasma membrane, they may not be 
present in concentrations significant enough to exhibit cation transport activity due to self-
aggregation in solution.   
A series of synthetic anion channels was investigated for their antimicrobial 
activity.  Heptapeptides 13 and 14, seen in Figure 5.4, are members of the well-
characterized class of compounds known as Synthetic Anion Transporter (SATs).  
Whereas compound 13 has established chloride transport ability and channel 
functionality,20 compound 14 is cationic.  Cationic peptides such as Polymyxin B21 and 
synthetic lipopeptides characterized by Shai et al.22 have shown antimicrobial activity due 
to membrane disruption and cell necrosis.  These compounds selectively target membranes 
that are rich in anionic phospholipids—a characteristic common to both Gram positive and 
Gram negative bacteria,23 as well as a number of fungi,24 but is atypical of mammalian 
cells. 
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Figure 5.4 Heptapeptide synthetic anion transporters (SATs) 13 and 14 investigated for 
antimicrobial activity in E. coli. 
 
As with the aplosspans discussed above, no antimicrobial activity is observed for 
compounds 13 and 14 in E. coli. The anion channel functionality of these compounds in 
biological model systems suggest that ion homeostasis can be disrupted in natural systems.  
Previous studies with airway epithelial cells confirm that they are, in fact, active in natural 
systems.25  However, the composition of bacterial membranes—particularly the higher 
proportion of anionic phospholipids—may preclude membrane activity in E. coli.  
Complexation with anionic phospholipid head-groups would presumably lower chloride 
transport rate.  Although membrane disruption, such as seen with the previously-mentioned 
Polymyxin B and lipopeptides, could occur, this does not appear to be the case, even with 
the cationic heptapeptide 14.  Finally, the heptapeptide sequence, unlike the 
antimicrobially-active hydraphile structure, is biotic in nature, and metabolism may occur 
in situ, effectively destroying the applied transporter molecule.  In an effort to circumvent 
this latter drawback in using the heptapeptide SATs, only abiotic synthetic compounds 
were tested for the remainder of the survey.  
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The next three compounds studied for antimicrobial activity are members of the 
pyrogallol[4]arene family of compounds detailed in Chapter 4—branched chain  2-propyl 
(15) and 3-pentyl (16), as well as straight chain 1-undecyl (17), which has been shown to 
exhibit channel functionality in asolectin black lipid membranes.26   These compounds, as 
seen in Figure 5.5, do not exhibit antimicrobial activity when applied as either ethanolic or 
DMSO solutions to inoculated growth cultures.  Compound 16 precipitates from ethanol at 
concentrations greater than 32 μM.  The same holds true for compounds 15 and 17 at a 
final concentration higher than 64 μM.  
 
Figure 5.5 Pyrogallol[4]arenes 15-17 tested for antimicrobial activity in E. coli. 
 
The potential for these compounds to act as antimicrobial agents seemed greater 
due to the known channel functionality of 17 and their abiotic structural motif.  However, 
the limited solubility of the compounds in aqueous solution, particularly of 3-pentyl 
compound 16, precluded membrane insertion rather than assisted in the process, as with 
the dipicolinic dianilides.  Chronologically, these studies were performed before those in 
Chapter 4, so the understanding of the aggregation of 16 was not yet complete.  In 
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retrospect, the strong intermolecular cogging interactions observed in the solid state, 
expanded in the nanoscale, would prevent any significant interaction with membranes. 
 
Compound Solvent MIC Compound Solvent MIC 
18 DMSO >16 μM 23 DMSO >128 μM 
19 DMSO >128 μM 24 DMSO >128 μM 
20 EtOH >128 μM 25 DMSO >128 μM 
21 DMSO >128 μM 26 DMSO >128 μM 
22 DMSO >128 μM 27 DMSO >128 μM 
Figure 5.6 Synthetic anion receptors 18-27 detailed previously in Chapters 2 and 3 and 
tested here for antimicrobial activity in E. coli. All of these compounds were applied to 
growing cultures of bacteria using dimethyl sulfoxide as solvent.  The solubility of these 
compounds varied, though all were inactive at the highest concentrations that could be 
tested. 
 
A final set of compounds tested for antimicrobial activity includes the anion 
receptors modeled, synthesized, and characterized in Chapters 2 and 3 of this work.  The 
anion-binding character of these compounds, seen in Figure 5.6, is similar to that of SATs 
13 and 14.  However, the abiotic composition of the compounds (excepting compound 20 
with two glycine residues) suggests that they may be resistant to microbial metabolism. 
 As the observations show, however, these anion receptors, like the heptapeptide 
SATs, elicit no antimicrobial activity.  As before, the anionic character of bacterial 
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membranes may impede anion transport and preclude disruption of ion homeostasis, 
lending no significant growth inhibition.    
 
Growth curves of S. epidermidis in the presence of ion transporters 
 
Figure 5.7 Synthetic anion receptors 23 and 24 detailed previously in Chapter 3 and 
cation transporter 28 shown previously to elicit antimicrobial activity in Gram positive 
bacteria.17 
 
N,N’-Didodecyl-4,13-diaza-18-crown-6, compound 28, has been shown to have 
antimicrobial activity against the Gram positive bacterium Bacillus subtilis.  Presumably, 
this activity results from the disruption of ion homeostasis due to transmembrane sodium 
transport that is observed in phospholipid vesicles.17 
With diaza-crown 28 being a known sodium transporter and 24 being a proven 
chloride transporter,27 co-application of the two species may produce synergistic or 
deleterious effects.  Compound 24 itself, as shown above, displays no antimicrobial 
activity in Gram negative E. coli, but this study tests its effects on Staphylococcus 
epidermidis, a Gram positive bacterium with significant differences in cell wall 
composition and architecture.  S. epidermidis is used as the target organism as it has not 
been previously assessed for antimicrobial activity in our research group.  Additionally, S. 
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epidermidis is in the same genus as Staphylococcus aureus, a microbe known for 
developing resistance to antibiotics.  Antibiotic-resistant S. aureus infects an estimated 
100,000 people, killing nearly 20,000 in the United States, annually.28   
With a co-application of an anion and cation transporter, three results can be 
expected: 
1. Transporters of both chloride and sodium working in tandem would elicit a 
synergistic effect that increases the antimicrobial activity of 28 alone.  This 
can be due to a more rapid disruption of ion homeostasis  
2. Transport of sodium and chloride in tandem elicits a deleterious effect 
wherein the antimicrobial activity of 28 is decreased.   
3. The presence of a chloride transporter would not have any impact in  
bacterial growth rates 
 
Whereas the third result would show that no activity is implicated in this particular 
biological system, either of the first two results would be a positive indication of activity in 
biological systems.  The lack of antimicrobial activity by 23 and 24 in the first section of 
this chapter  
To monitor the effects of the co-application of transporters, bacterial growth curves 
were measured using spectrophotometric means (OD600) over a 24 hour growth period with 
recordings made every 30 minutes.  While the minimum inhibitory concentration (MIC) 
and IC50 (or the concentration required for the inhibition of 50% of bacterial) can yield 
quantitative results, they are determined at only one given time point and give no sense of 
dynamic characteristics.  Growth curves measure the optical density of cultures at regular 
intervals—yielding an understanding of bacteriostatic activity that is present for a certain 
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time frame.  They can also give a better understanding of the interaction of two compounds 
in a bacterial culture as more data is recorded over the time frame, providing more than the 
“snapshot” afforded by antimicrobial assays. 29  
The MIC of 28  was determined using the methods outlined above, showing a lethal 
concentration of 16 μM.  The growth curves of the three compounds alone are shown in 
Figure 5.8 with 28 applied at a lethal concentration and 23 and 24 applied at 50 μM.  The 
growth curve of both 23 and 24 nearly overlap with the control, indicating that they elicit 
no antimicrobial activity when applied alone. 
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Figure 5.8 (Top) Growth curves of S. epidermidis grown with either 23, 24 and 28 
compared to the control. (Bottom) Growth curves of  28 grown at a lethal concentration 
(16 μM) and sub-lethal concentrations (2 and 4 μM) compared to the control. 
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Figure 5.9 (Top) Growth curves of S. epidermidis grown with 2 μM of 28 applied alone 
(dark boxes), with 50 μM of 23 (light down triangles) or with 50 μM of 24 (light up 
triangles) compared to the control. (Bottom) Growth curves with co-application using 4 
μM. 
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One important facet of this dynamic study is the length of lag time before the 
cultures began to undergo mitosis and proliferate.  The addition of stressors or beneficial 
compounds can alter these lag times as the bacteria “mature” more slowly or more rapidly, 
respectively.30 A summary of these results, focusing on the lag phase of the growth 
cultures are seen in Table 5.1. 
Anion 
Transporter 
Concentration 
(μM) 
Cation 
Transporter 
Concentration 
(μM) 
Lag Phase 
(hours) 
Final 
OD600 
None 0 None 0 3.0 >2.5 
23 50 None 0 3.0 >2.5 
24 50 None 0 3.0 >2.5 
None 0 28 16 19.0a 0.1 
None 0 28 4 19.0 1.0 
23 50 28 4 17.5 >2.5 
24 50 28 4 15.0 >2.5 
None 0 28 2 13.5 >2.5 
23 50 28 2 8.5 >2.5 
24 50 28 2 3.0 >2.5 
Table 5.1 Summary of the lag phase and final optical density after 24 hours of growth. A 
higher OD600 signifies more growth at a given time while a shorter lag phase signifies 
quicker growth.  aDeviation from the baseline occurs at this time, but exponential growth 
does not follow. 
 
The co-application with the synthetic anion transporter, p-nitro substituted 
dicipicolinic dianilide 24, with a cation transporter, C12 diazacrown 28, shows that a 
significant deleterious effect is imposed on the antimicrobial activity of the latter.  As 
shown in Figure 5.9, the growth curve of this culture nearly overlaps with the control 
culture, indicating that the antimicrobial activity of 28 is completely negated.  When 28 is 
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co-applied with the unsubstituted dianilide, 23, the lag phase of bacterial growth is roughly 
5 hours shorter indicating that while 23 does not efficiently transport chloride in 
phospholipid vesicles, and exhibits weaker chloride binding interactions, mitigation of the 
antimicrobial activity of 28 is still seen.  At the 4 μM concentration of 28, this mitigating 
effect is still seen, but the presence of 24 does not completely negate the activity of 28, and 
the difference in lag phase between co-application of 23 versus 24 is not as significant.   
 
Development of antimicrobial resistance in E. coli to hydraphile, 1  
The initial step in the antimicrobial resistance study was the confirmation of the 
previously determined minimum inhibitory concentration (MIC) of hydraphile, 1, when 
applied to E. coli.  Four iterations of the assay yielded an average MIC of 10 μM—a value 
that agrees with the established value of 9.4 μM.31  The superficial difference arises from 
the fact that the previous studies produced dilution series by a mass to volume ratio, 
whereas the current study factored in the molecular weight of the compound, resulting in 
exact micromolar values. 
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 From this initial MIC determination, a sub-MIC (i.e. “sub-lethal”) concentration of 
8 μM (4/5 of the MIC) of 1, in ethanolic solution, as well as an ethanol blank, is applied to 
stock E. coli in successive 24 hour growth periods, transferring a portion of the last growth 
culture into fresh growth media, complete with the given concentration of 1.  The non-
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transferred portion of each growth culture is then frozen and preserved for later assays.  
This process is repeated in this study eleven additional times to yield 288 hours of growth 
and 12 testable samples for both the control and sub-lethal application of 1. 
 The development of antibiotic resistance in the test organism is gauged using two 
methods, the minimum inhibitory concentration assay32 and the spectrophotometric assay 
of growth,33 both outlined previously.  The former is a quick and easy estimation of 
antibiotic activity, while the latter can yield more sensitive results by compiling and using 
data from growth at all concentrations of antibiotic.  The data garnered from 
spectrophotometric assays can be mathematically fit to a sigmoidal curve on a logarithmic 
concentration scale to determine the IC50, or the concentration required for 50% inhibition 
through interpolation.1 
The studies detailed below have determined the MIC and IC50 for E. coli cultures 
grown at both 8 μM and at 0 μM (blank) for up to 288 hours at each 24 hour interval, with 
each assay performed in at least three and up to five replications at each relevant 
concentration. For each iteration of spectrophotometric assays, results were normalized in 
the following fashion: (1) The absorbance values for all spectrophotometric readings were 
first adjusted by subtracting out the blank absorbance value—the optical density of 
uninoculated culture in the presence of only ethanol (which is normalized to 0% survival).  
(2) These results were then normalized by dividing by the adjusted optical density of 
inoculated culture with only ethanol added (which is normalized to 100% survival) to yield 
a percentage value.  These adjusted, normalized, and averaged values were plotted against 
their concentrations on a logarithmic scale.  A sigmoidal curve was fit to the data, and the 
concentration at which 50% inhibition of growth results can be interpolated from the 
resulting equation as shown in Figure 5.10. 
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Figure 5.10 Sigmoidal curve fit of the percent growth readings for the original stock 
culture.  The results for all replications are shown.  A 50% survival (50% inhibition) line 
is added to show the interpolative determination of the IC50 value from the curve.  A 
second dashed line intersecting the 50% growth line is added to show the approximate 
IC50 concentration. The actual value is derived from the calculated equation. 
 
Figure 5.11 Sigmoidal curve fit of the percent growth readings for the culture grown 
continuously for 144 hrs in 8 μM of 1 and 1% ethanol (Test, down triangles) and with 1% 
ethanol only (Control, open boxes).  The results for all replications are shown.  Vertical 
dashed lines show the concentration differences in the IC50 values of the test and control. 
The effective concentration of 1 at this time recording is the difference between the two 
concentrations. 
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 MIC IC50 
Hours Control Test Difference Control Test Difference 
0 10.0 10.0 0.0 3.2 3.2 0.0 
24 12.0 13.0 1.0 5.0 5.9 0.9 
48 14.0 20.0 6.0 7.2 10.5 3.3 
72 15.2 22.4 7.2 8.8 12.1 3.3 
96 16.0 24.0 8.0 8.7 13.3 4.6 
120 18.7 26.7 8.0 9.5 14.7 5.1 
144 17.6 27.2 9.6 9.4 16.0 6.6 
168 17.3 26.7 9.3 8.9 16.6 7.7 
192 16.0 24.0 8.0 9.9 16.2 6.3 
216 17.6 27.2 9.6 10.5 17.4 6.9 
240 18.7 26.7 8.0 10.7 15.9 5.3 
264 16.0 26.7 10.7 9.8 17.9 8.1 
288 17.6 27.2 9.6 9.3 16.2 7.0 
Table 5.2 Average MICs of at least three independent trials for both control and test 
cultures.  IC50 values are interpolated from a curve fit to the normalized growth 
percentages of the same trials used for determining MIC values. 
 
   These same methods and mathematical relationships can be applied to the other 
samples taken from each culture.  This has been done with cultures grown for every 24 h 
interval up to 288 h.  These results can all be compared to the original results from the 
stock culture of E. coli, and a time-dependent trend can be established. To describe this 
trend, the effects of the hydraphile alone must be differentiated from the effects of adding 
ethanol to the growing cultures.  Thus, the activity values of the blank samples are 
subtracted from the activity values of the test growth cultures to yield the effect of the 
presence of hydraphile at the given concentration.  MIC values can be subtracted from one 
another to yield these results, and the differences in the interpolated values from the IC50 
curves can be used for the effective activity.  An example of this is shown in Figure 5.11 
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with dashed lines showing where on the concentration coordinate the IC50 value for the test 
and control cultures fall. The tests, blanks, and final results for both methods are 
summarized in Table 5.2, IC50 curves fit to normalized measurements can be seen in 
Appendix A and the final results are graphically represented in Figure 5.12. 
The results show that while the concentration required to effect antimicrobial 
activity increases with constant exposure to hydraphile, some portion of this increase can 
be attributed to growth in the presence of 1% ethanol.  After about 6 days, or 144 hours of 
growth, this change in effective concentration plateaus, for both the test and control 
cultures. 
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Figure 5.12 (Top) Change in the measured MIC (left) and IC50 (right) over time for 
cultures grown in the presence of hydraphile 1 and 1% ethanol (triangles, “sub lethal”) 
and 1% ethanol only (squares, “control”).  MIC error bars represent the range of 
replicates recorded, IC50 error bars represent the standard deviation from the curve fit to 
the data points at each time point. (Bottom) Difference in effective concentrations of the 
MIC (open circles) and IC50 (open diamonds) between the control and test.  
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Conclusions 
The investigation of activity in biological systems is an overarching goal of 
chemical biologists.  The ability of a synthetic transmembrane ion transporting agent to 
elicit antimicrobial activity is just one example of how this goal can be realized.  As 
demonstrated by these investigations, not all ion transport agents effect antimicrobial 
activity.  Compounds that exhibit ion transport activity in biological model systems, such 
as phospholipid vesicles and phospholipid planar bilayer membranes, are, by definition, 
membrane active.  However, due to the heterogeneous character of natural systems with 
membrane proteins and sugars, a wider variety of phospholipids,34 efflux proteins that 
actively pump toxic substances out of the cell,35 and (in the case of E. coli and other Gram 
negative organisms) a second bilayer membrane forming the bacterial cell wall, 
complications can certainly arise.  The fact that any of these compounds exhibit membrane 
activity at all is surprising, given the complexity of these systems and their defenses. 
While previous work has established that cation channels, as well as cation carriers, 
can effect antimicrobial activity, the compounds surveyed in the present study show that 
neither anion channels nor anion carriers can reproduce the effect.   Conceivably, the 
disruption of the balance of anions within a target system would impair growth or cause 
apoptosis.  However, the anionic nature of bacterial membranes can impede the ability of 
anion carriers and channels to effect their intended chloride transport purpose in bacteria. 
The co-application with the synthetic anion transporter, p-nitro substituted 
dicipicolinic dianiline 24 with a cation transporter, C12 diazacrown 28, shows that the 
antimicrobial activity of the latter is completely negated when applied at 2 μM.  As shown 
in Chapter 3, the unsubstituted dianilide, 23, does not bind chloride as strongly or transport 
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chloride as efficiently in phospholipid vesicles, but the antimicrobial activity of 28 is 
likewise mitigated in the presence of 23, albeit to a lesser extent.  The simultaneous 
transport of chloride and sodium by each species is implicated in the negation of the 
antimicrobial activity of 28.  Presumably, the disruption of the sodium gradient by 28 is 
eliminated as an environmental stressor by the presence of 24 as a chloride transporter or 
as a transport blocker, interacting directly with 28. 
Finally, these studies show that E. coli evolve resistance to C12 benzyl channel, 
compound 1, over extended periods of constant exposure to a sub-lethal concentration, but 
the development of resistance does not continue to develop after an initial time period.  
Using either the MIC or IC50 as a gauge, E. coli has developed only a two-fold resistance to 
compound 1 over 288 h.  The assays also show that resistance develops continuously until 
about 144 h, or 6 days of growth, and then begin to plateau.  This characteristic is 
promising as the individuals that are resistant to the effects of the antibiotic are not being 
selected for, and application of a high enough concentration of hydraphile 1 continues to 
elicit bactericidal function even after a continuous application of high, but sub-lethal, 
concentrations of the drug.   
The sensitivity of the MIC assays used in the original antimicrobial studies is 
improved by utilizing intercalated two-fold dilutions. The IC50 spectrophotometric assays 
show a level of sensitivity that is not reached with the stepped threshold levels seen in the 
MIC assays and better precision is more readily attained. 
These spectrophotometric assay methods can be applied to both standard antibiotics 
or other hydraphiles for a relevant comparison.  If C12 benzyl channel performs better over 
continued sub-MIC exposure times than standard antibiotics, then there may be some 
176 
advantage that the compound and related structures possess that circumvent the downfalls 
of other antibiotics. 
 
Experimental 
 
General 
All UV-Vis absorbance spectra were recorded on a Beckman Coulter DU 7400 
Spectrophotometer.  All microbiological assays are performed using sterile technique.  All 
equipment and growth media solutions are autoclaved to 121°C with sterilizing conditions 
confirmed by autoclave tape.  Equipment that is prepackaged as sterile is not similarly 
sterilized and assumed usable as delivered.   All transfers are performed with sterile 
equipment that is flamed (passed over a Bunsen burner a number of times in rapid 
succession) before and after transfers, and all unique transfers use a new micropipette tip.  
Before each liquid transfer or inoculation, the liquid is vortexed for at least 3 seconds to 
ensure proper mixing and even distribution of nutrients, agents, and/or bacteria.  To ensure 
accuracy and reproducibility, all assays are replicated from 3 to 5 times at each relevant 
concentration. 
The study tests the viability of Escherichia coli DH5α cells with a plasmid 
expressing ampicillin resistance.  Unless otherwise noted, all inoculations are of the 
standard inoculum size of 5 x 10 5 CFU ml-1.  This is measured as an approximate optical 
density of 0.5 at 600nm compared to growth media blank.  Cultures grown from frozen 
stock are thus grown to an optical density of between 0.45 and 0.55.   
The growth media used in all experiments is LB Miller broth, which contains 10g 
L-1 casein peptone, 10 g L-1 sodium chloride, and 5 g L-1 yeast extract.  The growth media 
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is made selective for ampicillin resistance by the addition of 50μM ampicillin, and is pH 
balanced at 7.0 by 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
buffer. 
 
Compounds Studied 
 
Compound 1 
This compound was synthesized by Dr. Wei Wang and was used as received.  Synthetic 
details are reported in the literature. 36 
Compounds 2-9 
These compounds were synthesized by Dr. Wei Wang and were used as received.  
Synthetic details are reported in the literature.2 
Compounds 10-11 
These compounds were synthesized by Dr. Wei Wang and were used as received.  
Synthetic details are reported.37 
Compound 12 
This compound was synthesized by Dr. Wei Wang and was used as received.  Synthetic 
details are reported in the literature.38 
Compound 13 
This compound was synthesized by Dr. Lei You and was used as received.  Synthetic 
details are reported in the literature.39 
Compound 14 
This compound was synthesized by Dr. Lei You and was used as received.  Synthetic 
details are reported in the literature.40 
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Compounds 15-17 
These compounds were synthesized by Dr. Oleg Kulikov and were used as received.  
Synthetic details are reported in the literature.41 
Compounds 18-17 
These compounds were synthesized by me, as detailed in Chapter 2 of this work. 
Compounds 23-27 
These compounds were synthesized by me, as detailed in Chapter 3 of this work. 
Compound 28 
This compound was synthesized by Dr. Wei Wang and was used as received.  Synthetic 
details are reported in the literature. 42 
 
Serial Dilutions 
The compound of interest is dissolved in either ethanol or DMSO at a concentration 
one hundred times the desired in-culture concentration.  A volume of 20 μL is added to 
each culture, which in total has a volume of 2000μL.  Two-fold serial dilutions of the test 
antibiotic are established using either the macrobroth dilution method or the stock solution 
dilution method.  The latter entails diluting the stock solution down a series of solutions 
containing the solvent used for the antibiotic. These pre-diluted solutions are then each 
added to the series of growth media. The macrobroth method involves the same dilution 
aspect, but is performed with pre-inoculated liquid media in each culture tube.   Two 
different series of dilutions can be used to establish two series of intercalated 
concentrations.  In most experimental replications, the macrobroth dilution method is used 
to create two intercalated series for testing, though for at least one replication of each assay 
the stock solution dilution method is used to validate both the macrobroth method and 
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statistical distribution.  The standard dilution concentrations for the intercalated series are 2 
μM and its two-fold multiples (128, 64, 32, 16, 8, 4, 2, 1, 0.5) and 3 μM and its two-fold 
multiples (96, 48, 24, 12, 6, 3, 1.5, 0.75). 
 
Minimum Inhibitory Concentration 
The minimum inhibitory concentration (MIC) is determined using a modification 
of the methods outlined by the NCCLS.32  The modification entails using two intercalated 
series of serial two-fold dilutions of a given antibiotic instead of the standard single series.  
The use of intercalated series is expected to yield more sensitive results.  The MIC is 
determined by inoculating each test tube in the series with a standard inoculum size and 
growing at 37°C, while agitating at 200 rpm for 16 hours.  The MIC is determined by a 
visual inspection of turbidity. An antibiotic concentration at which the resulting solution is 
cloudy (turbid) is one in which growth has not been inhibited.  A concentration at which 
the resulting solution is transparent is a concentration at which growth is inhibited.   The 
lowest concentration at which this latter scenario is true is thus determined as the MIC.  If 
growth is present at the highest concentration at both series, the MIC is listed as higher 
than that concentration and, for all intents and purposes, the compound is inactive. 
 
 
Spectrophotometric Assays 
Using the same dilution and growth procedures as used for MICs (the same grown 
cultures can be used, as well), the optical density (absorbance) at 600nm is measured for 
each dilution using a UV/Vis spectrophotometer.  All readings are compared to a blank 
consisting of uninoculated growth media with the test compound present. 
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The spectrophotometric data were normalized by subtracting the absorbance of 
uninoculated culture and 1% ethanol as the blank for all values before dividing by the 
blank-adjusted absorbance of an inoculated culture grown with 1% ethanol to yield the 
adjusted and normalized growth percentages.  Using the graphing software GraphPad, data 
points from all of the replications were plotted against the logarithmic concentration of 1 
and, using non-linear regression analysis with equation 1, fit to a variable-slope sigmoidal 
dose-response curve as previously described.1 
 (eq.1) 
 Values are fit to equation 1 where “Y” equals the percentage of growth, “X” equals 
log[hydraphile] of each dilution, “Top” is the maximal growth (100%), normalized to the 
results of the ethanol blank and “Bottom” is the minimum growth (or 0%).  The resulting 
value, “LogEC50,” is converted to a micromolar concentration for reporting in Table 5.3 
and Figure 5.12. 
 
Continuous Growth 
E. coli from stock culture is used to inoculate two growth cultures—one containing 
a sub-MIC concentration (8 μM) of C12 benzyl channel hydraphile, 1, in ethanol and one 
containing a blank with only ethanol added (1% present in culture).  Each culture, with 
compound solution and inoculum added, has a volume of 2mL.  This first generation is 
incubated for 24h at 37°C while agitating at 200 rpm.   
After one 24h cycle, an 100 μL inoculum (5% of volume) is transferred from the 
first generation culture to fresh growth media with the appropriate amount of compound 
present.  The concentrations for growth after the first cultures are adjusted to be additive 
with compound already present in previous growth that is transferred over with the 
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inoculum so that a constant 8 μM is present.  This second set of growth cultures is again 
incubated for 24 h at 37°C while agitating at 200 rpm, and the process is repeated for a 
total of twelve sets of growth cultures.    
Meanwhile, the remnants of these growth cultures (1900 μL) are frozen to –80°C 
using glycerol added to yield 15% volume as a cryoprotectant.  A portion of these frozen 
cultures are revived at a later date by adding 50 μL of thawed culture to fresh growth 
media. These are grown out to mid-logarithmic phase (OD600 = 0.5) and used to inoculate 
cultures grown for the MIC and IC50 studies, using a different thawed culture for each 
replication. 
 
Growth Curves 
The methodology for this investigation uses a modified procedure from an earlier 
study comparing antibiotics and investigating synergistic effects.29  Using regular (non-
selective) growth media without ampicillin, S. epidermidis was grown from stock culture 
to mid-logarithmic phase, and is subsequently used to inoculate ten growth cultures.  Three 
cultures were grown containing only diaza-crown 28 at three concentrations: 16 μM, 4 μM 
and 2 μM—the first being the pre-determined MIC of 16 μM in S. epidermidis and the 
latter two below the MIC.   Two cultures were grown containing either dipicolinic 
dianilide 23 or 24 alone, each at 50 μM.  Six cultures were grown containing a 
combination of 23 or 24 (at 50 μM) and diaza-crown 28 at the three tested concentrations.  
For cultures with only one type of transporter present, the solvent used for the other 
transporter type is thus added to eliminate experimental differences.  Finally, a control 
culture was grown with no compounds present in 0.5% DMSO and 0.5% ethanol. 
Each culture was measured for growth by the optical density at 600 nm assay 
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method. Absorbance readings above 2.5 approach higher deviation from linearity and can 
be thought of as “full growth” for this purpose.   
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